OMNOVA Solutions Inc. Annual Report 2018

← All annual reports

FY2018 Annual Report · OMNOVA Solutions Inc.

Loading PDF…

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the year ended November 30, 2018

Commission File Number 1-15147

OMNOVA Solutions Inc.

(Exact name of registrant as specified in its charter)

Ohio

(State of Incorporation)

25435 Harvard Road, Beachwood, Ohio

(Address of principal executive offices)

34-1897652
(I.R.S. Employer Identification No.)

44122-6201
(Zip Code)

Securities registered pursuant to Section 12(b) of the Act:

Registrant’s telephone number, including area code (216) 682-7000

Title of each class

Common Stock, par value 10¢ per share

Name of each exchange
on which registered

The New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities

Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days. Yes

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be

contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-
K or any amendment to this Form 10-K.

Indicate by check mark whether the registrant has submitted electronically every interactive data file required to be submitted pursuant to
Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required
to submit such files.) Yes

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of

“accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act (check one):

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth
company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12-b of the Exchange Act) Yes

The aggregate market value of the voting stock held by nonaffiliates of the registrant was $442,729,184 based on the closing price per

share of $10.20 on May 31, 2018, the last business day of the registrant’s most recently completed second quarter.

As of January 22, 2019, there were 44,846,069 outstanding Common Shares of the Company’s $0.10 par value.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the 2019 Proxy Statement of OMNOVA Solutions Inc. are incorporated into Part III of this Report.

OMNOVA SOLUTIONS INC.

Annual Report on Form 10-K
For the Year Ended November 30, 2018

Table of Contents

Item
Number

PART I

PART II

PART III

PART IV

Business

Risk Factors

Unresolved Staff Comments

Properties

Legal Proceedings

Mine Safety Disclosures

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity
Securities

Selected Financial Data

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Quantitative and Qualitative Disclosures About Market Risk

Consolidated Financial Statements and Supplementary Data

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Controls and Procedures

Other Information

Directors and Executive Officers of the Registrant

Executive Compensation

Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

Certain Relationships and Related Transactions, Director Independence

Principal Accountant Fees and Services

Exhibits and Financial Statement Schedules

Signatures

Item 1.

Business

Introduction

PART I

OMNOVA Solutions Inc. (referred to in this report as "OMNOVA Solutions", "OMNOVA", the "Company", "we", "us", or "our") became an

independent, publicly-traded company on October 1, 1999, when it was spun off by GenCorp Inc., its former parent company. OMNOVA
Solutions is incorporated under the laws of the State of Ohio, and its headquarters is located at 25435 Harvard Road, Beachwood, Ohio
44122-6201.

OMNOVA Solutions is a global innovator of performance enhancing chemistries and surfaces for a variety of commercial, industrial and
residential end uses. Our products provide a variety of important functional and aesthetic benefits to hundreds of products that people use daily.
We hold leading positions in key market categories, which have been built through innovative products, customized product solutions, strong
technical expertise, well-established distribution channels, recognized brands, and long-standing customer relationships. We have strategically
located manufacturing, technical and other facilities globally to service our broad customer base.

During fiscal 2018, OMNOVA operated two business segments: Specialty Solutions and Performance Materials. We derived 63% of our
2018 net sales from the Specialty Solutions segment and 37% from the Performance Materials segment. Financial information relating to the
Company’s business segments is included in Note O to the Consolidated Financial Statements of this report.

Specialty Solutions

Markets and Products

The Specialty Solutions segment consists of three business lines: Specialty Coatings & Ingredients, Oil & Gas, and Laminates & Films. The

Specialty Solutions segment develops, designs, produces, and markets a broad line of specialty products for use in coatings, adhesives,
sealants, elastomers, laminates, films, nonwovens, and oil & gas products. These products are used in numerous applications, including
architectural and industrial coatings; nonwovens used in hygiene products, filtration and construction; drilling additives for oil and gas drilling,
cementing and fracking; elastomeric modification of plastic casings and hoses used in household and industrial products and automobiles; tapes
and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets; flooring; ceiling tile;
furnishings; manufactured housing; health care patient and common area furniture; and a variety of industrial films applications. The segment's
products improve the performance of customers’ products, including stain, rust and aging resistance; surface modification; gloss; softness or
hardness; dimensional stability; high heat and pressure tolerance; and binding and barrier (e.g. moisture, oil) properties.

The following table shows major Specialty Solutions products, end-use applications, and brand names:

Product Line

Specialty Coatings &
Ingredients

% of Specialty
Solutions Fiscal
2018 Net Sales

51%

Oil & Gas

Laminates & Films

15%

34%

Primary Products

End-use Applications

Brand Names

SB, SBA, acrylic,
vinyl acrylic, styrene
acrylic and polyvinyl
acetate emulsion
polymers, glyoxal
resins, elastomeric
modifiers, silicone
emulsions,
polyethylene resins,
fluorosurfactants and
opacifiers

Nonwovens, Textiles,
Graphic Arts,
Automotive
Thermoplastics,
Specialty Coatings,
Buildings &
Construction, Home &
Personal Care

OMNABOND, SUNSIZE,
GENFLO, GENCRYL,
OMNAPEL, SEQUABOND,
SUNCRYL, ACRYGEN,
SUNBOND, SEDGERES,
SEDGELEV, SEQUACLEAN,
SEQUASOFT, SEDGELCLEAN,
SEDGEDYE, SEDGEFIX,
SEDGEGARD, SEDGEKIL,
SEDGELUB, SEDGEMUL,
SEDGESCOUR, SEDGESOFT,
SUNKOTE, MYKON,
PERMAFRESH, SEQUAPEL, X-
CAPE, MYKOSOFT,
MYKOWICK, NOVACRYL,
SECOAT, SECRYL,
SEQUABOND, CDP,
GENGLAZE, STYLECOAT,
OMNAGLO, MORGLO, RWL,
ML, MORFLO, MORSHINE,
CONREZ, NM, NH, GENCEAL,
HYDROPLIOLITE, PLIOLITE,
PLIOWAY, PLIOTEC, GENCEAL,
POLYFOX, SUNIGUM,
CHEMIGUM, LYTRON

Drilling fluid additives
& systems,
stimulation additives,
and cement additives

Fluid loss control and
sealing, emulsifiers,
lubricants, and
rheological modifiers
for drilling fluids

PEXOSTART, PEXOSEAL,
PEXOTROL, PEXOPLUG,
PEXOMUL, PEXOVIS,
PEXOTHIN, PEXOGUARD,
PEXOLUBE

RADIANCE,
SURF(X), DESIGN4, EFX,
DURAMAX, HARMONY,
VIEWNIQUE

Vinyl, paper, and
specialty laminates;
performance films

Decorative and
protective surfacing for
retail display and food
service fixtures,
kitchen and bath
cabinets,
manufactured housing
and recreational
vehicle interiors,
flooring, commercial
and residential
furniture, home
furnishings and
consumer appliances,
wall panel systems,
decorative wall
surfacing; industrial
films for banners,
tents, ceiling tiles,
decking, health care
furniture, and bath and
spa surrounds

Specialty Coatings & Ingredients. OMNOVA Specialty Coatings & Ingredients is a leading global supplier of polymers, waterborne and
solvent borne dispersions, elastomers, and other specialty chemicals for a variety of product categories. Applications for our specialty polymers
and chemicals include: specialty coatings; nonwovens (such as disposable hygiene products, engine filters, roofing mat, scrub pads);
construction; adhesives; tape; floor care; textiles; graphic arts; home & personal care; and various other specialty applications. Our focus is on
developing unique products for custom applications that address specific customer needs, including enhanced functionality, improved durability,
high temperature, chemical and UV resistance, corrosion resistance, improved environmental performance, and improved processibility. Sales of
our Specialty Coatings & Ingredients products represented 33% of our consolidated net sales for 2018, 29% for 2017, and 29% for 2016.

Oil & Gas. OMNOVA's Oil & Gas is a leading supplier of specialty wellbore chemicals used in demanding applications all over the world. We

offer a wide range of solutions including fluid loss control and sealing, emulsifiers, lubricants, and rheological modifiers for drilling fluids. The
business also offers flow control and properties enhancement in cementing operations, gel additives for hydraulic fracturing fluids, and
strengthening agents. We design unique polymers that meet conventional and unconventional drilling and completion requirements. Sales of our
Oil & Gas products represented 9% of our consolidated net sales for 2018, 7% for 2017, and 6% for 2016.

Laminates & Films. OMNOVA's Laminates & Films business line is a leading supplier of vinyl, paper, and specialty laminates, and
performance films. Our laminates are used as alternatives to wood, paint, stone, stainless steel, high pressure laminates, and thermally fused
laminates in markets where durability, design, and cost are key requirements. We offer our customers a broad range of designs and textures, as
well as proprietary coating technology that provides enhanced durability and scratch and stain resistance. Applications for our laminates include:

kitchen and bath cabinets; manufactured housing and recreational vehicle interiors; flooring; commercial and residential furniture; retail display
fixtures; home furnishings; consumer appliances; bath and spa surrounds; food service tables; wall protection; and architectural accents. Films
applications include: luxury vinyl tile (LVT); awnings; tents; flooring; promotional graphics; medical products; movie screens; decking; ceiling tile;
and shower pan liners. Sales of our Laminates and Films products represented 21% of our consolidated net sales for 2018, 20% for 2017, and
18% for 2016.

A key strength of our laminates business is our coating technology, including ultraviolet, melamine, urethane, and thermally cured coatings,

which provide greater durability for high-wear applications. In addition, our laminates business has differentiated itself in the market as a single-
source supplier through its harmony programTM of integrated vinyl and paper laminate designs for the furniture and cabinet industries by building
a unique library of matched vinyl and paper laminate designs, with a variety of patterns and textures, and developing rapid make-to-order
production capabilities. We also offer SURF(X)® 3D Laminates for multi-dimensional applications for the office and health care furniture and
retail display fixture and food service markets. These laminates offer a cost effective alternative to high pressure laminates, thermally fused
melamine and real wood veneers. They provide furniture makers with design flexibility in rounded surfaces, eliminating the need for unsightly
and expensive edge-banding, and providing enhanced cleanability/disinfection and durability with increased chip and crack resistance.

Markets and Customers

The Specialty Solutions segment includes many product categories that are performance driven, where product innovation, technical
service, application support, and key account focus are key competitive differentiators. Each product line markets its products to different
industries under numerous brand names.

Marketing and Distribution

Our Specialty Solutions segment primarily sells its products directly to manufacturers through dedicated internal marketing, sales, and
technical service teams focused on providing highly responsive customized solutions. Distributors are used to help expand sales coverage
geographically and with newer customers.

Competition

OMNOVA’s Specialty Coatings & Ingredients business line retains strong, industry recognized brands in antioxidants, specialty coatings,
and elastomeric modifiers. OMNOVA's Laminates & Films business lines compete with numerous companies, including international companies.
Many of these companies focus on only one product line and/or market and are smaller and privately-owned. Competitors include:

• Specialty Coatings & Ingredients: Pulcra Chemicals, Schill + Seilacher, Goulston, DowDupont, BASF, Engineered Polymer Solutions,

Evonik, Arkema, Arlanxeo, Paratech, Nitriflex

• Oil & Gas: American Gilsonite, BASF, Ashland, Drilling Specialties Company

• Laminates & Films: Wilsonart, Toppan Printing, Renolit Corporation, LG Chemical America, PolyOne Corporation, and I2M

Performance Materials

Markets and Products

The Performance Materials segment serves mature markets including plastics, paper, carpet and coated fabrics with a broad range of

polymers based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, high styrene
pigments, polyvinyl acetate, acrylic, styrene acrylic, calcium stearate, glyoxal, and bio-based chemistries. Performance Materials' custom-
formulated products are tailored latexes, resins, binders, antioxidants, hollow plastic pigment, coated fabrics, and rubber reinforcing which are
used in tire cord, polymer stabilization, industrial rubbers, carpet, paper, and various other applications. Its products provide a variety of
functional properties to enhance the Company’s customers’ products, including greater strength, adhesion, dimensional stability, ultraviolet
resistance, improved processibility, and enhanced appearance.

SUNREZ, OMNAREZ,
SUNKOTE,
SEQUALFLOW,
SUNKEM, GENCRYL,
ECOKOTE, ACCUKOTE,
LYTRON,
REACTOPAQUE,
GENFLO, GENCRYL PT,
OMNAGLIDE,
SEQUAREZ, OMNATUF,
OMNABLOC, GENCAL,
NOVAGREEN,
UNIQPRINT

GENTAC, WINGSTAY,
PLIOLITE. PLIOCORD,

BOLTAFLEX,
BOLTASOFT, QUANTUM,
NAUTOLEX, PREFIXX

The following table shows our Performance Materials products, end-use applications and brand names:

Product Line

Paper and Carpet

% of Performance
Materials Fiscal
2018 Net Sales

40%

Primary Products

End-use Applications

Brand Names

SB SBA styrene acrylic
and vinyl acetate latex
binders crosslinkers,
lubricants hollow plastic
pigments, and bio-based
polymers

Paper, Paperboard,
Packaging, Carpet

Performance
Additives

Coated Fabrics

44%

16%

Styrene butadiene vinyl
pyridine, antioxidants,
reinforcing resins,
phenolic antioxidants

Vinyl and urethane coated
fabrics

Tire Cord, Plastics, Synthetic
Latex Gloves, and Rubber
Products

Upholstery and surfacing for
transportation, marine, offices,
hotels, hospitals and health
care facilities, stores, schools,
restaurants, public buildings,
residences, and industrial
applications

Paper and Carpet. OMNOVA Solutions is an innovative supplier of custom-formulated SB and SBA latex and hollow plastic pigments for

carpet, paper and paperboard coatings. Applications for our products include paper and paperboard coatings used in specialty papers, food
cartons, household and other consumer and industrial packaging, magazines, catalogs, direct mail advertising, and brochures. Our products for
the carpet industry secure carpet fibers to the carpet backing and adhere the primary backing to the secondary backing, while meeting the
stringent manufacturing, environmental, odor, flammability, and flexible installation requirements of our customers. Our strong historical position
in residential carpeting has been enhanced by new products to serve that market, as well as innovations in commercial carpet backing binders
that provide moisture barrier and other properties, enabling the replacement of higher cost polyurethane binders. Sales of our Paper and Carpet
products represented 15% of our consolidated net sales for 2018, 24% for 2017, and 23% for 2016.

Performance Additives. OMNOVA is also a leading global supplier of vinyl pyridine latex which is used in bonding fabric to rubber for tire
and belting applications. In addition, the Company is a leading global supplier of antioxidants used in polymer stabilization and synthetic latex
gloves. Sales of our Performance Additives products represented 16% of our consolidated net sales for 2018, 13% for 2017, and 14% for 2016.

Coated Fabrics. OMNOVA Solutions is a leading North American and Asian supplier of vinyl and urethane coated fabrics for transportation,
marine, commercial, residential, and health care applications. Our durable coated fabrics are well-suited for demanding, high-use environments
and offer a cost effective alternative to other surfacing materials, such as leather and textile fabrics. Applications for our coated fabrics include:
transportation seating (automotive OEM, bus and other mass transit, marine, and motorcycle); automotive aftermarket applications; contract and
health care furniture; residential applications; stadium and arena seating; and healthcare equipment. A key differentiator for our coated fabrics
products is our PreFixx® protective coating, long recognized for delivering the industry's best-in-class performance. Sales of our Coated Fabrics
products represented 6% of our consolidated net sales for 2018, 7% for 2017, and 10% for 2016.

Markets and Customers

Our Performance Materials segment is a leader in its targeted product categories, which are highly competitive based on quality, customer

service, product performance, supply chain, field technical support, and product innovations.

Marketing and Distribution

Our Performance Materials segment primarily sells their products directly to manufacturers through dedicated internal marketing, sales, and

technical service teams focused on providing highly responsive customized solutions. Distributors are used to help expand sales coverage
geographically and with newer customers.

Our Performance Materials segment distributes its products primarily through a direct sales force and agents to manufacturers of retail
store fixtures, cabinets, furniture, seating, and health care components, and other products. Many of our Coated Fabrics products have strong,
well-recognized brand names that are promoted through trade shows, industry periodicals, our website (www.omnova.com), and other media.

Competition

OMNOVA’s Performance Materials segment competes with numerous companies, including international companies. Many of these

companies focus on only one product line and/or market and are smaller and privately-owned.

Competitors include:

• Paper and Carpet: BASF, Trinseo, Mallard Creek, Eco Synthetix

• Performance Additives: Feiya, Addivant, Raschig, Synthomer, Jubilant, Croslene

• Coated Fabrics: Morbern, Beneke, Uniroyal, Spradling International, CGT

International Operations

Net sales from our foreign operations were $320.2 million in 2018, $301.4 million in 2017, and $305.9 million in 2016. These net sales
represented 41.6% of our total net sales in 2018, 38.5% in 2017, and 40.3% in 2016. Long-lived assets primarily consist of net property, plant,
and equipment. Long-lived assets of our foreign operations totaled $90.1 million at November 30, 2018, $84.2 million at November 30, 2017, and
$77.4 million at November 30, 2016. Our consolidated long-lived assets totaled $205.8 million at November 30, 2018, $208.9 million at
November 30, 2017, and $202.7 million at November 30, 2016.

Intellectual Property

We regard patents, trademarks, copyrights, and other intellectual property as important to our success, and we rely on them globally to

protect our investments in products and technology. Our patents expire at various times, but we believe that the loss or expiration of any
individual patent would not materially affect our business. We, like other companies in the industries in which we operate, may be subject to
claims of alleged infringement of the patents, trademarks, and other intellectual property rights of third parties from time to time.

Seasonal Factors

We historically experience stronger sales and income in our second, third, and fourth quarters, comprised of the three-month periods
ending May 31, August 31, and November 30. Our performance in the first quarter (December through February) has historically been affected
by generally lower levels of customer manufacturing, construction, and refurbishment activities during the holidays and cold weather months.

Environmental Matters

Our business operations are subject to numerous federal, state, local, and foreign environmental laws and regulations. These laws and
regulations not only affect our current operations, but also could impose liability on us for past operations that were conducted in compliance with
then applicable laws and regulations. For further discussion of capital and noncapital expenditures for environmental compliance, please refer to
“Management’s Discussion and Analysis of Financial Condition and Results of Operations—Environmental Matters” of this report, which is
incorporated herein by reference.

Employees

As of November 30, 2018, the Company employed approximately 1,900 employees globally. Approximately 11% of the Company’s U.S.
employees are covered by collective bargaining agreements in the U.S. of which approximately 140 employees are covered by agreements that
expire within the next 12 months. In addition, certain of our foreign employees are also covered by collective bargaining agreements.

Raw Materials

We utilize a variety of raw materials, primarily monomers, in the manufacture of our products. Most of these raw materials have been, and
we expect will continue to be, generally available from multiple suppliers. Monomer costs, which are a major component of the polymers-based
products, include butadiene, styrene, acrylates, acrylonitrile, vinyl acetate and vinyl pyridine, polyvinyl chloride (PVC) resins, textiles, plasticizers,
paper, and titanium dioxide.

The cost of raw materials has a significant impact on our profitability. We generally attempt to respond to raw material cost increases
through productivity programs and price increases to our customers. The success of attempted price increases depends on a variety of factors
including the specific market application and competitive environment. Under certain circumstances, we are not able to pass along some or all of
the increase. In addition, if accepted by customers, price increases generally lag the increase in raw material costs. Index pricing applies to
approximately 25% of our total net sales.

Research and Development

OMNOVA Solutions' technology and design centers support research and development efforts across our businesses and complement the

resources focused on innovation in both of our segments. Our efforts are focused on developing new applications with our base technologies
and enhancing the functionality of our products in existing applications, as well as developing new product and technology platforms.

Research and development costs were $17.7 million in 2018, $18.9 million in 2017, and $20.8 million in 2016. Our research and

development costs relating to new products were $6.1 million in 2018, $7.5 million in 2017, and $8.2 million in 2016. Research and development
expenses include the costs of technical activities that are critical to developing new products, services, processes or techniques, as well as those
expenses for technical activities that may improve existing products or processes. Information relating to research and development expense is
set forth in Note A to the Consolidated Financial Statements of this report.

Available Information

Our website is located at www.omnova.com. We make available on our website all materials that we file electronically with the U.S.
Securities and Exchange Commission ("SEC"), including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports
on Form 8-K, and amendments to those reports, as soon as reasonably practicable after we electronically file or furnish such materials to the
SEC. OMNOVA Solutions' Business Conduct Policies and Corporate Governance Guidelines and charters for the Committees of the OMNOVA

Solutions Board of Directors are also available on our website and in print to any shareholder who requests a copy. All requests must be made in
writing and addressed to OMNOVA Solutions Inc., Attn: Corporate Secretary, 25435 Harvard Road, Beachwood, Ohio 44122-6201.

Item 1A. Risk Factors

This Annual Report includes descriptions of our current business, operations, and financial condition, as well as “forward-looking

statements” as defined by federal securities laws. All forward-looking statements by the Company, including verbal statements, are intended to
qualify for the protections afforded forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect Management’s current expectation, judgment, belief, assumption, estimate or forecast about future events, circumstances or
results and may address business conditions and prospects, strategy, capital structure, debt and cash levels, sales, profits, earnings, markets,
products, technology, operations, customers, raw materials, claims and litigation, financial condition, and accounting policies among other
matters. Words such as, but not limited to, “will,” “may,” “should,” “projects,” “forecasts,” “seeks,” “believes,” “expects,” “anticipates,” “estimates,”
“intends,” “plans,” “targets,” “optimistic,” “likely,” “would,” “could,” "committed," and similar expressions or phrases identify forward-looking
statements.

All descriptions of our current business, operations and financial condition, as well as all forward-looking statements, involve risks and
uncertainties. Many risks and uncertainties are inherent in business generally. Other risks and uncertainties are more specific to the Company’s
businesses and strategy, or to any new businesses which the Company may enter into or acquire. There also may be risks and uncertainties not
currently known to us. The occurrence of any of such risks and uncertainties and the impact of such occurrences is often not predictable or within
the Company’s control. Such impacts could adversely affect the Company’s business, operations, or financial condition, as well as the
Company's actual and projected results and the value of an investment in the Company. In some cases, such effect could be material. Certain
risks and uncertainties facing the Company are described below or elsewhere in this Annual Report.

All written and verbal descriptions of our business, operations and financial condition and all forward-looking statements attributable to the

Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the risks, uncertainties, and cautionary
statements contained and referenced herein. All such descriptions and any forward-looking statement speak only as of the date on which such
description or statement is made, and the Company undertakes no obligation, and specifically declines any obligation, other than that imposed
by law, to publicly update or revise any such description or forward-looking statements whether as a result of new information, future events or
otherwise.

Market and Economic Risks

Our business is sensitive to general economic, business, and industry conditions.

We are exposed to general economic, business and industry conditions, both in the United States and internationally. Adverse global
economic and financial conditions are difficult to predict and mitigate against, and therefore the potential impact is difficult to estimate. The end
markets that we serve can be sensitive to changes in general economic conditions and can be volatile, with significant, rapid, and unpredictable
reductions in demand and/or increases in raw material and other costs. Adverse general economic conditions may cause, among other things,
significant reductions in available capital and liquidity from banks and other credit providers, substantial volatility in equity and currency values
worldwide, and/or a prolonged recessionary or slow growth period. In addition, downturns in our customers’ particular industries, and markets,
even when overall economic conditions are favorable, may also adversely affect our sales, profitability, operating results, and cash flows.

Our suppliers may be similarly affected by general economic conditions which may affect their access to capital and liquidity, and which may

in turn cause them to raise prices or reduce or eliminate production.

Raw material prices and availability have a significant impact on results.

The cost of raw materials has a significant impact on results. The principal raw materials that we use in our business are derived from
petrochemicals and chemical feedstocks. The prices of many of these raw materials are cyclical and volatile and are affected by supply and
demand factors beyond our control. While we generally attempt to pass along higher raw material costs to our customers in the form of price
increases, there historically has been a delay between an increase in our raw material costs and our ability to increase the prices of our products.
Additionally, we may not be able to increase the prices of our products due to competitive pricing pressure and other factors.

We generally have multiple global raw material suppliers. However, in some cases there are a limited number of suppliers which are
capable of delivering certain raw materials that meet our standards. Certain raw materials are only available from a single source. While we use
a limited number of raw materials which are available only from a single source and we order those materials in limited quantities, the loss of any
of these raw materials could significantly impact our ability to deliver differentiated products in some of our most specialized businesses.
Accordingly, sole source and limited source suppliers generally have greater pricing and supply leverage.

In some cases, we may choose to sole source certain raw materials to obtain certain commercial advantages, including superior pricing and

terms. Any disruption in raw material availability from one of these suppliers may require us to secure raw material supplies from alternative
suppliers on less favorable terms.

Various factors, including feedstock shortages, production disruptions, natural disasters, the financial stability of our suppliers, supplier
commitments to others, and internal raw material use by suppliers have reduced and eliminated, and in the future may reduce or eliminate, the
availability of certain raw materials. Additionally, disruptions in transportation could delay receipt of raw materials. As a result of any of the
foregoing events, higher prices and shortages could occur in the future, which may result in customers switching to substitutes for our products.

The occurrence or threat of extraordinary events, including natural disasters, political disruptions, terrorist attacks, public health
issues, and acts of war, could significantly disrupt production, and decrease market demand for our products.

Extraordinary events, including natural disasters, political disruptions, terrorist attacks, public health issues, and acts of war could adversely

affect the economy generally, and disrupt our business and operations resulting in a loss of sales and customers. In addition, in many cases we
do not have redundant manufacturing or transportation capability and thus, any disruption of production or transportation may result in loss of
sales and customers. Such events may also disrupt our supply chain and access to necessary raw materials.

We are subject to the risks of doing business in foreign countries and markets.

We conduct a significant portion of our business in countries outside of the United States. Accordingly, our business is subject to risks

related to the differing legal, political, social, regulatory, and economic requirements and conditions. Risks associated with international
operations, include, but are not limited to:

•

fluctuations in currency exchange rates;

region to region fluctuations in key raw material costs;

transportation delays and interruptions;

• political and economic instability and disruptions, including instability and disruptions caused by actual or threatened trade and tariff

disputes with the United States, Brexit, or other Brexit-like events;

•

failure to have or obtain, delays in obtaining, or the revocation of governmental licenses and permits;

the imposition of duties and tariffs;

import and export controls;

• government control of capital transactions, including the borrowing of funds for operations or the expatriation of cash;

• difficulties in staffing and managing operations;

•

limitations on our ability to enforce legal rights and remedies;

• more stringent environmental, health and safety laws and regulations;

• potentially adverse tax consequences; and

• government expropriation of a business or assets.

We participate in highly competitive markets.

Many of the markets in which we operate are highly competitive. The bases of competition may include product performance and quality,
price, product availability, and security of supply and customer service. Some of our competitors are larger and have more financial resources
than us. We may also experience increased competition from companies that offer alternative products based on technologies and processes
that have superior performance or better pricing, which could cause a decline in the market acceptance of our products. The increasing pressure
from our competitors to keep pace and develop new technologies and products requires us to incur substantial expense.

Ongoing consolidation in various industries continues to create individual customers with greater purchasing power and competitors with
greater financial and other resources. Customers in established markets like the United States and Europe face their own competitive pressures,
particularly from businesses in regions with lower overhead costs. These competitive pressures may require us to reduce prices and attempt to
offset such price reductions with improved operating efficiencies and reduced expenditures, which options may be limited or unavailable.
Additionally, larger competitors may be better positioned to weather prolonged periods of reduced prices, which may incentivize them to reduce
prices even when not dictated by market and competitive conditions.

Legal, Regulatory, and Compliance Risks

We are subject to extensive and increasing governmental regulation.

Our business is subject to numerous foreign, federal, state and local regulations which govern and restrict numerous aspects of our
business and involve significant compliance cost. These regulations may change rapidly, and new regulations or interpretations of regulations
may be applied to us, due to circumstances beyond our control. We expect regulations, and the costs associated with compliance, to continue to
increase.

Among these regulations are increasingly stringent environmental and health and safety regulations. The cost of compliance with these
regulations is significant and increasing, and violating these regulations can result in substantial costs, including fines, damages, criminal or civil
sanctions, remediation costs, and interruptions in our operations. These regulations may also restrict or prohibit our ability to use certain raw
materials key to our products or prohibit the sale of our products altogether.

Certain environmental requirements provide for strict, and under certain circumstances joint and several, liability for investigation and
remediation of releases of regulated materials or from properties owned or operated by us or our predecessors and from properties where
substances were sent for off-site treatment or disposal.

We may be unable to effectively protect our intellectual property or may be subject to intellectual property claims.

For certain products we rely on trademark, trade secret, patent, and copyright laws to protect our intellectual property. We cannot be sure
that these intellectual property rights will be successfully asserted in the future or that they will not be invalidated or circumvented. In addition, the
laws of some foreign countries in which our products are or may be sold do not protect our intellectual property rights to the same extent as the
laws of the United States. The failure or inability of us to protect our proprietary information could make us less competitive.

From time to time, we may be subject to claims or allegations that we infringe upon or have misappropriated the intellectual property of third

parties. Defending against such claims is costly and intellectual property litigation often involves complex questions of fact and law, with
unpredictable results. We may be forced to acquire rights to such third-party intellectual property on unfavorable terms (if rights are made
available at all), pay damages, modify accused products to be non-infringing, or stop selling the applicable product altogether.

We are subject to claims and litigation.

From time to time, we are subject to various claims, proceedings, and lawsuits related to products, services, contracts, employment,

environmental, safety, intellectual property, and other matters arising out of our business operations or the business operations of our
predecessors. Whether founded or unfounded, if any such claims, proceedings, or lawsuits are not resolved in our favor, they may result in
significant financial liability, negatively impact our business operations, and harm the reputation of the Company. The costs of investigating and
defending against claims can be substantial. We may not have applicable insurance coverage, and any such insurance coverage that we do
have may be inadequate to cover the full cost of a particular claim.

Resolutions of claims, proceedings, and lawsuits can be unpredictable and can often take years. As a result, any estimates of liability that

we may have made could be materially over or understated.

Changes in accounting policies, standards, and interpretations could materially affect how we report our financial condition, results of
operations, and cash flows.

The Financial Accounting Standard Board ("FASB"), regulatory agencies, and other bodies that establish accounting standards periodically

change the financial accounting and reporting standards governing the preparation of the Company’s consolidated financial statements.
Additionally, those bodies that establish and interpret the accounting standards (such as the FASB and the SEC) may change prior
interpretations or positions on how these standards should be applied. These changes can be difficult to predict and can materially affect how the
Company records and reports its financial condition, results of operations, and cash flows. In unusual circumstances, the Company could be
required to retroactively apply a new or revised standard, resulting in changes to previously reported financial results.

We may be subject to the actions of activist shareholders.

We have been the subject of activity by activist shareholders, and shareholder activism generally is increasing. Responding to shareholder

activism can be costly and time-consuming, disrupt our operations, and divert the attention of Management and our employees from our strategic
initiatives. Activist campaigns can create perceived uncertainties as to our future direction, strategy, or leadership and may result in the loss of
potential business opportunities, harm our ability to attract new employees, investors, customers, and joint venture partners, and cause our stock
price to experience periods of volatility or stagnation.

Business and Strategic Risks

Our manufacturing facilities are subject to operating risks.

We are dependent on the continued operation of our manufacturing facilities. These facilities are subject to hazards associated with the

manufacturing, handling, storage, and transportation of chemical materials and products, including tank and pipeline leaks and ruptures,
explosions, fires, inclement weather, natural disasters, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions,
and environmental risks. These hazards can cause personal injury and loss of life, severe damage to, or destruction of, property and equipment,
and environmental contamination. The occurrence of material operating problems at our facilities may diminish or eliminate our ability to
manufacture product. Further, from time to time, we may experience capacity limitations in our manufacturing operations. If we are unable to
effectively forecast our customers’ demand, it could affect our ability to successfully manage such operating capacity limitations.

We may be unable to achieve, or may be delayed in achieving, the objectives and benefits of our cost reduction initiatives.

We continuously utilize operational excellence program improvements such as our One OMNOVA initiative, LEAN SixSigma, manufacturing

footprint optimization, global supply chain management, Enterprise Resource Planning (ERP) and other initiatives in an effort to improve
efficiencies and lower our cost structure. There may be unanticipated difficulties in implementing one or more of these initiatives, and we may not
ultimately realize the full benefits of, or be able to sustain the benefits anticipated by, these initiatives. Additionally, even if we achieve these
goals, the cost of implementing these initiatives could ultimately exceed their benefits. In addition, certain of these initiatives have resulted in us
streamlining and consolidating our manufacturing capacity, increasing the risk of business interruption if a consolidated manufacturing site
experiences operational or other difficulties.

Our sales and profitability depend on our ability to develop and commercialize innovative new products that can be value priced.

Our specialization strategy requires that we develop, introduce, sell, and support innovative new products and technologies on a timely
basis and that we make significant investments in research and development to do so. We may be unsuccessful in developing or introducing
new products, modifying our existing products, achieving market acceptance of new products, or securing pricing that reflects the investment into
and value of our new products.

We may not be able to identify or complete transactions with attractive acquisition candidates.

As part of our business strategy, we have pursued, and may continue to pursue, targeted acquisition opportunities. Implementing this
business strategy requires Management to identify and evaluate acquisition candidates (including potential synergies, business opportunities,
and growth prospects), and to successfully negotiate the acquisition with the target company and its stakeholders. There are a limited number of
attractive acquisition candidates. Even if we identify attractive acquisition candidates we may not be able to reach agreement on an acceptable
acquisition price. If we complete an acquisition, we may not achieve the anticipated benefits, such as reduced costs or increased sales.

We may not be able to successfully integrate acquisitions into our operations.

The integration of acquisitions into our operations involves a number of risks, including:

• difficulty integrating operations and personnel at different locations;

• diversion of Management attention;

• potential disruption or loss of business due to negative reactions to the acquisition by customers, suppliers, and other key constituencies;

• difficulties in assimilating the technologies and products of the acquisition;

• inability to retain key personnel;

• difficulties integrating operational and financial information technology systems;

• difficulty in expanding product manufacturing to new sites; and

• inability to maintain uniform standards, controls, procedures, and policies.

These risks may be magnified in acquisitions of significant size and scale. If we are unable to effectively integrate operations and personnel

in a timely and efficient manner after an acquisition is completed, we may not realize the projected benefits of the acquisition.

Our information systems may experience an interruption or a breach in security.

We rely heavily on electronic communications, information technology systems (both internal systems and external systems provided by
third parties) and the internet to operate our factories, sell our products, fulfill orders, manage inventory, and bill, collect, and make payments.
Our systems are vulnerable to damage or interruption from natural disasters, power loss, telecommunication failures, computer viruses,
computer denial-of-service attacks, unauthorized intrusion, and other events, any of which could interrupt our business operations. Our business
may also be subject to break-ins, sabotage, and intentional acts of vandalism.

Cybersecurity attacks can originate from a wide variety of sources, including persons who are linked to terrorist organizations or hostile

foreign governments. Those same parties may also attempt to fraudulently induce employees, customers, or other users of our systems to
disclose sensitive information in order to gain access to our systems, our data or the data of our customers.

Our security systems may not be able to protect our systems from attacks or other disruptions due to the rapid evolution and sophistication

of cyberattack methods. Any significant disruption or slowdown of our current or future information systems as a result of a system security
failure could disrupt the flow of operational information, cause orders to be lost or delayed, cause disruption and damage to our manufacturing
facilities, damage our reputation with our customers, or cause our customers to cancel orders. Additionally, the theft of sensitive data and our
inability to protect our trade secrets or information concerns our employees, customers, or suppliers could have an adverse effect on our
business, customers, suppliers, and employees. These risks may increase in the future as we increase our usage of mobile platforms and
expand our internal usage of third-party, web-based products and applications.

We generally do not have long-term contracts with our customers.

With some exceptions, most of our business is conducted on a purchase order basis rather than through long-term contracts. Accordingly,

customers may elect to discontinue business with us with limited or no notice and with limited recourse by OMNOVA.

Certain product lines contribute disproportionately to the Company’s profitability.

Certain of the Company’s product lines and certain of its customers contribute disproportionately to the Company’s operating profit. A

downturn in the markets those product lines serve, or the loss of these customers, could have an adverse affect on our financial results.

We are exposed to credit risk from our customers.

We extend credit on most of our sales, which exposes us to the risk of customer nonpayment. In deciding whether to extend credit or enter

into other transactions, we may rely on information furnished by or on behalf of customers, including financial statements, credit reports, and
other information. We may also rely on representations of these customers or third-parties as to the accuracy and completeness of credit risk
related information. The inaccuracy of that information or those representations would affect our ability to accurately evaluate the credit risk of a
customer. Even with accurate information, negative changes in economic, business, or industry conditions may increase the credit risk of
customers who are initially determined to have acceptable credit risk.

Employee healthcare costs continue to increase.

We maintain a self-insured healthcare plan under which we generally share the cost of health care with certain of our employees and

retirees. Employee healthcare is a significant operating cost for us, and these costs have continued to escalate well in excess of other
inflationary trends over the past several years. If healthcare costs continue to increase, we may not be able or willing to pass these costs along
to our employees and retirees.

We may be unable to attract or retain key employees.

Many parts of our business are highly technical and specialized. Global competition for skilled employees meeting our specialized needs is
intense and our business success is dependent on our ability to attract highly-qualified new employees or retain our key employees. Our inability
to attract necessary talent or the unanticipated departure of any key member of Management or any key employee, could adversely affect our
ability to implement strategic initiatives and effectively operate our business.

We are subject to collective bargaining agreements with certain employees.

Approximately 11% of our employees located in the United States are covered by collective bargaining agreements. In addition, certain

employees of our foreign operations are also covered by collective bargaining agreements. We may not be able to renew our collective
bargaining agreements on terms similar to current terms, or renegotiate collective bargaining agreements on terms acceptable to us. The
prolonged failure to renew or renegotiate a collective bargaining agreement could result in work stoppages. Additionally, in foreign jurisdictions
where we operate, national unions and foreign governments may be unable to reach agreements, which could result in work stoppages that are
out of the Company’s control. In addition, if a collective bargaining agreement is negotiated at higher-than-anticipated cost, absorbing those
costs or passing them through to customers in the form of higher prices may make us less competitive.

Our U.S. pension plan is underfunded, requiring the Company to make significant cash contributions to the plan.

The Company’s U.S. pension plan is underfunded, and we are required to make significant cash contributions to it to comply with minimum

funding requirements imposed by benefit and tax laws. Contribution amounts are based on plan performance, interest rates, and pension funding
legislation, among other factors. We currently expect to make a contribution of $6.4 million to our U.S. pension plan during 2019, in part to satisfy
our requirements under the Pension Protection Act of 2006. We cannot predict whether changing conditions including interest rates, pension
assets performance, discount rates, government regulation, or other factors will require us to make future contributions in excess of current
expectations, or whether we will have the funds necessary to make minimum pension contributions at the times that they may be required.

We maintain cash balances in foreign financial institutions.

We maintain cash balances in foreign financial institutions. While we monitor the financial institutions that we maintain accounts with, we
may not be able to recover our funds in the event that the financial institution would fail. In addition, we may be limited by foreign governments in
the amount and timing of funds to be repatriated from foreign financial institutions.

We carry a significant amount of goodwill on our balance sheet.

As of November 30, 2018, we had goodwill of $70.9 million. The future occurrence of a potential indicator of impairment, such as a
significant adverse change in business climate, an adverse action or assessment by a regulator, unanticipated competition, a material negative
change in relationships with significant customers, strategic decisions made in response to economic or competitive conditions, loss of key
personnel, or a more-likely-than-not expectation that a reporting unit or a significant portion of a reporting unit will be sold or disposed of, could
result in goodwill impairment charges. We have recorded goodwill impairment charges in the past, and such charges materially affected our
historical results of operations. For additional information, see Note A, Goodwill and Intangible Assets, to the accompanying consolidated
financial statements.

The market price for our common shares is particularly volatile.

The market for our common shares is characterized by significant price volatility, and we expect that our share price will continue to be
volatile. The trading of relatively small quantities of our common shares may cause disproportionate movements upwards and downwards in our
share price due to our small market capitalization and low trading volume, and the cyclical nature of our business may create prolonged periods
of higher or lower share prices not correlated to Company performance or to general economic or market conditions.

Debt Risks

Our substantial debt could adversely affect our financial health and prevent us from fulfilling our obligations.

We have substantial debt and, as a result, significant debt service obligations. Our substantial debt could:

• make it more difficult for us to satisfy our obligations with respect to our term loan and our revolving credit facility;

• increase our vulnerability to general adverse economic and industry conditions, including interest rate fluctuations, because a portion of

our borrowings, including those under our term loan and our revolving credit facility, are at variable rates of interest;

• require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing the availability of
our cash flow to fund working capital, capital expenditures, acquisitions, joint ventures, pension contributions and investments, and other
general corporate purposes;

• limit our flexibility in planning for, or reacting to, changes in our business and the markets we serve;

• limit our ability to obtain additional debt or equity financing due to applicable financial and restrictive covenants in our debt agreements,

and;

• place us at a competitive disadvantage compared to our competitors that have less debt.

Our ability to make scheduled payments on or to refinance our debt obligations and to fund planned capital expenditures and expansion

efforts and any acquisitions we may make in the future depends on our ability to generate cash in the future and our financial condition and
operating performance, which are subject to prevailing economic and competitive conditions and to certain financial, business and other factors
beyond our control. We could be required to obtain the consent of the lenders under our term loan and our revolving credit facility to refinance
material portions of our debt. We may not be able to maintain a level of cash flows from operating activities sufficient to permit us to pay the
principal, premium, if any, and interest on our debt.

If our cash flows and capital resources are insufficient to fund our debt service obligations, we may be forced to reduce or delay investments

and capital expenditures, sell assets, seek additional capital, or restructure or refinance our debt. These alternative measures may not be
successful and may not permit us to meet our scheduled debt service obligations. If our operating results and available cash are insufficient to
meet our debt service obligations, we could face substantial liquidity problems and might be required to dispose of material assets or operations
to meet our debt service and other obligations. We may not be able to consummate those dispositions or to obtain the proceeds that we could

realize from them, and these proceeds may not be adequate to meet any debt service obligations then due. Additionally, the agreements
governing our term loan and our revolving credit facility will limit the use of the proceeds from any disposition; as a result, we may not be allowed,
under these documents, to use proceeds from such dispositions to satisfy all current debt service obligations. Further, we may need to refinance
all or a portion of our debt on or before maturity, and we cannot assure that we will be able to refinance any of our debt on commercially
reasonable terms or at all.

Despite ongoing actions to reduce our debt, we may still be required to incur significant additional debt.

We may be able to incur substantial additional debt, including additional secured debt, in the future, and such additional debt may be

necessary to accomplish some of our strategic objectives. The terms of the agreements governing our term loan and revolving credit facility
restrict but do not completely prohibit us from incurring substantial additional debt. If new debt or other liabilities are added to our current debt
levels, the related risks that we and our subsidiaries now face could intensify.

The agreements governing our term loan and our revolving credit facility impose significant operating and financial restrictions on us,
which may prevent us from capitalizing on business opportunities.

The agreements governing our term loan and our revolving credit facility impose significant operating and financial restrictions on us. These

restrictions limit our ability, among other things, to:

• incur additional debt or issue certain disqualified stock and preferred stock;

• pay dividends or certain other distributions on our capital stock or repurchase our capital stock;

• make certain investments or other restricted payments;

• place restrictions on the ability of our restricted subsidiaries to pay dividends or make other payments to us;

• engage in transactions with affiliates;

• sell certain assets or merge with or into other companies;

• enter into sale and leaseback transactions;

• guarantee debt;

• create liens; and

• enter into unrelated businesses.

Our term loan and revolving credit facility require us to meet certain financial covenants, including covenants relating to senior net debt

leverage, minimum excess availability and a springing minimum fixed charge coverage ratio if average excess availability falls below a certain
level.

As a result of these covenants and restrictions, we may be limited in how we conduct our business and may be unable to raise additional
debt or equity financing to compete effectively or to take advantage of new business opportunities. The terms of any future debt we may incur
could include more restrictive covenants. We may not be able maintain compliance with these covenants in the future and, if we fail to do so, we
may be unable to obtain waivers from the lenders and/or amend the covenants.

Moreover, our revolving credit facility provides the lenders considerable discretion to impose reserves, which could materially impair the

amount of borrowings that would otherwise be available to us. There can be no assurance that the lenders under our revolving credit facility will
not impose such actions during the term of our revolving credit facility and further, were they to do so, the resulting impact of this action could
materially and adversely impair our ability to make interest payments on our debt.

If we default under our term loan or our revolving credit facility, we may not be able to service our debt obligations.

In the event of a default under our term loan or our revolving credit facility, the lenders under each of these facilities could elect to declare all
amounts borrowed, together with accrued and unpaid interest and other fees, to be due and payable. If such acceleration occurs, we may not be
able to repay the amounts due under our term loan, or our revolving credit facility. This could have serious consequences to our financial
condition, results of operations, cash flows and could cause us to become bankrupt or insolvent.

Our subsidiaries may incur obligations that will constrain their ability to provide us with cash, which may affect our ability to make
payments on our debt.

Our cash flows and our ability to service our debt, including our ability to make interest and principal payments when due, are dependent

upon cash dividends and other distributions or other transfers from our subsidiaries. Dividends, loans, and advances to us from our subsidiaries
may be restricted by covenants in certain debt agreements. If our subsidiaries incur obligations with these restrictive covenants, it will constrain
our subsidiaries' ability to provide us with cash, which may affect our ability to make payments on our debt.

The LIBOR calculation method may change and LIBOR is expected to be phased out after 2021.

The Company’s Term Loan B Credit Facility and its Senior Secured Credit Facility permit interest on the outstanding principal balance to be
calculated based on LIBOR. On July 27, 2017, the U.K. Financial Conduct Authority (the "FCA") announced that it will no longer require banks to
submit rates for the calculation of LIBOR after 2021. In the meantime, actions by the FCA, other regulators, or law enforcement agencies may
result in changes to the method by which LIBOR is calculated. At this time, it is not possible to predict the effect of any such changes or any
other reforms to LIBOR that may be enacted in the U.K. or elsewhere.

Item 1B. Unresolved Staff Comments

None.

Item 2.

Properties

The Company’s significant operating, manufacturing, distribution, research, design and/or sales, and marketing facilities are set forth below:

Corporate Headquarters
OMNOVA Solutions Inc.
25435 Harvard Road
Beachwood, OH

Manufacturing/Technical/Distribution Facilities:
Akron, OH
Auburn, PA
Calhoun, GA
Caojing, China
Chester, SC
Columbus, MS*
Fitchburg, MA
Green Bay, WI
Jeannette, PA
Le Havre, France
Mem Martins, Portugal
Mogadore, OH
Monroe, NC
Ningbo, China
Rayong, Thailand*
Stafford, TX
Villejust, France*

Leased property.

Global Technology Center
OMNOVA Solutions Global Technology Center
2990 Gilchrist Road
Akron, OH

Sales/Marketing:
Akron, OH
Bangkok, Thailand*
Beachwood, OH*
Madrid, Spain
Mem Martins, Portugal
Mumbai, India*
Rayong, Thailand*
Shanghai, China*
Singapore*
Villejust, France*
Valongo, Portugal*

For further discussion of our leased properties, please refer to Note M to the Consolidated Financial Statements of this report.

Item 3.

Legal Proceedings

From time to time, the Company is subject to various claims, proceedings and lawsuits related to products, services, contracts,

employment, environmental, safety, intellectual property, and other matters. The ultimate resolution of such claims, proceedings, and lawsuits is
inherently unpredictable and, as a result, the Company’s estimates of liability, if any, are subject to change. Actual results may materially differ
from the Company’s estimates and an unfavorable resolution of any matter could have a material adverse effect on the business, operations, or
financial condition of the Company. However, subject to the above and taking into account such amounts, if any, as are accrued from time to time
on the Company’s consolidated balance sheet, the Company does not believe, based on the information currently available to it, that the ultimate
resolution of these matters will have a material effect on the business, operations, or financial condition of the Company.

Item 4.

Mine Safety Disclosures

None.

PART II

Item 5.

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

The Company’s common shares are listed on the New York Stock Exchange and trade under the symbol OMN. At November 30, 2018, there

were 5,440 holders of record of the Company’s common shares. Information regarding the high and low quarterly sales prices of the Company’s
common share is contained in the Selected Quarterly Financial Data (Unaudited) and is incorporated herein by reference. The Company has not
declared a dividend on its common shares since 2001.

On September 25, 2018, the Company's Board of Directors authorized the repurchase of up to $20.0 million of the Company's common

shares, which authorization expires upon the completion of $20.0 million in repurchases. The Company may use various methods to make the
repurchases, including open market repurchases, negotiated block transactions, or open market solicitations for shares, all or some of which may
be effected through Rule 10b5-1 plans. The timing of repurchases will depend upon several factors including market or business conditions, and
repurchases may be discontinued at any time.

The Company did not repurchase any of its common shares during the three months ended November 30, 2018.

Information concerning long-term debt appears in Note K to the Consolidated Financial Statements and is incorporated herein by reference.

Information concerning securities authorized for issuance under the Company’s equity compensation plans is set forth in Equity Compensation
Plan Information of Item 12 in this Annual Report is incorporated herein by reference.

The graph below matches OMNOVA Solutions Inc.'s cumulative 5-Year total shareholder return on common stock with the cumulative total

returns of the S&P 500 index and the S&P Industrials index. The graph tracks the performance of a $100 investment in our common share and in
each index (with the reinvestment of all dividends) from November 30, 2013 to November 30, 2018.

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among OMNOVA Solutions Inc., the S&P 500 Index
and the S&P Industrials Index

$180

$160

$140

$120

$100

$80

$60

$40

$20

2013

2014

2015

2016

2017

2018

OMNOVA Solutions Inc.

S&P 500

S&P Industrials

*$100 invested on 11/30/13 in stock or index, including reinvestment of dividends.
Fiscal year ending November 30.

2013

2014

2015

2016

2017

2018

OMNOVA Solutions Inc.

100.00

76.26

85.84

109.59

122.15

S&P 500

S&P Industrials

100.00

116.86

114.65

120.07

113.88

129.75

131.97

159.43

157.55

93.04

169.43

155.88

Item 6.

Selected Financial Data

The following table sets forth the Company’s selected financial data for all periods presented. The selected financial data as of

November 30, 2018, 2017, 2016, 2015, and 2014, and for each of the five years in the period ended November 30, 2018 are derived from the
Company’s audited consolidated financial statements.

Statement of operations data:

Net Sales

....................................................................................

Cost of goods sold (exclusive of depreciation) ...................

Gross profit .........................................................................

Selling, general, and administrative ....................................

Depreciation and amortization ............................................

Asset impairments ..............................................................

Loss (gain) on asset sales ..................................................

Restructuring and severance ..............................................

Interest expense .................................................................

Debt issuance costs write-off ..............................................

Acquisition and integration related expense .......................

Other (income) expense, net ..............................................

Income (loss) from continuing operations before income taxes ..

Income tax (expense) benefit ......................................................

Income (loss) from continuing operations ...................................

Income (loss) from discontinued operations, net of tax ...............

Net income (loss) ........................................................................

Basic Income (Loss) Per Share:

Income (loss) per share from continuing operations ...................

Income (loss) per share from discontinued operations ...............

Basic net income (loss) per share ............................................... $

Diluted Income (Loss) Per Share:

Income (loss) per share from continuing operations ...................

Income (loss) per share from discontinued operations ...............

Diluted net income (loss) per share ............................................

General:

Capital expenditures ...................................................................

Total assets ....................................................................................

Long-term debt ...........................................................................

Cash ...........................................................................................

2018

2017

2016

2015

2014

(Dollars in millions, except per share data)

769.8

579.1

190.7

104.2

30.2

13.5

(0.9)

3.5

19.3

0.8

4.1

1.5

176.2

14.5

6.2

20.7

—

783.1

582.3

200.8

117.1

27.9

32.9

0.4

5.7

21.5

—

0.3

(0.9)

204.9

(4.1)

(83.7)

(87.8)

—

759.9

556.0

203.9

118.5

30.6

5.7

0.3

11.1

24.7

2.9

0.9

(0.7)

194.0

9.9

(10.3)

(0.4)

—

838.0

644.1

193.9

119.3

34.0

19.4

0.2

5.9

28.3

0.6

0.4

6.9

215.0

(21.1)

2.4

(18.7)

0.9

20.7

(87.8)

(0.4)

(17.8)

0.46

—

0.46

—

0.46

(1.98)

—

(1.98)

—

(1.98)

(0.01)

—

(0.01)

—

(0.01)

(0.41)

0.02

(0.39)

(0.41)

0.02

(0.39)

23.8

25.1

25.6

24.0

589.2

329.7

54.1

612.8

361.8

88.0

687.3

366.0

72.0

687.2

357.2

44.9

987.4

788.0

199.4

120.2

34.8

—

0.5

0.9

32.9

0.8

—

(2.4)

187.7

11.7

0.4

12.1

(0.6)

11.5

0.26

(0.01)

0.25

0.26

(0.01)

0.25

29.8

829.2

409.6

99.5

See Management's Discussion and Analysis of Financial Condition and Results of Operations and Notes to Consolidated Financial Statements.

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

OMNOVA Solutions is a global innovator of performance enhancing chemistries and surfaces for a variety of commercial, industrial, and
residential end uses. Our products provide a variety of important functional and aesthetic benefits to hundreds of products that people use daily.
We hold leading positions in key market categories, which have been built through innovative products, customized product solutions, strong
technical expertise, well-established distribution channels, recognized brands, and long-standing customer relationships. We have strategically
located manufacturing, technical and other facilities globally to service our broad customer base. Please refer to Item 1. Business, of this Annual
Report on Form 10-K for further description of and background on the Company and its operating segments.

The Company’s Chief Operating Decision Maker ("CODM"), its Chief Executive Officer ("CEO"), makes decisions, assesses performance,
and allocates resources prospectively by reporting segment. Segment information has been prepared in accordance with guidance promulgated
by the FASB.

The Company has two reporting segments: "Specialty Solutions", a segment focused on the Company's higher growth specialty business
lines, and "Performance Materials," a segment comprised of the Company's mature business lines. These reporting segments were determined
based on products and services provided. Accounting policies of the segments are the same as those described in Note A—Description of
Business and Significant Accounting Policies of the Company’s Consolidated Financial Statements. For a reconciliation of the Company’s
segment operating performance information, refer to Note O of the Company’s Consolidated Financial Statements.

A majority of the Company’s raw materials are derived from petrochemicals and chemical feedstocks, where prices can be cyclical and

volatile. Styrene, a key raw material for the Company, is generally available worldwide, and OMNOVA has supply contracts with several
producers. OMNOVA believes there is adequate global capacity to serve demand. OMNOVA’s styrene purchases for 2016 through 2018 and the
range of market prices were as follows:

2018 ................................................................................................................................................

2017 ................................................................................................................................................

2016 ................................................................................................................................................

102

129

144

$0.53 - $0.73

$0.48 - $0.72

$0.39 - $0.54

Pounds Purchased
(in millions)

Market Price
Range Per Pound

Butadiene, a key raw material for the Company, is generally available worldwide, but its price is volatile. OMNOVA has supply contracts with

several producers. At times, when the demand for butadiene exceeds supply, it is sold on an allocated basis. OMNOVA’s butadiene purchases
for 2016 through 2018 and the range of market prices were as follows:

2018 ................................................................................................................................................

2017 ................................................................................................................................................

2016 ................................................................................................................................................

103

111

$0.36 - $0.79

$0.39 - $1.42

$0.24 - $0.71

Pounds Purchased
(in millions)

Market Price
Range Per Pound

Other key raw materials utilized by the Company include acrylites, polyvinyl chloride (PVC) resins, textiles, and plasticizers. These raw

materials are generally available worldwide from several suppliers.

OMNOVA had indexed sales price contracts covering approximately 25% of its sales in 2018. These contract indexes are generally
comprised of several components: a negotiated fixed amount per pound, and the market price of key raw materials (i.e., styrene and butadiene).
The indexed contracts provide that OMNOVA will pass through the increases or decreases of key raw materials, generally within a 30 to 60 day
period. Indexed contracts vary in length, generally from 12 to 36 months.

The majority of OMNOVA’s customers do not maintain indexed contracts. Instead, the Company negotiates pricing with each customer

based on the cost of the raw materials components of the products being purchased and the value-added performance attributes of those
products. The Company’s pricing objective, which may or may not be met, is to recover raw material price increases for these non-indexed
contracts within three months.

Key Indicators

Key economic measures relevant to the Company include global economic growth rates, discretionary spending for durable goods, oil and
gas consumption and drilling levels, U.S. commercial real estate occupancy rates, U.S. office furniture sales, manufactured housing shipments,
housing starts and sales of existing homes, and forecasts of raw material pricing for certain petrochemical feed stocks. Key Original Equipment
Manufacturer ("OEM") industries, which provide a general indication of demand drivers to the Company, include commercial and residential
construction and refurbishment, automotive and tire production, furniture, flooring, and ABS manufacturing. These measures provide general
information on trends relevant to the demand for the Company’s products, but the trend information does not necessarily directly correlate with
demand levels in the markets which ultimately use the Company’s products in part because the Company's market share is relatively small in a
number of specialty markets.

Key operating measures utilized by the business segments include: orders; sales and pricing; working capital days; inventory; productivity;
plant utilization; new product vitality; cost of quality; order fill-rates, which provide key indicators of business trends; and safety and other internal
metrics. These measures are reported on various cycles including daily, weekly and monthly, depending on the needs established by operating
management.

Key financial measures utilized by Management to evaluate the results of its businesses and to understand the key variables impacting the

current and future results of the Company include sales and pricing; gross profit; selling, general, and administrative expenses; adjusted
operating profit; adjusted net income; consolidated earnings before interest, taxes, depreciation, and amortization (“EBITDA”) as set forth in the
Net Leverage Ratio in the Company’s $350,000,000 Term Loan Credit Agreement; Adjusted EBITDA, working capital; operating cash flows;
capital expenditures; cash interest expense; adjusted earnings per share; return on invested capital; and applicable ratios, such as inventory
turnover; working capital turnover; return on sales and assets; and leverage ratios. These measures, as well as objectives established by the
Company's Board of Directors, are reviewed at monthly, quarterly, and annual intervals and compared with historical periods.

Results of Operations of 2018 Compared to 2017

The Company's net sales in 2018 were $769.8 million, compared to $783.1 million in 2017. The acquisition of Resiquimica in September of

2018 accounted for $10.7 million of current year sales, while our former China-based coated fabric manufacturing operation, China Coated
Fabrics ("CCF"), which was sold in July of 2017, accounted for $10.4 million in sales in 2017. Excluding the effect of CCF, sales decreased $2.9
million or 0.4%. The Specialty Solutions business segment revenue increased 10.5% and the Performance Materials business segment revenue
decreased by 17.4%. Contributing to the net sales decrease of $2.9 million in 2018 were lower volume of $30.5 million, which was partially offset
by favorable foreign exchange of $14.7 million and favorable price/mix of $2.5 million.

Gross profit and gross profit margin in 2018 were $190.7 million and 24.8%, compared to $200.8 million and 25.6% in 2017. The decrease

in gross profit margin resulted from lower volumes, primarily within Performance Materials. Volume decreased primarily due to the Company's
continued strategic transition away from the commodity paper coatings market, and the sale of CCF, which were partially offset by improved
volume in oil & gas, coatings and performance additives.

Selling, general, and administrative expense in 2018 decreased $12.9 million or 10.9%, to $104.2 million, compared to $117.1 million in
2017. The decrease in 2018 reflects the One OMNOVA cost reduction initiatives, and reductions in outside services and incentive compensation.

On December 22, 2017, U.S. federal tax legislation, commonly referred to as the Tax Cuts and Job Act (the “Tax Act”) was signed into law

which, among other items: reduced the U.S. corporate income tax rate effective January 1, 2018 from 35% to 21%; repealed the Alternative
Minimum Tax (“AMT”); imposed a one-time transition tax on accumulated foreign earnings not previously subject to U.S. taxation; provides a
U.S. federal tax exemption on future distributions of foreign earnings; and beginning in fiscal 2019, creates a new minimum tax on certain
foreign-sourced earnings. The U.S. corporate tax rate reduction resulted in a blended federal statutory tax rate of 22.2% for fiscal 2018 (based
on 35% corporate rate through December 31, 2017 and 21% from that date through the end of fiscal 2018). The Securities and Exchange
Commission Staff Accounting Bulletin No.118 (“SAB 118”), provides a measurement period that should not extend beyond one year from the Tax
Act enactment date for companies to complete the accounting under ASC 740, Income Taxes. While the Company was able to make reasonable
estimates of the items above, the ultimate impact may differ from these provisional amounts due to additional analysis, changes in interpretations
and assumptions, additional regulatory guidance that may be issued and actions we may take as a result of the Tax Act. Adjustments to the
provisional amounts recorded by the Company that are identified within a subsequent measurement period of up to one year from the enactment
date will be included as an adjustment to income tax expense in the period the amounts are determined.

Income tax benefit was $6.2 million in 2018, compared to income tax expense of $83.7 million in 2017. The 2018 income tax benefit was

different than the statutory income tax rate primarily due to items related to the Tax Act. As a result of the Tax Act, the Company recorded a
provisional net tax benefit of approximately $9.9 million, comprised of: a tax benefit of $4.1 million related to the re-measurement of the U.S.
deferred taxes for the reduction of the U.S. federal corporate income tax rate; a tax benefit of $0.9 million associated with the reversal of the
valuation allowance against the existing AMT credit carryforward as it is refundable under the Tax Act; and a tax benefit of $4.9 million associated
with the reversal of the valuation allowance on a portion of the U.S. deferred tax assets as a result of deferred tax liabilities for indefinite lived
intangible assets now considered available as a source of income as a result of the Tax Act. In addition, the Company recognized a $0.9 million
income tax benefit related to the impact of a French tax rate change on the Company’s deferred tax liabilities. Based on recently enacted French
tax legislation during the first quarter of 2018, the French tax rate will be reduced to 25.0% beginning in 2022 and the Company's deferred tax
liabilities were reduced to appropriately reflect this legislation as a current period tax benefit. The 2017 income tax expense was higher than the
statutory income tax rate of 35% primarily as a result of a $79.9 million income tax expense related to valuation allowances on deferred tax
assets. Of that amount, $75.7 million income tax expense was recorded in the U.S. during the fourth quarter of 2017. Additionally, a $19.6 million
goodwill impairment was recorded in the fourth quarter of 2017 for which no tax benefit was realized as the goodwill impairment is permanently
non-deductible for tax purposes. The tax impact of the goodwill impairment was $6.9 million. These charges were partially offset by a $3.4 million
income tax benefit from French legislative changes during the year.

Segment Discussion

The following Segment Discussion presents information used by the Company in assessing the results of operations by business segment.
The Company believes that this presentation is useful for providing the investor with an understanding of the Company’s business and operating
performance because these measures are used by the CODM, its CEO, in making decisions, assessing performance and allocating resources.

Year Ended
November 30,

2018

2017

(Dollars in millions)

Net Sales

Specialty Solutions ........................................................................................................................................... $

.....................................................................................................................................
Performance Materials .....................................................................................................................................

Total Net Sales .........................................................................................................................................................

Segment Operating Profit

Specialty Solutions ........................................................................................................................................... $

Performance Materials .....................................................................................................................................

Total segment operating profit ...................................................................................................................................

Interest expense .......................................................................................................................................................

Corporate expenses .................................................................................................................................................

Corporate severance ................................................................................................................................................

Asset impairment ......................................................................................................................................................

Acquisition and integration related expense .............................................................................................................

Gain on sale .............................................................................................................................................................

Debt issuance costs write-off ....................................................................................................................................

Pension settlement ...................................................................................................................................................

487.6

282.2

769.8

70.7

(9.8)

60.9

(19.3)

(24.0)

(0.9)

(0.1)

(2.2)

0.9

(0.8)

—

Income (Loss) Before Income Taxes ..................................................................................................................... $

14.5

441.4

341.7

783.1

59.9

(12.6)

47.3

(21.5)

(24.5)

(2.9)

(1.8)

(0.3)

—

(0.4)

(4.1)

Specialty Solutions

Specialty Solutions' net sales increased $46.2 million, or 10.5%, to $487.6 million in 2018, compared to $441.4 million in 2017. The
acquisition of Resiquimica accounted for $10.7 million of the increase. The increased sales were primarily driven by improved volumes of $25.9
million, price/mix of $11.3 million, and favorable foreign exchange of $9.0 million. Volume was up in Specialty Coatings & Ingredients, Oil & Gas,
and Laminates & Films. Net sales for the Specialty Coatings & Ingredients line increased $20.3 million to $251.6 million in 2018 compared to
$231.3 million in 2017. Net sales for the Oil & Gas line increased $16.7 million to $71.3 million compared to $54.6 million in 2017. Net sales for
the Laminates & Films line increased $9.2 million to $164.7 million in 2018 compared to $155.5 million in 2017.

This segment generated an operating profit of $70.7 million in 2018, compared to $59.9 million in 2017. The increase in segment operating

profit was due in part to increased volume, cost reduction initiatives, favorable foreign exchange, and improved price/mix, partially offset by
higher raw material and operating costs. Segment operating profit includes items which Management excludes when evaluating the results of the
Company' segments. Those items for 2018 totaled $3.7 million and included $1.8 million of acquisition and integration related expense, $1.2
million of asset impairment, facility closure and other costs, and $0.7 million of restructuring and severance charges. Those items for 2017
totaled $0.9 million and included $0.6 million of restructuring and severance charges and $0.3 million of operational improvement costs.

Performance Materials

Performance Materials' net sales decreased $59.5 million or 17.4% to $282.2 million in 2018, compared to $341.7 million in 2017. During
2017, the Company sold CCF which accounted for $10.4 million of net sales in 2017. The decrease of $59.5 million was driven primarily by lower
volume of $46.0 million, the divestiture of CCF of $10.4 million, and unfavorable price/mix of $8.8 million, partially offset by favorable foreign
exchange of $5.7 million. Volumes were down, primarily in Paper, due to the Company's exit of the commodity paper business. Net sales for
Performance Additives increased $4.8 million to $106.0 million in 2018 compared to $101.2 million in 2017. Coated Fabrics' net sales decreased
$10.9 million to $44.3 million in 2018, compared to $55.2 million in 2017, primarily due to the sale of CCF. Paper and Carpet net sales decreased
$52.9 million to $113.6 million in 2018, compared to $166.5 million in 2017.

Segment operating losses were $9.8 million in 2018, and $12.6 million in 2017. The segment operating loss in 2018 was primarily due to an

asset impairment charge of $9.2 million related to the styrene-butadiene (SB) production transition from Green Bay, Wisconsin to Mogadore,
Ohio, to offset the impact from lower volumes within the Company's commodity paper business. Segment operating profit includes items which
Management excludes when evaluating the results of the Company's segments. Those items for 2018 totaled $16.7 million and include asset
impairments, facility, and other costs of $14.3 million, accelerated depreciation of $1.1 million, restructuring and severance of $1.1 million and
environmental charges of $0.2 million. Those items for 2017 totaled $33.3 million and include asset impairment charges and facility closure costs
of $33.6 million, restructuring and severance costs of $1.7 million, and a reversal of an environmental charge of $2.0 million.

Interest and Corporate Expenses

Interest expense was $19.3 million and $21.5 million for 2018 and 2017, respectively. The decrease was primarily attributable to the $40.0

million Term Loan B prepayment made during the first quarter of fiscal 2018, resulting in a lower average outstanding debt balance in fiscal 2018
compared to fiscal 2017.

Corporate expenses were $24.0 million in 2018, compared to $24.5 million in 2017. The decrease is primarily due to lower incentive compensation

expense and outside service costs.

Results of Operations of 2017 Compared to 2016

The Company's net sales in 2017 were $783.1 million, compared to $759.9 million in 2016. CCF, which was sold in July of 2017, accounted

for $10.4 million in sales in 2017 and $26.2 million in sales in 2016. Our India-based chemicals manufacturing operation, which was sold in
February 2016, accounted for $3.4 million in sales in 2016. Excluding the effect of CCF and India, sales increased $42.4 million or 5.8%. The
Specialty Solutions business segment revenue increased 9.2% and the Performance Materials business segment revenue decreased by 3.9%.
Contributing to the net sales increase of $42.4 million in 2017 were improved customer pricing of $61.5 million, which was partially offset by
unfavorable volume of $18.7 million and currency exchange of $0.4 million. The favorable pricing increase was primarily due to higher raw
material costs and their related impact on pricing index formulas in certain markets of Performance Materials. The lower volume was driven
primarily by market weakness in paper and antioxidants, which were only partially offset by improved volumes in laminates, nonwovens, and oil
and gas.

Gross profit and gross profit margin in 2017 were $200.8 million and 25.6%, compared to $203.9 million and 26.8% in 2016. The slightly
lower gross profit margin was primarily due to unfavorable raw material costs, lower volumes, and slightly higher manufacturing costs as a result
of manufacturing footprint initiatives, which were partially offset by favorable price and mix.

Selling, general, and administrative expense in 2017 decreased $1.4 million to $117.1 million, compared to $118.5 million in 2016. The
decrease in 2017 reflects savings from cost reduction programs implemented during the prior year along with reductions in outside services
related to one-time project implementations, partially offset by a bad debt provision of $2.1 million.

During the fourth quarter of 2017, one of the Company’s largest carpet customers was acquired by a competing carpet manufacturer. This
customer had previously filed for bankruptcy reorganization, and due to the Company’s preferred supplier status, the Company continued to sell
product to this customer and concluded that all past due amounts from the customer were likely to be collected. As a result of the eventual sale
of the customer's business, in the fourth quarter of 2017, the Company was informed that its supply contract with the customer would not be
renewed and therefore the Company was no longer considered a preferred supplier. Accordingly, the Company recorded a bad debt provision of
$2.1 million, in the fourth quarter on 2017, as it now believes that a significant portion of the outstanding balance owed by this customer is
unlikely to be collected.

Income tax expense was $83.7 million in 2017, compared to an income tax expense of $10.3 million for 2016. The 2017 income tax
expense was higher than the statutory income tax rate of 35% primarily as a result of a $79.9 million income tax expense related to valuation
allowances on deferred tax assets. Of that amount, $75.7 million income tax expense was recorded in the U.S. during the fourth quarter of 2017.
These valuation allowances are discussed in more detail under the heading "Significant Accounting Estimates and Management Judgments - F)
Income Taxes". Additionally, a $19.6 million goodwill impairment was recorded in the fourth quarter of 2017 for which no tax benefit was realized
as the goodwill impairment is permanently non-deductible for tax purposes. The tax impact of the goodwill impairment is $6.9 million. These
expenses were partially offset by a $3.4 million income tax benefit from French legislative changes during the year. The 2016 effective tax rate
was higher than the statutory income tax rate of 35% primarily as a result of a $2.2 million tax expense related to the payment of an
intercompany dividend and a $1.6 million tax expense related to a newly enacted French deemed distribution tax. The French deemed
distribution tax, enacted in 2016, was reversed in the first quarter of 2017 as the law was repealed in late December of 2016. A $1.8 million tax
expense was also recorded for foreign valuation allowances on deferred tax assets in which no benefit is expected to be realized. In addition, the
Company realized a $1.0 million tax benefit related to foreign taxes in jurisdictions in which the tax rate is lower than the U.S. federal statutory
rate.

Segment Discussion

Year Ended
November 30,

2017

2016

(Dollars in millions)

Net Sales

Specialty Solutions ............................................................................................................................................ $

Performance Materials ......................................................................................................................................

Total Net Sales .......................................................................................................................................................... $

Segment Operating Profit

Specialty Solutions ............................................................................................................................................ $

Performance Materials ......................................................................................................................................

Total segment operating profit ....................................................................................................................................

Interest expense ........................................................................................................................................................

Corporate expenses ..................................................................................................................................................

Corporate severance .................................................................................................................................................

Operational improvement costs .................................................................................................................................

Asset impairment .......................................................................................................................................................

Acquisition and integration related expense ..............................................................................................................

Debt issuance costs write-off .....................................................................................................................................

Pension settlement ....................................................................................................................................................

441.4

341.7

783.1

59.9

(12.6)

47.3

(21.5)

(24.5)

(2.9)

—

(1.8)

(0.3)

—

(0.4)

Income (Loss) Before Income Taxes ...................................................................................................................... $

(4.1)

404.3

355.6

759.9

59.8

8.5

68.3

(24.7)

(25.8)

(4.9)

0.8

—

(0.9)

(2.9)

—

9.9

Specialty Solutions

Specialty Solutions' net sales increased $37.1 million to $441.4 million in 2017, compared to $404.3 million in 2016. The increased sales

were primarily driven by improved customer pricing of $23.3 million, and favorable volume of $14.1 million, which were slightly offset by
unfavorable currency translation effects of $0.3 million. Improved pricing was driven by higher contract-based index prices as a result of higher
raw material costs. Volume was up in Laminates & Films, Oil & Gas, Nonwovens and EMOD but were partially offset by declines in Coatings,
Home & Personal Care, and Construction. Net sales for the Specialty Coatings & Ingredients line increased $12.6 million to $231.3 million in
2017 compared to $218.7 million in 2016. Net sales for the Oil & Gas line increased $8.7 million to $54.6 million compared to $45.9 million in
2016. Net sales for the Laminates & Films line increased $15.9 million to $155.5 million in 2017 compared to $139.6 million in 2016.

This segment generated an operating profit of $59.9 million in 2017, compared to $59.8 million in 2016. The slight increase in segment

operating profit was due in part to effective cost reduction initiatives and favorable pricing, which offset higher raw material costs. In 2016, the
segment's operating profit was impacted primarily by the segment wide restructuring initiative and the asset impairment charges. Management
excludes these and other items when evaluating segment performance. Those items for 2017 totaled $0.9 million and included $0.6 million of
restructuring and severance charges and $0.3 million of operational improvement costs. Those items for 2016 totaled $0.4 million and included
facility closure costs of $1.5 million and $0.2 million of severance charges, partially offset by favorable adjustments of $1.3 million related to
operational and other improvement items. The segment operating profit was also impacted by higher manufacturing costs, which were offset by
margin expansion and and favorable mix.

Performance Materials

Performance Materials' net sales decreased $13.9 million to $341.7 million in 2017, compared to $355.6 million in 2016. During May 2017,

the Company sold CCF which accounted for $10.4 million of net sales in 2017 and $26.2 million in 2016. In the first quarter of 2016 the Company
sold its India operation which accounted for $3.4 million of net sales in 2016. Excluding these sold operations, net sales increased $5.2 million.
The increase of $5.2 million was driven primarily by higher pricing of $38.2 million, which was primarily offset by lower volumes of $32.8 million,
and unfavorable foreign currency translation effects of $0.1 million. Coated Fabrics' net sales decreased $16.3 million to $55.2 million in 2017
compared to $71.5 million in 2016, primarily due to the sale of CCF. Net sales for the Performance Additives decreased $6.0 million to $101.2
million in 2017 compared to $107.2 million in 2016, primarily due to decreased volumes. Paper and Carpet net sales increased $12.4 million to
$166.5 million in 2017 compared to $154.1 million in 2016, primarily due to improved pricing for carpet.

Segment operating loss was $12.6 million for 2017, compared to operating profit of $8.5 million for 2016. The decrease in segment
operating profit was primarily due to a goodwill impairment charge of $19.6 million related to lower volumes within the paper market. Segment
operating profit includes items which management excludes when evaluating the results of the Company's segments. Those items for 2017
totaled $13.7 million and include asset impairment charges and facility closure costs of $14.2 million, restructuring and severance costs of $1.7
million and a reversal of an environmental charge of $2.2 million. Those items for 2016 totaled $11.5 million and include acquisition and
integration related expense, asset impairment charges of $5.7 million related to the sale of CCF, workforce reduction actions of $3.3 million, $3.0
million of accelerated depreciation expense, environmental costs of $0.3 million, and favorable adjustments of $1.9 million related to operational
and other improvement items.

Interest and Corporate Expenses

Interest expense was $21.5 million and $24.7 million for 2017 and 2016, respectively. The decrease was attributable to a lower interest rate
in connection with the Company's refinanced term loan credit facility, and full redemption of its outstanding $150 million Senior Notes, which was
finalized in November of 2016. The Company incurred $1.9 million of additional interest expense between August and November 2016, the

amount of additional interest expense was less than the cost of the early redemption premium that the Company would have incurred by
redeeming the Senior Notes in August 2016.

Corporate expenses were $24.5 million in 2017, compared to $25.8 million in 2016. The decrease is due to cost reduction programs

implemented during the prior year along with reductions in outside services related to one-time project implementations.

Restructuring Plans

The Company initiated the following restructuring plans:

2018 Restructuring Plan

During the third quarter of fiscal 2018, the Company announced its plan to close its styrene butadiene manufacturing facility in Green Bay,

Wisconsin, moving production to our Mogadore, Ohio facility. The Company incurred $1.8 million of restructuring and severance expenses in
fiscal 2018 related to this plan. Total estimated restructuring and severance costs for this plan are expected to be between $5.0 million to $8.0
million. As of November 30, 2018, $0.8 million was paid for this plan. The plan is expected to be completed no later than the third quarter of fiscal
2019.

2017 Restructuring Plan

Restructuring and severance activities initiated in 2017 include the One OMNOVA initiative announced during the first quarter of 2017. The

One OMNOVA initiative is focused on improving functional excellence in marketing, sales, operations, supply chain and technology, as well as
various corporate functions. The plan is designed to reduce complexity and drive consistency across the global enterprise through a
standardized, integrated business system. Total estimated costs for this initiative are expected to be between $5.0 million and $7.0 million. For
this initiative, the Company has incurred costs of $5.2 million, of which $1.7 million was incurred in 2018, and $3.5 million in 2017. As of
November 30, 2018, $5.1 million was paid for this plan. The plan was substantially completed at the end of 2018.

2016 Restructuring Plan

Restructuring and severance activities initiated in 2016 included continued cost reduction and efficiency improvement actions, as well as a

change in the Company’s CEO. For these activities, the Company has incurred and paid restructuring and severance costs of $7.6 million,
including $2.1 million of costs recognized in 2017, and $5.5 million of costs recognized in 2016. As of November 30, 2018, the plan was
considered complete.

Financial Resources and Capital Spending

The following table reflects key cash flow measures from continuing operations:

Cash provided by (used in) operating activities ............................................................................... $

Cash provided by (used in) investing activities ................................................................................ $

Cash provided by (used in) financing activities ................................................................................ $

Increase (decrease) in cash and cash equivalents .......................................................................... $

2018

2017

2016

(Dollars in millions)

56.7

(46.0)

(42.7)

(33.9)

47.8

(28.6)

(6.6)

16.0

50.9

(20.3)

0.6

33.1

Cash provided by operating activities was $56.7 million in 2018, compared to $47.8 million in 2017 and $50.9 million in 2016. The $8.9

million increase in 2018 was primarily due to higher earnings after consideration of non-cash items and improved working capital. Working
capital days improved to 46.8 days in 2018 compared to 56.5 days in 2017. The decrease in cash provided by operating activities in 2017
compared to 2016 was due to an increase in accounts receivable, which was driven by higher sales occurring later in the fourth quarter of 2017
compared to 2016.

Cash used in investing activities was $46.0 million in 2018, compared to $28.6 million in 2017 and $20.3 million in 2016. The $17.4 million
increase in 2018 was driven primarily by the acquisition of Resiquimica S.A. of $22.8 million. Included in 2017 are capital expenditures of $25.1
million, primarily related to manufacturing equipment, and acquisition and disposal of businesses of $7.3 million partially offset by the collection
of a $3.8 million note receivable. Included in 2016 were capital expenditures of $25.6 million, primarily related to manufacturing equipment,
partially offset by proceeds from the sale of the India operation. The Company expects capital expenditures of approximately $30.0 million to
$35.0 million during 2019.

Cash used in financing activities was $42.7 million in 2018, compared with $6.6 million in 2017. The $36.1 million increase in 2018 was

driven primarily by debt repayments of $66.2 million and borrowings of $24.3 million. Cash used in financing activities was $6.6 million in 2017,
and was due primarily to $4.2 million of payments on the Company's debt, and $2.2 million of common stock redeemed in the repayment of
employees withholding taxes. Cash provided by financing activities was $0.6 million in 2016, and was due primarily to payments for fees on the
Company's debt refinancing of $4.3 million, and $0.7 million of common stock redeemed in the repayment of employees withholding taxes, offset
by additional borrowings as a result of refinancing our Term Loan. Gross debt was $329.7 million as of November 30, 2018, which includes
$302.1 million for the term loan and capital lease obligations of $15.6 million, compared to $361.8 million as of November 30, 2017. The
Company made a $40 million prepayment on its outstanding Term Loan B balance during the first quarter of fiscal 2018. OMNOVA’s cash

balance of $54.1 million at November 30, 2018 consists of $13.1 million in the U.S., $22.4 million in Europe, and $18.6 million in Asia. As of
November 30, 2018, the Company is not aware of any restrictions regarding the repatriation of its non-U.S. cash.

The Company believes that its cash flows from operations, together with existing credit facilities and cash on hand will be adequate to fund

its cash requirements for at least the next twelve months.

Debt

Information regarding the Company's debt is disclosed in Note K to the Company's consolidated financial statements.

Contractual Obligations

The following table summarizes the Company's contractual obligations for the periods indicated:

Payments Due By Period

Total

2019

2020 - 2021

2022 - 2023

Beyond
2023

Short-term and long-term debt ..................................................... $

314.1

Capital lease obligations ............................................................

(1)

Interest payments on long-term debt .........................................

(2)

Operating leases ..........................................................................

Purchase obligations ....................................................................

Pension and post-retirement funding obligations .......................

(3)

22.4

87.5

16.2

12.4

57.4

3.5

1.5

19.4

3.9

12.4

7.1

(Dollars in millions)

19.0

291.6

3.0

39.6

4.9

—

23.8

90.3

2.8

28.5

2.8

—

17.2

—

15.1

—

4.6

—

9.3

Total ........................................................................................................ $

510.0

47.8

(1)

Includes principal and effective interest payments.

342.9

29.0

(2) Based on outstanding debt balances as of November 30, 2018 and estimated interest rates. As those are based on estimates, actual future payments may be

different.

(3) Payments are based on Company estimates and current funding laws. As those are based on estimates, actual future payments may be different.

Significant Accounting Estimates and Management Judgments

The Company’s discussion and analysis of its results of operations, financial condition, and liquidity are based upon the Company’s
consolidated financial statements as of November 30, 2018, which have been prepared in accordance with U.S. generally accepted accounting
principles. The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the
reported amounts of assets and liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities as of the date of the
consolidated financial statements. Periodically, the Company reviews its estimates and judgments including those related to product returns,
accounts receivable, inventories, litigation, environmental reserves, pensions, and income taxes. The Company bases its estimates and
judgments on historical experience and on various assumptions that it believes to be reasonable under the circumstances. Actual results may
materially differ from these estimates under different assumptions or conditions.

Management believes the following critical accounting policies affect its more significant estimates and assumptions used in the preparation

of its consolidated financial statements:

A) Revenue Recognition

The Company recognizes revenue when the following criteria are met: 1) persuasive evidence of an arrangement exists; 2) delivery has

occurred; 3) an established sales price has been set with the customer; 4) collection of the sale revenue from the customer is reasonably
assured; and 5) no contingencies exist. Delivery is considered to have occurred when the customer assumes the risk and rewards of ownership.
The Company estimates and records provisions for customer quantity rebates and sales returns and allowances as reduction in revenue in the
same period the related revenue is recognized, based upon its historical experience.

B) Allowance For Doubtful Accounts

The Company’s policy is to identify customers that are considered doubtful of collection based upon the customer’s financial condition,
payment history, credit rating and other relevant factors; and reserves the portion of such accounts receivable for which collection does not
appear likely. The allowance for doubtful accounts was $3.3 million and $2.9 million at November 30, 2018 and 2017, respectively.

C) Allowance For Inventory Obsolescence

The Company’s policy is to maintain an inventory obsolescence reserve based upon specifically identified, discontinued, or obsolete items

and a percentage of quantities on hand compared with historical and forecasted usage and sales levels. A sudden and unexpected change in
design trends and/or material preferences could impact the carrying value of the Company’s inventory and require the Company to increase its
reserve for obsolescence. The reserve for inventory obsolescence was $6.9 million and $6.4 million at November 30, 2018 and 2017,
respectively.

D) Litigation and Environmental Reserves

From time to time, the Company is subject to claims, lawsuits, and proceedings related to product liability, product warranty, contract,
employment, environmental, and other matters. The Company provides a reserve for such matters when it concludes a material loss is probable
and the amount can be estimated. Costs related to environmental compliance are also accrued when it is probable a loss has been incurred and
the amount of loss can be estimated.

E) Pensions and Other Post-retirement Plans

The Company accounts for its pension and other post-retirement plans by recognizing in its balance sheet the overfunded or underfunded
status of defined benefit post-retirement plans, measured as the difference between the fair value of plan assets and the benefit obligation (the
projected benefit obligation for pension plans and the accumulated post-retirement benefit obligation for other post-retirement plans). The
Company recognizes the change in the funded status of the plan in the year in which the change occurs through Accumulated Other
Comprehensive (Loss) Income. As of May 2007, the Company's U.S. defined benefit pension plan have been closed to all new hires and since
December 1, 2011, future service benefits were frozen and fully vested for all participants. Therefore, there is no future service benefit accrual for
the Company’s U.S. defined benefit plans.

The most significant elements in determining the Company’s pension expense are the expected return on plan assets and the discount
rate. The assumed long-term rate of return on assets is applied to a calculated value of plan assets, which recognizes changes in the fair value
of plan assets in a systematic manner over five years. This produces the expected return on plan assets that is included in pension (expense)
income. For our U.S. plan, the difference between this expected return and the actual return on plan assets is deferred and amortized over the
estimated remaining life expectancy of plan participants. The net deferral of past asset gains (losses) affects the calculated value of plan assets
and, ultimately, future pension (expense) income.

The Company recorded pension expense of $1.3 million in 2018 and $2.1 million in 2017. Pension expense is calculated using the discount

rate to discount plan liabilities at the prior year measurement date. Discount rates of 3.66% and 4.12% were used to calculate the pension
expense in 2018 and 2017, respectively. The Company anticipates 2019 expense to be approximately $2.0 million based on a weighted average
discount rate of 4.41%. An increase or decrease of 25 basis points in the discount rate would decrease or increase expense on an annual basis
by approximately $0.1 million. Cash contributions to the pension plans were $6.3 million in 2018 and $7.6 million in 2017.

The Company, in consultation with its actuary, determined the discount rate used to discount the U.S. plan liabilities at the plan’s

measurement date, which was November 30, 2018. The discount rate reflects the current rate at which the pension liabilities could be effectively
settled at the end of the year. In determining the discount rate, we used spot rates on a yield curve matching benefit payments to determine the
weighted average discount rate that would be applied in determining the benefit obligation at November 30, 2018. Changes in discount rates, as
well as the net effect of other changes in actuarial assumptions and experience, have been recognized in Accumulated Other Comprehensive
Income (Loss). The Company, in consultation with its actuary, determined the discount rate used to measure defined benefit pension plan
obligations as of November 30, 2018 should be 4.41%, compared to 3.66% in 2017. A 25 basis point change in the discount rate would increase
or decrease the projected benefit obligation by approximately $6.5 million.

The Company utilizes an approach that discounts the individual expected cash flows underlying interest and service costs using the
applicable spot rates derived from the yield curve used to determine the benefit obligation to the relevant projected cash flows. The spot rates
used to determine service and interest costs for 2018 ranged from 1.92% to 4.08%. The ultimate spot rate used to discount cash flows beyond
30 years was 4.08% for 2018. The spot rates used to determine service and interest costs for 2019 expense ranged from 3.28% to 4.85%. The
ultimate spot rate used to discount cash flows beyond 30 years was 4.83% for 2019.

The use of disaggregated discount rates results in a different amount of Interest Cost compared to the traditional single weighted-average
discount rate approach because of different weightings given to each subset of payments. The use of disaggregated discount rates affects the
amount of Service Cost because the benefit payments associated with new service credits for active employees tend to be of longer duration
than the overall benefit payments associated with the plan’s benefit obligation. As a result, the payments would be associated with longer-term
spot rates on the yield curve, resulting in lower present values than the calculations using the traditional single weighted-average discount rate.

The Company uses the Mercer modified version (MRP - 2007) of the Society of Actuaries’ (SOA) RP-2014 mortality table for the pre-
retirement mortality base table. The Company also uses the Mercer Industry Longevity Experience Study (MILES) table for the Chemical, Oil &
Gas and Utilities industry and the Consumer Goods and Food & Drink industry for the post-retirement mortality base table.

To develop the expected long-term rate of return on assets assumption, the Company, in consultation with its actuary, considered the
historical returns and the future expectations for returns for each asset class, as well as the target allocation of the pension portfolio. This
resulted in the selection of a long-term rate of return on assets assumption of 7.68% for both 2018 and 2017. The measurement dates of
November 30, 2018 and 2017 were used to determine these rates. A 25 basis point change in the assumed rate of return for assets would
increase or decrease pension expense by approximately $0.5 million. Pension plan assets are measured at fair value or at Net Asset Value
("NAV") for certain collective trusts on the measurement date.

Based on current estimates of pension asset performance, interest and discount rate assumptions, the Company expects it will be required

to make a cash contributions to its pension plans of $6.4 million in 2019.

Factors that could impact future cash requirements and timing of any such cash equivalents are:

• Investment returns which differ materially from the Company’s 7.68% return assumption for 2019;

• Significant changes in interest rates, affecting the discount rate; and

• Opportunities to reduce future cash requirements by accelerating contributions ahead of the minimum required schedule. Voluntary

contributions in excess of minimally required amounts may prevent the need for larger contributions in the future.

F) Income Taxes

The Company follows the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are

determined based on the difference between the financial reporting and tax bases of assets and liabilities using the enacted tax rates that will be
in effect in the period the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets, if based
on the weight of all available positive and negative evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not
be realized. Changes in tax laws and rates may affect recorded deferred tax assets and liabilities along with our effective tax rate in the future.

A high degree of judgment is required to determine the extent a valuation allowance should be provided against deferred tax assets. On a

quarterly basis, the Company assesses the likelihood of realization of its deferred tax assets considering all available evidence, both positive and
negative. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected
future earnings, carry-back and carry-forward periods and tax strategies that could potentially enhance the likelihood of the realization of a
deferred tax asset. The weight given to the positive and negative evidence is commensurate with the extent to which the evidence may be
objectively verified. It is generally difficult to outweigh objectively verifiable negative evidence of cumulative financial reporting losses.

As a result of historical restructuring charges and impairments over the last few years, including a significant goodwill impairments recorded

in the fourth quarter of 2017, the Company entered into a U.S. jurisdiction three-year cumulative loss position for the three year period ending
November 2017. The Company considered sources of positive evidence, including the Company’s year over year growth in its core earnings,
expected future earnings, which if realized would enable the Company to utilize its net operating loss carryforwards, and a recent history of net
operating loss utilization. A cumulative loss position is considered significant negative evidence in assessing the realizability of a deferred tax
asset that is difficult to overcome when determining whether a valuation allowance is required. Based on the weight of all available positive and
negative evidence, the Company established a valuation allowance of $73.1 million in the fourth quarter of 2017 on its U.S. deferred tax assets.
In addition, a $3.3 million valuation allowance was established on a capital loss incurred in the U.S. on the stock sale of a foreign subsidiary
during the third quarter of 2017. For the three year period ended November 2018, the U.S. jurisdiction remains in a three-year cumulative loss
position. Considering the weight of available positive and negative evidence, the Company does not believe the positive evidence (some of
which is subjective) overcomes the negative objective evidence of a 3-year cumulative loss position. Therefore, the Company concludes that the
valuation allowance should remain on its U.S. deferred tax assets as of November 30, 2018.

The Company has not provided for U.S. income taxes on undistributed earnings on certain of its non-U.S. subsidiaries as such amounts are

considered permanently reinvested outside the U.S. As a result of the Tax Act, to the extent that foreign earnings previously treated as
permanently reinvested are repatriated, the related U.S. tax liability primarily attributable to withholding taxes may be creditable. However, based
on the Company's policy of permanent reinvestment, it is not practicable to determine the U.S. federal income tax liability, if any, which would be
payable if such earnings were not permanently reinvested. As of November 30, 2018, the non-U.S. subsidiaries have cumulative foreign retained
earnings of $60.6 million.

The Company utilizes a recognition threshold and measurement attribute for the financial statement recognition and measurement of an

income tax position taken or expected to be taken in an income tax return. For those benefits to be recognized, an income tax position must be
more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of
benefit that is more-likely-than-not of being realized upon ultimate settlement.

The Company’s accounting policy for interest and/or penalties related to underpayments of income taxes is to include interest and

penalties in income tax expense. For 2018, the Company recognized minimal income tax expense related to interest and penalties.

On December 22, 2017, U.S. federal tax legislation, commonly referred to as the Tax Cuts and Job Act (the “Tax Act”) was signed into law
which, among other changes: reduced the U.S. corporate income tax rate effective January 1, 2018 from 35% to 21%; repealed the Alternative
Minimum Tax (“AMT”); imposed a one-time transition tax on accumulated foreign earnings not previously subject to U.S. taxation; provides a
U.S. federal tax exemption on future distributions of foreign earnings; and beginning in fiscal 2019, creates a new minimum tax on certain
foreign-sourced earnings. The U.S. corporate tax rate reduction resulted in a blended federal statutory tax rate of 22.2% for fiscal 2018 (based
on 35% corporate rate through December 31, 2017 and 21% from that date through the end of fiscal 2018). The Securities and Exchange
Commission Staff Accounting Bulletin No.118 (“SAB 118”), provides a measurement period that should not extend beyond one year from the Tax
Act enactment date for companies to complete the accounting under ASC 740, Income Taxes. While the Company was able to make reasonable
estimates of the items above, the ultimate impact may differ from these provisional amounts due to additional analysis, changes in
interpretations and assumptions, additional regulatory guidance that may be issued and actions we may take as a result of the Tax Act.
Adjustments to the provisional amounts recorded by the Company that are identified within a subsequent measurement period of up to one year
from the enactment date will be included as an adjustment to income tax expense in the period the amounts are determined.

G) Share-Based Compensation

The Company uses the fair value method of accounting to record share-based compensation based on the grant date fair value. While the

Company regularly evaluates the use of share-based compensation, its practice has been to issue restricted shares or restricted share units,
which are required to be expensed using the fair value method. Beginning with grants in 2018, the Company determined that its Performance
Share Units ("PSU's") would vest and be paid in OMNOVA common shares. The fair value of PSU's, Restricted Share Awards ("RSA's") and
Restricted Share Units ("RSU's") is determined based on the closing market price of the Company’s common shares at the date of grant. Refer
to Note N to the Company’s Consolidated Financial Statements for further discussion of share-based compensation.

H) Long-Lived Assets

Long-lived assets, such as property, plant, and equipment, and finite-lived intangibles are stated at historical cost less accumulated

depreciation and amortization.

Construction in process ("CIP") is not depreciated until the asset is placed in service. Refurbishment costs that extend the useful life of the

asset are capitalized, whereas ordinary maintenance and repair costs are expensed as incurred. Interest expense incurred during the
construction phase is capitalized as part of CIP until the relevant projects are completed and placed into service.

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset

may not be recoverable. Recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to the
estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future
cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the estimated fair value of the
asset. Assets to be disposed of are reported at the lower of the carrying amount or the estimated disposal price less costs to sell. Depreciation
ceases for assets meeting the held-for-sale criteria.

During 2018, the Company's Board of Directors approved a plan to close the Green Bay, Wisconsin plant shifting styrene butadiene
manufacturing to its production plant in Mogadore, Ohio. As a result, the Company determined that certain plant and equipment were impaired
and recognized an impairment charge of $9.2 million, primarily in the Performance Materials segment, to write-down the asset group to fair value
based on the market approach analysis. Also during 2018, the Company recognized other asset impairment charges of $2.7 million related to
idled assets.

During the fourth quarter of 2017, due to anticipated lower volumes in the paper market, the Company performed an impairment analysis of

the related asset group. Based on this analysis, it was determined that the fair value of the asset group was in excess of the book value, and
accordingly, the Company concluded no impairment was necessary.

During the fourth quarter of 2016, due to changes in markets and expected lower capacity utilization at the CCF facility, the Company
performed an impairment analysis of this asset group. Based on this analysis, it was determined that the fair value of the asset group was less
than book value, and accordingly, the Company recognized an impairment charge of $5.4 million and reduced Property, Plant, and Equipment by
$5.2 million and intangible assets by $0.2 million. The CCF facility also recognized $0.3 million of impairment charges during the first quarter of
2016 related to equipment. Additionally, during the second quarter of 2017, in connect with the pending sale of the CCF operations, the
Company further recognized an additional impairment charge of $12.8 million to write down the asset group to the contract sale price which
approximated fair value.

I) Goodwill and Intangible Assets

Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed in a business

combination. Goodwill and other indefinite lived intangible assets are tested for impairment at least annually as of September 1, and whenever
events or circumstances indicate that the carrying amount may not be recoverable. The Company performs the impairment analysis at the
reporting unit level using a two-step impairment test. The first step identifies potential impairments by comparing the estimated fair value of a
reporting unit with its carrying value. Fair value is typically estimated using a market approach method or a discounted cash flow analysis based
on level 3 inputs in the fair value hierarchy, which requires the Company to estimate future cash flows anticipated to be generated by the
reporting unit, as well as a discount rate to measure the present value of the anticipated cash flows. If the estimated fair value of a reporting unit
exceeds its carrying value, goodwill is not considered impaired and the second step is not necessary. If the carrying value of a reporting unit
exceeds the estimated fair value, the second step calculates the possible impairment by comparing the implied fair value of goodwill with the
carrying value. If the implied fair value of goodwill is less than the carrying value, an impairment charge is recognized.

The impairment test for indefinite lived intangible assets consists of comparing the fair value of the asset with its carrying value. The
Company estimates the fair value of its indefinite lived intangible assets using a fair value model based on a market approach method or
discounted future cash flows. If the carrying amounts exceed the estimated fair value, an impairment loss would be recognized in the amount of
the excess. Key inputs used in determining the fair value of the trademarks/tradenames were expected future revenues and royalty rates, and
accordingly, their fair value is impacted by selling prices, which for the Company is based in part on raw material costs. As of September 1, 2018,
the Company performed its annual impairment test for indefinite lived intangible assets and determined that there was one tradename
associated with Performance Materials that was impaired by $1.5 million and as a result, the carrying value equals the fair value of this
tradename as of the annual impairment testing date. A sensitivity analysis was performed by the Company on this tradename and a hypothetical
100 basis point increase in the discount rate used to value this tradename would result in additional impairment of $0.3 million. Trademarks and
tradenames continue to be important to the Company, and we continue to focus on long-term growth, however, if recent trends continue, the
long-term assumptions relative to growth rates and profitability of the trademarks and tradenames may not be attained, which could result in
additional impairment to one or more of the Company's trademarks and tradenames.

Estimating future cash flows requires significant judgments and assumptions by Management including sales, operating margins, royalty
rates, discount rates, and future economic conditions. To the extent that the reporting unit is unable to achieve these assumptions, impairment
losses may occur.

Finite lived intangible assets, such as customer lists, patents, certain trademarks/tradenames, and licenses, are recorded at cost or

estimated fair value when acquired as part of a business combination. Intangible assets with finite lived are amortized over their estimated useful
lives with periods ranging from 3 to 53 years.

J) Foreign Currency Translation

The financial position and results of operations of the Company’s foreign subsidiaries are measured using the local currency as the
functional currency. Assets and liabilities of operations denominated in foreign currencies are translated into U.S. dollars at exchange rates in
effect at the balance sheet date, while revenues and expenses are translated at the weighted average exchange rates each month during the
year. The resulting translation gains and losses on assets and liabilities are recorded in Accumulated Other Comprehensive Income (Loss), and
are excluded from net income until realized through a sale or liquidation of the investment.

K) Leasing Arrangements

Operating lease expenses are recorded on a straight-line basis over the non-cancelable lease term, including any optional renewal terms

that are reasonably expected to be exercised. Leasehold improvements related to these operating leases are amortized over the estimated
useful life or the non-cancelable lease term, whichever is shorter.

Capital leases are recorded at the lower of fair market value or the present value of future minimum lease payments with a corresponding

amount recorded in property, plant, and equipment. Current portions of capital lease payments are included in Amounts due banks and non-
current capital lease obligations are included in Long-term debt in our Consolidated Balance Sheets.

Environmental Matters

The Company’s policy is to conduct its businesses with due regard for the preservation and protection of the environment. The Company

devotes significant resources and Management attention to comply with environmental laws and regulations. The Company’s Consolidated
Balance Sheets as of November 30, 2018 and 2017 reflects reserves for environmental remediation efforts of $1.5 million and $1.6 million,
respectively.

Capital expenditures for projects related to environmental matters were $1.0 million in 2018, $1.0 million in 2017, and $1.1 million in 2016.

During 2018, non-capital expenditures for environmental compliance and protection totaled $10.0 million, all of which were for recurring costs
associated with managing hazardous substances and pollution abatement in ongoing operations. Similar non-capital expenditures were $8.8
million and $6.5 million in years 2017 and 2016, respectively. The Company anticipates that non-capital environmental expenditures for the next
several years will be consistent with 2018 expenditure levels.

New Accounting Pronouncements

New accounting pronouncements impacting the Company are disclosed in Note A to the Company’s consolidated financial statements.

Forward Looking Statements

This Annual Report includes forward looking statements as defined by federal securities laws. Please refer to Item 1A. Risk Factors of this

Report, which is incorporated herein by reference.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

The Company is exposed to market risk from changes in interest rates on its long-term debt obligations. As described in Note K to the
Consolidated Financial Statements, the Company’s Term Loan B, Senior Secured Revolving Credit Facility, and Eurodollar Revolving Loan bears
interest at variable rates. The Company has $314.1 million of variable rate debt as of November 30, 2018. The weighted average effective
interest rate of the Company’s outstanding debt was 5.33% for 2018. A hypothetical increase of 100 basis points would impact the Company’s
interest expense on its variable rate debt by approximately $3.1 million annually.

The Company is subject to foreign currency exchange rate risk. The Company has accumulated currency translation losses of $32.6 million

as of November 30, 2018, which is included in accumulated other comprehensive income (loss).

The Company does not enter into derivatives or other financial instruments for trading or speculative purposes.

Management’s Assessment of Internal Control Over Financial Reporting

Management of OMNOVA Solutions Inc. is responsible for establishing and maintaining adequate internal control over financial reporting,

as such term is defined in Exchange Act Rules 13a-15(f). In evaluating the Company’s internal control over financial reporting, Management has
adopted the framework in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission (2013 framework).

Under the supervision and with the participation of the Company’s Management, including the Chief Executive Officer and Chief Financial

Officer, the Company conducted an assessment of the effectiveness of the Company’s internal control over financial reporting. Management has
determined that the Company’s internal control over financial reporting is effective as of November 30, 2018.

On September 25, 2018, the Company acquired all of the outstanding shares of Resiquimica S.A. and certain related entities

("Resiquimica") from Socer - Imobiliaria e Investimentos, S.A. As permitted by the Securities and Exchange Commission, management excluded
the Resiquimica operations from its assessment of internal control over financial reporting as of November 30, 2018. Resiquimica operations
constituted 1% of total sales and net income and 8% of total assets. Resiquimica operations will be included in the Company's assessment of
internal control over financial reporting as of November 30, 2019.

The effectiveness of the Company’s internal control over financial reporting as of November 30, 2018 has been audited by Ernst & Young

LLP, an independent registered public accounting firm, as stated in its report, which is included herein.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors of OMNOVA Solutions Inc.

Opinion on Internal Control over Financial Reporting

We have audited OMNOVA Solutions Inc.’s internal control over financial reporting as of November 30, 2018, based on criteria established in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO
criteria). In our opinion, OMNOVA Solutions Inc. ("the Company") maintained, in all material respects, effective internal control over financial reporting
as of November 30, 2018, based on the COSO criteria.

As indicated in the accompanying Management’s Assessment of Internal Control Over Financial Reporting, management’s assessment of and
conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Resiquimica S.A. and certain related
entities (“Resiquimica”), which is included in the 2018 consolidated financial statements of the Company and constituted 8% of total assets as of
November 30, 2018 and 1% of net sales and net income for the year then ended. Our audit of internal control over financial reporting of the Company
also did not include an evaluation of the internal control over financial reporting of Resiquimica.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the
consolidated balance sheets of the Company as of November 30, 2018 and 2017, and the related consolidated statements of operations,
comprehensive income (loss), shareholders’ equity and cash flows for each of the three years in the period ended November 30, 2018, and the
related notes and our report dated January 31, 2019 expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the
effectiveness of internal control over financial reporting included in the accompanying Management’s Assessment of Internal Control Over Financial
Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public
accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing
and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s
internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that
receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company;
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s
assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP

Akron, Ohio

January 31, 2019

Item 8.

Consolidated Financial Statements and Supplementary Data

INDEX TO FINANCIAL STATEMENTS

Report of Management

Report of Independent Registered Public Accounting Firm

Consolidated Statements of Operations for the years ended November 30, 2018, 2017, and 2016

Consolidated Statements of Comprehensive Income (Loss) for the years ended November 30, 2018, 2017, and 2016

Consolidated Balance Sheets at November 30, 2018 and 2017

Consolidated Statements of Shareholders’ Equity for the years ended November 30, 2018, 2017, and 2016

Consolidated Statements of Cash Flows for the years ended November 30, 2018, 2017, and 2016

Notes to Consolidated Financial Statements

Page
Number

To the Shareholders of OMNOVA Solutions Inc.:

REPORT OF MANAGEMENT

Management of OMNOVA Solutions Inc. is responsible for preparing the accompanying consolidated financial statements and for assuring their
integrity and objectivity. These financial statements were prepared in accordance with U.S. generally accepted accounting principles and fairly
represent the transactions and financial condition of the Company in all material respects. The financial statements include amounts that are based
on management’s best estimates and judgments. The Company’s financial statements have been audited by Ernst & Young LLP, an independent
registered public accounting firm that has been selected and approved by the Audit Committee of the Board of Directors and ratified by the
shareholders. Management has made available to Ernst & Young LLP all of the Company’s financial records and related data, internal audit reports,
as well as the minutes of shareholders’ and directors’ meetings.

Management of the Company has established and maintains a system of internal controls over financial reporting that is designed to provide
reasonable assurance that assets are safeguarded, transactions are properly recorded and executed in accordance with management’s authorization
and the books and records accurately reflect the disposition of assets. The system of internal controls includes appropriate division of responsibility.
The Company maintains an internal audit function that independently assesses the effectiveness of the internal controls through a program of
internal audits.

The Audit Committee is composed of directors who are not officers or employees of the Company. It meets regularly with members of Management,
the internal auditors, and representatives of the independent registered public accounting firm to discuss the adequacy of the Company’s internal
control over financial reporting, financial statements, and the nature, extent, and results of the audit effort. Management reviews with the Audit
Committee all of the Company’s significant accounting policies and assumptions affecting the results of operations. Both the independent registered
public accounting firm and internal auditors have access to the Audit Committee without the presence of Management.

/s/ Anne P. Noonan
Anne P. Noonan
President and Chief Executive Officer

/s/ Paul F. DeSantis
Paul F. DeSantis
Senior Vice President and Chief Financial Officer; Treasurer

January 31, 2019

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors of OMNOVA Solutions Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of OMNOVA Solutions Inc. ("the Company") as of November 30, 2018 and 2017,
and the related consolidated statements of operations, comprehensive income (loss), shareholders’ equity and cash flows for each of the three
years in the period ended November 30, 2018, and the related notes (collectively referred to as the “consolidated financial statements”). In our
opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at November 30, 2018
and 2017, and the results of its operations and its cash flows for each of the three years in the period ended November 30, 2018, in conformity with
U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s
internal control over financial reporting as of November 30, 2018, based on criteria established in Internal Control-Integrated Framework issued by
the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated January 31, 2019 expressed an
unqualified opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included
performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in
the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Ernst & Young LLP

We have served as the Company's auditor since 1999.

Akron, Ohio

January 31, 2019

OMNOVA SOLUTIONS INC.

Consolidated Statements of Operations

Years Ended November 30,

2018

2017

2016

(Dollars and shares in millions, except per share data)

Net Sales ....................................................................................................................................... $

Cost of goods sold (exclusive of depreciation) ................................................................................

Gross profit

.....................................................................................................................................

769.8

579.1

190.7

783.1

582.3

200.8

Other Costs and Expenses:

Selling, general, and administrative ................................................................................................

104.2

117.1

Depreciation and amortization ........................................................................................................

Asset impairments ..........................................................................................................................

(Gain) Loss on asset sales .............................................................................................................

Restructuring and severance ..........................................................................................................

Interest expense .............................................................................................................................

Debt issuance costs write-off ..........................................................................................................

Acquisition and integration related expense ....................................................................................

Other (income) expense, net

..........................................................................................................

Total Other Costs and Expenses .......................................................................................

Income (loss) before income taxes .................................................................................................

Income tax (expense) benefit ..........................................................................................................

Net Income (loss) .......................................................................................................................... $

30.2

13.5

(0.9)

3.5

19.3

0.8

4.1

1.5

176.2

14.5

6.2

20.7

Net Income (Loss) Per Share - Basic and Diluted ...................................................................... $

0.46

Weighted average shares outstanding - Basic ................................................................................

Weighted average shares outstanding - Diluted .............................................................................

44.6

44.9

27.9

32.9

0.4

5.7

21.5

—

0.3

(0.9)

204.9

(4.1)

(83.7)

(87.8)

(1.98)

44.4

759.9

556.0

203.9

118.5

30.6

5.7

0.3

11.1

24.7

2.9

0.9

(0.7)

194.0

9.9

(10.3)

(0.4)

(0.01)

44.0

See notes to consolidated financial statements.

OMNOVA SOLUTIONS INC.

Consolidated Statements of Comprehensive Income (Loss)

Years Ended November 30,

2018

2017

2016

(Dollars in millions)

Net income (loss) .......................................................................................................................... $

20.7

(87.8)

(0.4)

Components of other comprehensive income (loss):

Foreign currency translations:

Realized net change during the period ............................................................................................

Unrealized net change during the period ........................................................................................

Unrealized net change on intercompany foreign debt during the period .........................................

Tax effect

........................................................................................................................................

Foreign currency translations, net of tax .........................................................................................

Post-retirement benefit plans:

Actuarial net gain (loss):

Net gain (loss) arising during period .............................................................................................

Amortization of net loss included in net periodic benefit cost .......................................................

Settlement charge ...........................................................................................................................

Prior service cost:

...........................................................................................................................

Prior service credit arising during period ......................................................................................

Amortization of prior service credits included in net periodic benefit cost .....................................

Tax effect

........................................................................................................................................

Post-retirement benefit plans, net of tax .........................................................................................

Other comprehensive income (loss), net of tax .........................................................................

—

(8.2)

(1.1)

(0.2)

(9.5)

8.4

4.5

—

0.1

(0.6)

12.4

2.9

(6.3)

8.9

6.2

(2.3)

6.5

2.6

3.9

0.4

(0.1)

—

(0.1)

6.7

13.2

Comprehensive income (loss) ..................................................................................................... $

23.6

(74.6)

See notes to consolidated financial statements.

5.9

(5.5)

0.4

(0.2)

0.6

(8.9)

3.6

—

2.1

(3.2)

(2.6)

(3.0)

OMNOVA SOLUTIONS INC.

Consolidated Balance Sheets

November 30,

2018

2017

(Dollars in millions, except share data)

ASSETS:

Current Assets

Cash and cash equivalents ........................................................................................................................... $

54.1

Accounts receivable, net

...............................................................................................................................

Inventories, net

.............................................................................................................................................

Prepaid expenses and other .........................................................................................................................

Total Current Assets ...........................................................................................................................

Property, plant, and equipment, net

..............................................................................................................

Intangible assets, net

....................................................................................................................................

Goodwill

........................................................................................................................................................

Other non-current assets ..............................................................................................................................

112.1

78.8

8.0

253.0

205.8

53.5

70.9

6.0

Total Assets ......................................................................................................................................... $

589.2

LIABILITIES AND SHAREHOLDERS’ EQUITY:

Current Liabilities

Short-term debt

............................................................................................................................................. $

4.2

Accounts payable ..........................................................................................................................................

Accrued payroll and personal property taxes ................................................................................................

Employee benefits ........................................................................................................................................

Other current liabilities ..................................................................................................................................

Total Current Liabilities ......................................................................................................................

Long-term debt ..............................................................................................................................................

Post-retirement benefits other than pensions ................................................................................................

Pension liabilities ..........................................................................................................................................

Deferred income taxes ..................................................................................................................................

Other non-current liabilities ...........................................................................................................................

Total Liabilities ....................................................................................................................................

Shareholders’ Equity

Preference stock - $1.00 par value; 15 million shares authorized; none outstanding ....................................

Common stock - $0.10 par value; 135 million shares authorized; 48.3 million shares issued as of
November 30, 2018 and 2017, respectively ..................................................................................................
........................................................................................................................

Additional contributed capital

Retained deficit

.............................................................................................................................................

Treasury stock at cost - 3.4 million and 3.5 million shares as of November 30, 2018 and 2017,

respectively ...............................................................................................................................................

Accumulated other comprehensive loss ........................................................................................................

Total Shareholders’ Equity .................................................................................................................

101.1

15.5

2.9

10.1

133.8

318.7

5.3

51.6

13.4

8.8

531.6

—

4.8

345.9

(145.4)

(25.3)

(122.4)

57.6

Total Liabilities and Shareholders’ Equity ........................................................................................ $

589.2

See notes to consolidated financial statements.

88.0

99.0

76.5

12.5

276.0

208.9

56.0

66.3

5.6

612.8

4.2

78.3

26.1

2.9

5.1

116.6

349.8

6.3

70.5

23.4

8.0

574.6

—

4.8

343.4

(159.2)

(25.5)

(125.3)

38.2

612.8

l
a
t
o
T

’
s
r
e
d
o
h
e
r
a
h
S

y
t
i
u
q
E

r
e
h
t
O
d
e
t
a
l
u
m
u
c
c
A

e
v
i
s
n
e
h
e
r
p
m
o
C

)
s
s
o
L
(
e
m
o
c
n

y
r
u
s
a
e
r
T

k
c
o
t
S

d
e
n
i
a
t
e
R

t
i
c
i
f
e
D

l
a
n
o
i
t
i
d
d
A

d
e
t
u
b
i
r
t
n
o
C

l
a
t
i
p
a
C

n
o
m
m
o
C

k
c
o
t
S

f
o
r
e
b
m
u
N

n
o
m
m
o
C

s
e
r
a
h
S

g
n
d
n
a
t
s
t
u
O

)
s
n
o

i
l
l
i

m
n

s
e
r
a
h
s
d
n
a

s
r
a
l
l

o
D

(

C
N

S
N
O
T
U
L
O
S
A
V
O
N
M
O

y
t
i
u
q
E

’
s
r
e
d
o
h
e
r
a
h
S

f
o
s
t
n
e
m
e
t
a
t
S
d
e
t
a
d

i
l

o
s
n
o
C

6
1
0
2
d
n
a

,
7
1
0
2
,
8
1
0
2

,
0
3

r
e
b
m
e
v
o
N
d
e
d
n
E
s
r
a
e
Y
e
h
t

r
o
f

1
.
9
0
1

)
9
.
5
3
1
(

)
6
.
5
2
(

)
9
.
3
7
(

7
.
9
3
3

8
.
4

8
.
4
4

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

5
1
0
2

,
1

r
e
b
m
e
c
e
D
e
c
n
a
l
a
B

)
4
.
0
(

6
.
0

)
2
.
3
(

7
.
3

8
.
9
0
1

)
8
.
7
8
(

5
.
6

9
.
2

7
.
6

5
.
2

)
4
.
2
(

2
.
8
3

7
.
0
2

)
5
.
9
(

)
9
.
6
(

4
.
2
1

8
.
2

)
1
.
0
(

6
.
7
5

6
.
0

)
2
.
3
(

)
4
.
0
(

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
s
s
o
l
(
e
m
o
c
n

t
e
N

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
n
o

i
l
l
i

m
2

0
$

o
x
a

e
n
(

s
n
o

i
t

a
s
n
a
r
t

y
c
n
e
r
r
u
c
n
g
e
r
o
F

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
n
o

i
l
l
i

m
1
2
$

x
a

e
n
(

s
n
a
p

t
i
f
e
n
e
b
t
n
e
m
e
r
i
t
e
r
-
t
s
o
P

)
5
.
8
3
1
(

)
2
.
3
2
(

)
3
.
4
7
(

0
.
1
4
3

8
.
4

1
.
5
4

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

6
1
0
2

0
3

r
e
b
m
e
v
o
N
e
c
n
a
l
a
B

4
.
2

3
.
1

3
.
0

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

e
c
n
a
u
s
s

e
r
a
h
s
n
o
m
m
o
C

5
.
6

7
.
6

)
8
.
7
8
(

9
.
2

)
3
.
2
(

5
.
2

)
1
.
0
(

)
3
.
0
(

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

s
e
x
a

e
e
y
o
p
m
e

n
o
d
e
h
h
t
i

w
s
e
r
a
h
s
n
o
m
m
o
C

)
s
s
o
l
(
e
m
o
c
n

t
e
N

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
n
o

i
l
l
i

m
3

2
$

o
x
a

e
n
(

s
n
o

i
t

a
s
n
a
r
t

y
c
n
e
r
r
u
c
n
g
e
r
o
F

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

e
g
n
a
h
c

g
n
i
t
n
u
o
c
c
a

r
o
f

t
n
e
m
t
s
u
d
A

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
n
o

i
l
l
i

m
1
0
$

x
a

e
n
(

s
n
a
p

t
i
f
e
n
e
b
t
n
e
m
e
r
i
t
e
r
-
t
s
o
P

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

n
o

i
t

a
s
n
e
p
m
o
c
d
e
s
a
b
-
e
r
a
h
S

)
3
.
5
2
1
(

)
5
.
5
2
(

)
2
.
9
5
1
(

4
.
3
4
3

8
.
4

8
.
4
4

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

7
1
0
2

0
3

r
e
b
m
e
v
o
N
e
c
n
a
l
a
B

)
4
.
2
2
1
(

)
3
.
5
2
(

)
4
.
5
4
1
(

9
.
5
4
3

8
.
4

9
.
4
4

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

8
1
0
2

0
3

r
e
b
m
e
v
o
N
e
c
n
a
l
a
B

)
5
.
9
(

4
.
2
1

7
.
0
2

)
9
.
6
(

2
.
0

8
.
2

)
3
.
0
(

1
.
0

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

r
e
h
t
O

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
s
s
o
l
(
e
m
o
c
n

t
e
N

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
n
o

i
l
l
i

m
2

0
$

o
x
a

e
n
(

s
n
o

i
t

a
s
n
a
r
t

y
c
n
e
r
r
u
c
n
g
e
r
o
F

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

e
g
n
a
h
c

g
n
i
t
n
u
o
c
c
a

r
o
f

t
n
e
m
t
s
u
d
A

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

)
n
o

i
l
l
i

m
6
0
$

x
a

e
n
(

s
n
a
p

t
i
f
e
n
e
b
t
n
e
m
e
r
i
t
e
r
-
t
s
o
P

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

n
o

i
t

a
s
n
e
p
m
o
c
d
e
s
a
b
-
e
r
a
h
S

.
s
t
n
e
m
e
t
a
t
s

a
c
n
a
n
i
f

d
e
t
a
d

i
l

o
s
n
o
c

o
t

s
e
t
o
n

e
e
S

OMNOVA SOLUTIONS INC.

Consolidated Statements of Cash Flows

Years Ended November 30,

2018

2017

2016

(Dollars in millions)

Operating Activities:

Net income (loss) ........................................................................................................................... $

20.7

(87.8)

(0.4)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

(Gain) loss on disposal of assets ...........................................................................................

Depreciation and amortization ...............................................................................................

Amortization and write-off of debt issuance costs ..................................................................

Asset impairments ..................................................................................................................

Non-cash stock compensation expense ................................................................................

Provision for uncollectible accounts .......................................................................................

Provision for obsolete inventories ..........................................................................................

Deferred income taxes ...........................................................................................................

Other ......................................................................................................................................

Changes in operating assets and liabilities, net of effect from acquisitions and divestitures of
businesses:

Accounts receivable ...............................................................................................................

Inventories .............................................................................................................................

Other current assets ..............................................................................................................

Current liabilities ....................................................................................................................

Other non-current assets .......................................................................................................

Other non-current liabilities ....................................................................................................

Contributions to defined benefit plan .....................................................................................

Net Cash Provided By (Used In) Operating Activities .........................................................

Investing Activities:

Capital expenditures ......................................................................................................................

Proceeds from note receivable ......................................................................................................

Acquisition and disposal of businesses .........................................................................................

Proceeds from sale of assets .........................................................................................................

Proceeds from insurance settlements ............................................................................................

(0.9)

30.2

2.1

13.5

2.8

0.6

1.0

(13.8)

—

4.3

4.1

4.9

(0.7)

(2.5)

(3.3)

(6.3)

56.7

(23.8)

—

(23.1)

0.9

—

0.4

27.9

1.5

32.9

1.9

2.1

0.3

77.1

—

(13.9)

(0.1)

8.0

2.1

(8.3)

11.3

(7.6)

47.8

(25.1)

3.8

(7.3)

—

0.3

30.6

4.7

5.7

3.5

0.3

—

5.2

(0.8)

4.1

4.4

(10.3)

11.6

(12.9)

11.1

(6.2)

50.9

(25.6)

—

5.2

—

0.1

Net Cash Provided By (Used In) Investing Activities .........................................................

(46.0)

(28.6)

(20.3)

Financing Activities:

Proceeds from borrowings .............................................................................................................

Repayment of debt obligations ......................................................................................................

Payments for debt refinancing .......................................................................................................

Acquisition related contingent consideration payments .................................................................

Other equity transactions ...............................................................................................................

Employee tax withholdings related to redemption of common shares ...........................................

Net Cash Provided By (Used In) Financing Activities ........................................................

Effect of exchange rate changes on cash ......................................................................................

Net Increase (Decrease) in Cash and Cash Equivalents ..........................................................

Cash and cash equivalents at beginning of period ........................................................................

Cash and Cash Equivalents at End of Period ..................................................................... $

Supplemental Cash Flow Information:

Cash paid for:

Interest .................................................................................................................................... $

Income taxes .......................................................................................................................... $

See notes to consolidated financial statements.

24.3

(66.2)

(0.9)

(0.4)

1.0

(0.5)

(42.7)

(1.9)

(33.9)

88.0

54.1

17.8

6.8

—

(4.2)

—

(0.2)

(2.2)

(6.6)

3.4

16.0

72.0

88.0

19.2

4.5

346.5

(340.9)

(4.3)

—

(0.7)

0.6

1.9

33.1

38.9

72.0

23.2

4.2

Note A—Description of Business and Significant Accounting Policies

Description of Business - The Company is a global innovator of performance enhancing chemistries and surfaces for a variety of
commercial, industrial and residential end uses. The Company's products provide a variety of important functional and aesthetic benefits to
hundreds of products that people use daily. The Company holds leading positions in key market categories, which have been built through
innovative products, customized product solutions, strong technical expertise, well-established distribution channels, recognized brands, and
long-standing customer relationships. The Company utilizes strategically-located manufacturing, technical and other facilities in North America,
Europe, China, and Thailand to service the broad customer base. The Company has two business segments: Specialty Solutions, which is
focused on the Company's higher growth specialty businesses, and Performance Materials, which is focused on the Company’s more mature
businesses.

Specialty Solutions - The Specialty Solutions segment consists of three business lines: Specialty Coatings & Ingredients, Oil & Gas, and

Laminates & Films. The Specialty Solutions segment develops, designs, produces, and markets a broad line of specialty products for use in
coatings, adhesives, sealants, elastomers, laminates, films, nonwovens, and oil & gas products. These products are used in numerous
applications, including architectural and industrial coatings; nonwovens used in hygiene products, filtration and construction; drilling additives for
oil and gas drilling, cementing and fracking; elastomeric modification of plastic casings and hoses used in household and industrial products and
automobiles; tapes and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets;
flooring; ceiling tile; furnishings; manufactured housing; health care patient and common area furniture; and a variety of industrial films
applications. The segment's products improve the performance of customers’ products, including stain, rust and aging resistance; surface
modification; gloss; softness or hardness; dimensional stability; high heat and pressure tolerance; and binding and barrier (e.g. moisture, oil)
properties.

Performance Materials - The Performance Materials segment serves mature markets including plastics, Paper, Carpet and Coated

Fabrics with a broad range of polymers based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl
pyridine, high styrene pigments, polyvinyl acetate, acrylic, styrene acrylic, calcium stearate, glyoxal, and bio-based chemistries. Performance
Materials' custom-formulated products are tailored latexes, resins, binders, antioxidants, hollow plastic pigment, coated fabrics, and rubber
reinforcing which are used in tire cord, polymer stabilization, industrial rubbers, carpet, paper, and various other applications. Its products provide
a variety of functional properties to enhance the Company’s customers’ products, including greater strength, adhesion, dimensional stability,
ultraviolet resistance, improved processibility, and enhanced appearance.

Basis of Presentation - The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting

principles and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances have been eliminated.

Use of Estimates - The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting
principles requires Management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements
and accompanying notes. Actual results could differ from those estimates.

Revenue Recognition - The Company recognizes revenue when the following criteria are met: 1) persuasive evidence of an arrangement

exists; 2) delivery has occurred; 3) an established sales price has been set with the customer; 4) collection of the sale revenue from the
customer is reasonably assured; and 5) no contingencies exist. Delivery is considered to have occurred when the customer assumes the risk
and rewards of ownership. The Company estimates and records provisions for customer quantity rebates and sales returns and allowances as a
reduction in revenue in the same period the related revenue is recognized, based upon its historical experience.

Environmental Costs - The Company recognizes costs associated with managing hazardous substances and pollution in ongoing

operations as incurred. The Company accrues for costs, on an undiscounted basis, associated with environmental remediation when it becomes
probable that a liability has been incurred and the amount is estimable.

Research and Development Expense - Research and development costs were $17.7 million in 2018, $18.9 million in 2017, and $20.8
million in 2016. Our research and development costs relating to new products amounted to $6.1 million in 2018, $7.5 million in 2017, and $8.2
million in 2016, are charged to expense as incurred.

Cash and Cash Equivalents - The Company considers all highly liquid instruments with original maturities of 90 days or less as cash

equivalents.

Financial Instruments and Fair Value Measurements - Financial assets and financial liabilities carried on the balance sheet include cash
and deposits at financial institutions, trade receivables and payables, capital lease obligations, other receivables and payables, borrowings, and
derivative instruments. The accounting policies on recognition and measurement of these items are disclosed elsewhere in these consolidated
financial statements. Fair value is the price that would be received to sell an asset or the price paid to transfer a liability in an orderly transaction
between market participants at the measurement date.

The hierarchy prioritizes the inputs into three broad levels:

Level 1 inputs—Quoted market prices in active markets for identical assets or liabilities.
Level 2 inputs—Observable market based inputs or unobservable inputs that are corroborated by market data.
Level 3 inputs—Unobservable inputs that are not corroborated by market data.

Financial Risk—The Company is mainly exposed to credit, interest rate, and currency exchange rate risks which arise in the normal course

of business. See Note P for further discussion on these risks.

Derivative Instruments - The Company uses, from time to time, certain derivative instruments to mitigate its exposure to volatility in
interest rates and foreign currency exchange rates. The Company recognizes derivative instruments as either an asset or a liability at their
respective fair value. On the date a derivative contract is entered into, the Company may elect to designate the derivative as a fair value hedge,

a cash flow hedge, or a hedge of a net investment in a foreign operation based on the characteristics of the underlying contract. The Company
does not use fair value or net investment hedges. For a cash flow hedge, the fair value of the effective portion of the derivative is recognized as
an asset or liability with a corresponding amount in Accumulated Other Comprehensive Loss. Amounts in Accumulated Other Comprehensive
Income (Loss) are recognized in earnings when the underlying hedged transaction affects earnings. Ineffectiveness is measured by comparing
the present value of the cumulative change in the expected future cash flows of the derivative and the present value of the cumulative change in
the expected future cash flows of the related instrument. Any ineffective portion of a cash flow hedge is recognized in earnings immediately. For
derivative instruments not designated as hedges, the change in fair value of the derivative is recognized in earnings each reporting period.

The Company discontinues hedge accounting prospectively when it is determined that the derivative is no longer effective in offsetting
changes in the cash flows of the hedged item or Management determines that designation of the derivative as a hedging instrument is no longer
appropriate. Any prospective gains or losses in this scenario on the derivative would be recognized in earnings.

Foreign currency exchange contracts are used by the Company to manage risks from the change in exchange rates on cash payments
between the Company's foreign subsidiaries. These forward contracts are used on a continuing basis for periods of less than one year, however
these are not designated as cash flow hedges, consistent with the underlying hedged transactions. The hedging limits the impact of foreign
exchange rate movements on the Company’s operating results. As of November 30, 2018, the notional amount of outstanding forward contracts
was $16.5 million with a fair value of $0.1 million. As of November 30, 2017, the notional amount of outstanding forward contracts was $9.8
million with a fair value of $0.1 million.

The Company does not enter into derivative instruments for trading or speculative purposes.

Accounts Receivable Allowance - The Company’s policy is to identify customers that are considered doubtful of collection based upon
the customer’s financial condition, payment history, credit rating and other relevant factors; and reserves the portion of such accounts receivable
for which collection does not appear likely. The allowance for doubtful accounts was $3.3 million and $2.9 million at November 30, 2018 and
2017, respectively. The Company does not charge interest to its customers on past due accounts receivable.

Inventories - Inventories valued using the last-in, first out ("LIFO") cost method are stated at lower of cost or market. All other Inventories
are stated at the lower of cost or net realizable value. All U.S. produced inventory, which represents 46% of total inventory, is valued using the
LIFO method. The remaining portions of inventories, which are located outside of the U.S., are valued using the first-in, first-out ("FIFO") or an
average cost method. Inventory costs include direct overhead, freight, and duty.

The Company’s policy is to maintain an inventory obsolescence reserve based upon specifically identified, discontinued, or obsolete items

Notes Receivable - Notes receivable accepted by the Company are initially recognized at fair value. The Company does not subsequently

adjust the fair value of these notes receivable unless it is determined that the note receivable is impaired. The Company considers the issuer's
financial condition, payment history, credit rating, and other relevant factors when assessing the collectability of the note and to reserve the
portion of such note for which collection does not appear likely. Interest income is recognized as earned.

Litigation - From time to time, the Company is subject to claims, lawsuits, and proceedings related to product liability, product warranty,
contract, employment, environmental, and other matters. The Company provides a reserve for such matters when it concludes a material loss is
probable and the amount can be estimated.

Deferred Financing Fees - Debt issuance costs are capitalized as a reduction to the carrying value of the liability and amortized over the

life of the related debt. Deferred financing fee amortization is included in interest expense in the consolidated statements of operations.

Property, Plant, and Equipment - Property, plant, and equipment are initially recorded at cost. Construction in process is not depreciated

until the asset is ready for its intended use and is placed into service. Refurbishment costs that extend the useful life of the asset are capitalized,
whereas ordinary maintenance and repair costs are expensed as incurred. Interest expense incurred during the construction phase is capitalized
as part of construction in process until the relevant projects are completed and placed into service.

Depreciation is computed principally using the straight-line method using depreciable lives as follows:

Buildings and improvements ..................................................................................................................................................
Machinery and equipment
......................................................................................................................................................
Furniture and fixtures .............................................................................................................................................................
Software .................................................................................................................................................................................

25 to
5 to
3 to
3 to

40 years
15 years
10 years
5 years

Leasehold improvements are depreciated over the shorter of the lease term, including any expected renewal periods that are probable to

occur, or the estimated useful life of the improvement.

All of the Company’s long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount

may not be recoverable. If the sum of undiscounted expected future cash flows is less than the carrying amount of the asset or asset group, an
impairment loss is recognized based on the difference between the estimated fair value of the asset or asset group and its carrying value. For
further discussion on long-lived asset impairments, see Note C.

When specific actions to dispose of an asset or group of assets meet certain criteria, the underlying assets and liabilities are adjusted to the
lesser of carrying value or fair value and, if material, they are reclassified into a “held for sale” category in the consolidated balance sheet or they
are condensed and reported in other assets and liabilities.

Goodwill and Intangible Assets - Goodwill represents the excess of the purchase price over the fair value of assets acquired and

liabilities assumed in a business combination. Goodwill and other indefinite lived intangible assets are tested for impairment at least annually as
of September 1, and whenever events or circumstances indicate that the carrying amount may not be recoverable. The Company performs the
impairment analysis at the reporting unit level. The Company identifies potential impairments by comparing the estimated fair value of a reporting
unit with its carrying value. Fair value is typically estimated using a market approach method or a discounted cash flow analysis based on level 3
inputs in the fair value hierarchy, which requires the Company to estimate future cash flows anticipated to be generated by the reporting unit, as
well as a discount rate to measure the present value of the anticipated cash flows. If the estimated fair value of a reporting unit exceeds its
carrying value, goodwill is not considered impaired. If the carrying value of a reporting unit exceeds the estimated fair value, an impairment
charge is recognized as the difference between the estimated fair value and the carrying value.

As a result of the Company's annual goodwill impairment test during the fourth quarter of 2018, no impairment charges were required. As

part of its 2017 segment realignment, the Company allocated existing goodwill between two of its four reporting units based on their relative fair
values. As a result, $60.6 million of goodwill was allocated to the Specialty Solutions segment and $19.6 million of goodwill was allocated to the
Performance Materials segment. Prior to the segment realignment, all goodwill had been allocated to the prior Performance Chemicals segment.
During the second quarter of 2017, the Company performed goodwill impairment assessments before and after the segment realignment and
determined that no impairment was indicated as a result of these assessments. During the fourth quarter of 2017, the Company performed its
annual impairment test for goodwill and determined that there was no impairment as of September 1, 2017. Subsequently, the Company
updated its goodwill impairment analysis as of November 30, 2017, based upon continued deterioration in certain portions of the coated paper
market, the likelihood of the Company losing a significant portion of its paper business during 2018, and the bankruptcy of a large carpet
customer. As a result, all of the goodwill associated with the Performance Materials segment was impaired and the Company recorded a
goodwill impairment charge of $19.6 million.

The impairment test for indefinite lived intangible assets consists of comparing the estimated fair value of the asset with its carrying value.

The Company estimates the fair value of its indefinite lived intangible assets using a fair value model based on a market approach method or
discounted future cash flows. If the carrying values exceed the estimated fair values, an impairment loss would be recognized in the amount of
the excess. Key inputs used in determining the fair value of the trademarks/tradenames were expected future revenues and royalty rates, and
accordingly, the fair values are impacted by selling prices, which for the Company is based in part on raw material costs. As of September 1,
2018, the Company performed its annual impairment test for indefinite lived intangible assets and recorded impairment of $1.5 million related to
an individual tradename within the Performance Materials segment. As a result, the carrying value equals the fair value of this tradename as of
the annual impairment testing date. A sensitivity analysis was performed by the Company on this tradename and a hypothetical 100 basis point
increase in the discount rate used to value this tradename would result in additional impairment of $0.3 million. Trademarks and tradenames
continue to be important to the Company, and we continue to focus on long-term growth, however, if recent trends continue, the long-term
assumptions relative to growth rates and profitability of the trademarks and tradenames may not be attained, which could result in additional
impairment to one or more of the Company's trademarks and tradenames.

Estimating future cash flows requires significant judgments and assumptions by Management including sales, operating margins, royalty

rates, discount rates, and future economic conditions. To the extent that we are not able to achieve these assumptions, impairment losses may
occur.

Finite lived intangible assets, such as customer lists, patents, certain trademarks/tradenames, and licenses, are recorded at cost or

estimated fair value when acquired as part of a business combination. Intangible assets with finite lives are amortized over their estimated useful
lives with periods ranging from 3 to 53 years. Intangible assets are evaluated for impairment whenever events or circumstances indicate that the
undiscounted net cash flows to be generated by their use over their expected useful lives and eventual disposition may be less than their net
carrying value. No such events or circumstances occurred in 2018, 2017 or 2016.

Pension and Other Post-retirement Plans - The Company accounts for its pensions and other post-retirement benefits by (1) recognizing
the funded status of the benefit plans in our consolidated balance sheets, (2) recognizing, as a component of other comprehensive income or net
periodic benefit cost, the gains or losses and prior service costs or credits that arise during the period, (3) measuring defined benefit plan assets
and obligations as of the date of the Company's fiscal year end consolidated balance sheets and (4) disclosing additional information in the
notes to the consolidated financial statements about certain effects on net periodic benefit costs for the next fiscal year that arise from delayed
recognition of prior service costs or credits and transition assets or obligations.

Asset Retirement Obligations - The fair value of an asset retirement obligation is recorded when the Company has an unconditional legal

obligation to perform an asset retirement activity and the amount of the obligation can be reasonably estimated. In assessing asset retirement
obligations, the Company reviews the expected settlement dates or a range of estimated settlement dates, the expected method of settlement of
the obligation, and other factors pertinent to the obligations. Asset retirement obligations are not material as of November 30, 2018 and 2017.

Foreign Currency Translation - The financial position and results of operations of the Company’s foreign subsidiaries are measured using
the local currency as the functional currency. Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at exchange
rates in effect at the balance sheet date, while sales and expenses are translated at the average exchange rates each month during the year.
The resulting translation gains and losses on assets and liabilities are recorded in Accumulated Other Comprehensive (Loss), and are excluded
from net income until realized through sale or liquidation of foreign subsidiaries.

Income Taxes - The Company follows the liability method of accounting for income taxes. Under this method, deferred tax assets and

liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using the enacted tax
rates that will be in effect in the period in which the differences are expected to reverse. The Company records a valuation allowance to offset
deferred tax assets, if based on the weight of all available positive and negative evidence, it is more-likely-than-not that some portion, or all, of
the deferred tax assets will not be realized. Changes in tax laws and rates may affect recorded deferred tax assets and liabilities along with our
effective tax rate in the future.

A high degree of judgment is required to determine the extent a valuation allowance should be provided against deferred tax assets. The

Company assesses the likelihood of realization of its deferred tax assets considering all available evidence, both positive and negative. In
determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future

earnings, carry-back and carry-forward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax
asset. The weight given to the positive and negative evidence is commensurate with the extent to which the evidence may be objectively
verified. It is generally difficult to outweigh objectively verifiable negative evidence of cumulative financial reporting losses.

As a result of historical restructuring charges and impairments over the last few years, including a significant goodwill impairment recorded

in the fourth quarter of 2017, the Company was in a U.S. jurisdiction three-year cumulative loss position for the three year period ending
November 2017. The Company considered sources of positive evidence, including the Company’s year over year growth in its core earnings,
expected future earnings, which if realized would enable the Company to utilize its net operating loss carryforwards, and a recent history of net
operating loss utilization. A cumulative loss position is considered significant negative evidence in assessing the realizability of a deferred tax
asset that is difficult to overcome when determining whether a valuation allowance is required. Based on the weight of all available positive and
negative evidence, the Company established a valuation allowance of $73.1 million in the fourth quarter of 2017 on its U.S. deferred tax assets.
In addition, a $3.3 million valuation allowance was established in 2017 on a capital loss incurred in the U.S. on the stock sale of a foreign
subsidiary in 2017. For the three year period ended November 2018, the U.S. jurisdiction remains in a three-year cumulative loss position.
Considering the weight of available positive and negative evidence, the Company does not believe the positive evidence (some of which is
subjective) overcomes the negative objective evidence of a 3-year cumulative loss position. Therefore, the Company concludes that the
valuation allowance should remain on its U.S. deferred tax assets as of November 30, 2018.

The Company utilizes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax

position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be
sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is more-likely-than-
not of being realized upon ultimate settlement.

The Company’s accounting policy for interest and/or penalties related to underpayments of income taxes is to include interest and penalties

in tax expenses.

Operating Leases - Lease expense is recognized on a straight-line basis over the non-cancelable lease term, including any optional
renewal terms that are reasonably expected to be exercised. Leasehold improvements are depreciated over the shorter of the lease term,
including any expected renewal periods that are probable to occur, or the estimated useful life of the improvement.

Capital Leases - Capital leases are initially recorded at the lower of fair market value or the present value of future minimum lease

payments with a corresponding amount recognized in property, plant, and equipment. Depreciation on assets under capital leases is included in
depreciation expense. The current portion of capital lease obligations are included in short-term debt and non-current capital lease obligations
are included in long-term debt in our Consolidated Balance Sheets. The Company has two leased assets, land and the building for its corporate
headquarters, which are classified as capital leases with a present value of minimum lease payments of $15.6 million as of November 30, 2018.
The lease for the land commenced in November 2013 and expires in 18 years at which time the Company can acquire the land for a nominal
amount. The lease for the building commenced in November 2014 and expires in 20 years at which time the Company will receive the building at
no cost.

Share-Based Compensation - Share-based compensation is measured at the grant date, based on the calculated fair value of the award,
and is recognized as an expense over the requisite service period (generally the vesting period). Share-based compensation expense includes
expense related to restricted shares; restricted share units; and options issued, as well as share units deferred into the Company’s Deferred
Compensation Plan for Non-Employee Directors and performance shares awarded under the Company’s Long-Term Incentive Plan or 2017
Equity Incentive Plan. The Company did not capitalize any expense related to share-based compensation payments and recognizes share-
based compensation expense within Selling, General, and Administrative expense.

Accounting Standards Adopted in 2018

In October 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2016-16, Intra-Entity

Transfers of Assets Other Than Inventory, which removes the prohibition against the immediate recognition of the current and deferred income
tax effects of intra-entity transfers other than inventory. The guidance was effective for annual periods, including interim periods within those
annual periods, beginning after December 15, 2017 with early adoption permitted as of the beginning of the annual reporting period in which the
ASU was issued. ASU 2016-16 was adopted by the Company effective December 1, 2017 on a modified retrospective basis, resulting in a $6.9
million adjustment to retained earnings and a reduction in prepaid assets.

Accounting Standards Not Yet Adopted

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income

(Loss), which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for standard tax effects
resulting from the Tax Cuts and Jobs Act. ASU 2018-02 must be applied either in the period of adoption or retrospectively to each period in which
the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. This guidance is effective for
annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption permitted in any
interim period. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging, which applies targeted improvements to the hedge accounting

guidance, including removing the requirement to run the ineffective portion of a hedging instrument through current period income. The guidance
is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption
permitted in any interim period. Amendments from this ASU are to be applied prospectively, with a cumulative effect adjustment recorded to
retained earnings. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In March 2017, the FASB issued ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement

Benefit Cost, which requires that an employer report the service cost component in the same line item or items as other compensation costs
arising from services rendered by the pertinent employees during the period. The amendments in this Update also allow only the service cost
component to be eligible for capitalization when applicable. ASU 2017-07 must be applied retrospectively for the presentation of the service cost
component and the other components of net periodic pension cost and net periodic postretirement benefit cost in the income statement and

prospectively, on and after the effective date, for the capitalization of the service cost component of net periodic pension cost and net periodic
post-retirement benefit in assets. This guidance is effective for annual periods, including interim periods within those annual periods, beginning
after December 15, 2017 with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact
on its consolidated results of operations, balance sheets, or cash flows.

In January 2017, the FASB issued ASU No. 2017-01, Clarifying the Definition of a Business, which clarified existing guidance on the
definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as
acquisitions (or disposals) of assets or businesses. The guidance is effective for annual periods, including interim periods within those annual
periods, beginning after December 15, 2017 with early adoption permitted. The adoption of this ASU will not have an impact on the Company's
balance sheets, results of operations, or cash flows.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments,
which clarifies existing guidance related to accounting for cash receipts and cash payments and classification on the statement of cash flows.
This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is
permitted. The adoption of this ASU will not have an impact on the Company's balance sheets, results of operations, or cash flows.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires a lessee to recognize on the balance sheet the
assets and liabilities for the rights and obligations created by those leases with a lease term of more than twelve months. Leases will continue to
be classified as either financing or operating, with classification affecting the recognition, measurement and presentation of expenses and cash
flows arising from a lease. The new guidance is effective for the Company’s fiscal year that begins on December 1, 2019 and requires a modified
retrospective approach to the adoption for lessees related to capital and operating leases existing at, or entered into after, the earliest
comparative period presented in the financial statements, with certain practical expedients available. Early adoption is permitted. The Company
is currently evaluating the impact on its consolidated financial statements and related disclosures.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10: Recognition and Measurement of
Financial Assets and Financial Liabilities), which revised entities’ accounting related to: (i) the classification and measurement of investments in
equity securities; and (ii) the presentation of certain fair value changes for financial liabilities measured at fair value. The ASU also amends
certain disclosure requirements associated with the fair value of financial instruments. The new guidance is effective for the Company’s fiscal
year that begins on December 1, 2018 and requires a modified retrospective approach to adoption. Early adoption is only permitted for the
provision related to instrument-specific credit risk. The Company does not expect the adoption of this guidance to have a material impact on its
consolidated results of operations, balance sheets, or cash flows.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which clarifies existing accounting literature relating

to how and when a company recognizes revenue. This standard prescribes a five-step model for recognizing revenue, the application of which
will require a certain amount of judgment. The provisions of this ASU may be applied retroactively or on a modified retrospective (cumulative
effect) basis. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective
Date, which defers the effective date of ASU 2014-09 to fiscal 2019. The standard will require additional disclosures in the notes to the
consolidated financial statements, including qualitative and quantitative disclosures identifying the nature, amount, timing and significant
judgments impacting revenue from contracts with customers.

The Company will adopt ASU 2014-09 during the first quarter of fiscal year 2019 and will utilize the modified retrospective approach and

record a cumulative effect adjustment to retained earnings, to the extent necessary, for the impact of any current contracts then meeting the
standards' criteria for revenue recognition as of December 1, 2018. The Company is implementing controls to support recognition and disclosure
under the new standard. The Company has drafted an updated revenue recognition accounting policy. The Company has completed its contract
evaluations to document the various sales terms the Company uses in its sales contracts. As a result, the Company has completed its
assessment of its current revenue streams and concluded that the adoption will not have a material impact on its consolidated financial
statements , however, this standard will require new financial statement disclosures, which the Company is in the process of finalizing.

Note B—Restructuring and Severance

The following table summarizes restructuring and severance charges for the years ended 2018, 2017, and 2016:

November 30,

2018

2017

2016

(Dollars in Millions)

Severance Expense:

Specialty Solutions ................................................................................................................ $

Performance Materials ...........................................................................................................

Corporate ...............................................................................................................................

Total Severance Costs ............................................................................................................ $

0.7

1.1

0.9

2.7

0.6

1.7

2.9

5.2

Facility Closure Costs:

Specialty Solutions ................................................................................................................ $

— $

Performance Materials ..........................................................................................................

Total Facility Closure Costs ..................................................................................................... $

Total Restructuring and Severance Costs ......................................................................................

0.8

3.5

0.5

5.7

0.2

3.3

4.9

8.4

0.1

2.6

2.7

11.1

Costs for restructuring plans are recognized as a component of restructuring and severance expense within the consolidated statements of

operations. The Company initiated the following restructuring plans:

2018 Restructuring Plan

During the third quarter of fiscal 2018, the Company announced its plan to close its styrene butadiene manufacturing facility in Green Bay,

2017 Restructuring Plan

Restructuring and severance activities initiated in 2017 include the One OMNOVA initiative announced during the first quarter of 2017. The

One OMNOVA initiative is focused on improving functional excellence in marketing, sales, operations, supply chain and technology, as well as
various corporate functions. The plan is designed to reduce complexity and drive consistency across the global enterprise through a
standardized, integrated business system. Total estimated costs for this initiative are expected to be between $5.0 million and $7.0 million. For
this initiative, the Company has incurred costs of $5.2 million, of which $1.7 million was incurred in fiscal 2018, and $3.5 million was incurred in
fiscal 2017. As of November 30, 2018, $5.1 million was paid for this plan. The plan was substantially completed at the end of 2018.

2016 Restructuring Plan

Restructuring and severance activities initiated in 2016 included continued cost reduction and efficiency improvement actions, as well as a

The following table summarizes the Company’s liabilities related to restructuring and severance activities:

2016 ............................................................................................................. $

2017 .............................................................................................................

2018 .............................................................................................................

2.3

4.2

2.2

(Dollars in millions)

11.1

5.7

3.5

9.2

7.7

4.6

4.2

2.2

1.1

Beginning
Balance

Provision

Payments

Ending
Balance
November 30,

Note C—Asset Impairments and Sales of Businesses

During 2018, the Company's Board of Directors approved a plan to close the Green Bay, Wisconsin plant shifting styrene butadiene
manufacturing to its production plant in Mogadore, Ohio. The Company expects to complete the plant closure by the end of the third quarter of
2019. As a result, the Company determined that certain plant and equipment were impaired and recognized an impairment charge of $9.2
million, primarily in the Performance Materials segment, to write-down the asset group to fair value based on the market approach analysis. The
asset groups' remaining fair value of $2.5 million is being depreciated over the remaining estimated useful lives of the impacted assets and is
primarily included in the Performance Materials segment operating results. Also during 2018, the Company recognized other asset impairment
charges of $2.7 million related to idled assets within the Performance Materials segment.

During 2016, due to changes in markets and expected lower capacity utilization at the China Coated Fabrics manufacturing facility ("CCF"),

the Company performed an impairment analysis of this asset group. Based on this analysis, it was determined that the fair value of the asset
group was less than book value, and accordingly, the Company recognized an impairment charge of $5.4 million within the Performance
Materials segment and reduced Property, Plant, and Equipment by $5.2 million and intangible assets by $0.2 million. The CCF manufacturing
facility also recognized $0.3 million of impairment charges during 2016 related to idled equipment within the Performance Materials segment.

During 2017, Management approved a plan for the Company to sell its CCF manufacturing operations. As a result, during the second
quarter of 2017, the Company determined that the disposal group was impaired and recognized an additional impairment charge of $12.9
million, of which $11.8 million was included in the results of the Performance Materials segment and $1.1 million was included in Corporate
expenses. Included in the calculation of the impairment charge were deferred foreign currency translation gains of $6.3 million, which were
previously recorded in accumulated other comprehensive income ("AOCI"). Accordingly, the assets and liabilities of the CCF manufacturing
facility were reclassified to held for sale in the consolidated balance sheet as of November 30, 2016. The Company completed the planned sale
in July 2017, and recognized an additional loss on the sale of $0.4 million, for a total loss of $13.3 million. The Company continues to
manufacture and sell coated fabric products in the Asian region. Management considered other qualitative and quantitative factors and
concluded this sale did not represent a strategic shift in business.

During 2016, the Company completed the sale of its India operations (through the sale of 100% of the equity outstanding of the Company's
OMNOVA Solutions India Private Limited Subsidiary) to Apcotex Inc., a private industrial products manufacturer headquartered in India. The sale
included all assets and liabilities, contracts and other assets associated with the Company’s production of rubber related products. Under terms
of the sale, the Company received $5.2 million in cash. The sale price was equal to the net book value of these assets and liabilities and
therefore, there was no gain or loss recognized on this transaction. The Company continues to sell certain of its products within India through its
other subsidiaries in the ordinary course of business.

Note D—Income Taxes

The components of income (loss) before income taxes are as follows:

Income (Loss) Before Income Taxes:

U.S. ...............................................................................................................................................

Foreign ..........................................................................................................................................

Years Ended November 30,

2018

2017

2016

(Dollars in millions)

(2.0)

16.5

14.5

(9.1)

5.0

(4.1)

1.5

8.4

9.9

Years Ended November 30,

2018

2017

2016

(Dollars in millions)

Income Tax (Expense) Benefit:

Current:

U.S. Federal ..................................................................................................................................

(0.1)

(0.6)

U.S. State and Local .....................................................................................................................

Foreign ..........................................................................................................................................

Deferred:

U.S. Federal ..................................................................................................................................

U.S. State and Local .....................................................................................................................

Foreign ..........................................................................................................................................

(0.2)

(7.3)

(7.6)

10.5

(0.1)

3.4

13.8

(0.1)

(5.9)

(6.6)

(72.6)

(7.8)

3.3

(77.1)

Income Tax (Expense) Benefit ........................................................................................................

6.2

(83.7)

(0.6)

(0.2)

(4.3)

(5.1)

(2.4)

(0.5)

(2.3)

(5.2)
(10.3)

Years Ended November 30,

2018

2017

2016

(Dollars in millions)

Effective Income Tax (Expense) Benefit:

Tax at federal statutory rate ...........................................................................................................

(3.2)

1.4

Valuation allowances .....................................................................................................................

U.S. legislative change .................................................................................................................

Foreign taxes at different rates .....................................................................................................

U.S. tax on foreign dividends ........................................................................................................

Non-deductible impairment ...........................................................................................................

Executive stock compensation ......................................................................................................

Other permanent items .................................................................................................................

State and local taxes .....................................................................................................................

Foreign withholding tax .................................................................................................................

Foreign non-deductible interest .....................................................................................................

French business tax ......................................................................................................................

French legislation change .............................................................................................................

Non-taxable research and development .......................................................................................

Tax equity adjustment ....................................................................................................................

Other, net ..........................................................................................................................................

Effective Income Tax (Expense) Benefit ....................................................................................

5.5

4.1

(0.5)

—

0.2

(0.2)

(0.1)

(0.4)

(0.6)

0.9

0.3

0.4

0.2

6.2

(79.9)

—

1.3

(0.4)

(6.9)

0.3

(0.1)

(0.7)

(1.0)

(0.7)

(0.5)

3.4

0.2

—

(0.1)

(3.5)

(1.8)

—

1.0

(2.2)

—

0.1

(0.7)

(0.6)

(0.7)

(0.5)

(1.6)

0.2

—

(83.7)

(10.3)

In accordance with SAB 118 guidance, the Company estimated certain effects of the Tax Act and recorded a provisional net tax benefit of
approximately $9.9 million in fiscal 2018. The income tax benefit was comprised of tax for (i) $4.1 million related to the re-measurement of the
U.S. deferred taxes for the reduction of the U.S. federal corporate income tax rate, which included the impact of reducing the valuation allowance
previously recognized by $25.9 million (ii) $0.9 million associated with the reversal of the valuation allowance against the existing AMT credit
carryforward as it is refundable under the Tax Act, (iii) and $4.9 million associated with the reversal of the valuation allowance on a portion of the
U.S. deferred tax assets as a result of deferred tax liabilities for indefinite lived intangible assets now considered available as a source of income
as a result of the Tax Act.

The Company provisionally estimates minimal to zero income inclusion for the transition tax related to foreign earnings on which U.S.
income taxes were previously deferred. The Company intends to utilize existing net operating loss carryforwards to offset any income inclusion,
and therefore does not expect to pay cash taxes related to the transition tax. While the Company was able to make reasonable estimates of the
items above, the ultimate impact may differ from these provisional amounts due to additional analysis, changes in interpretations and
assumptions, additional regulatory guidance that may be issued and actions we may take as a result of the Tax Act. Adjustments to the
provisional amounts recorded by the Company that are identified within a subsequent measurement period of up to one year from the enactment
date will be included as an adjustment to income tax expense in the period the amounts are determined.

The Tax Act also includes provisions for Global Intangible Low-Taxed Income (“GILTI”) whereby minimum taxes are imposed on foreign
income in excess of a deemed return on the tangible assets of foreign corporations. This income will effectively be taxed at a 10.5% tax rate.
GILTI is effective for the Company starting in fiscal 2019. Because of the complexity of the new provisions, the Company is continuing to
evaluate how the provisions will be accounted for under the U.S. generally accepted accounting principles wherein companies are allowed to
make an accounting policy election to either (i) account for GILTI as a component of tax expense in the period in which the Company is subject
to the rules (the “period cost method”), or (ii) account for GILTI in the Company’s measurement of deferred taxes (the “deferred method”).
Currently, the Company has not made an accounting policy election and will only do so after its completion of the analysis of the GILTI
provisions.

For fiscal 2018, the Company’s income tax benefit was $6.2 million on global pretax income of $14.5 million. The Company's income tax
benefit was different than the statutory income tax rate primarily due to items related to the Tax Act, as noted above. In addition, the Company
recognized a $0.9 million income tax benefit related to the impact of a French tax rate change on the Company’s deferred tax liabilities. Based
on recently enacted French tax legislation during the first quarter of 2018, the French tax rate will be reduced to 25.0% beginning in 2022 and
the Company's deferred tax liabilities were reduced to appropriately reflect this legislation as a current period tax benefit.

Deferred Income Taxes

November 30,

2018

2017

(Dollars in millions)

Assets

Liabilities

Assets

Liabilities

Accrued estimated costs ....................................................................................... $

Inventory ................................................................................................................

Goodwill and intangible assets ..............................................................................

Depreciation ..........................................................................................................

Pension .................................................................................................................

NOLC’s and other carryforwards ...........................................................................

Post-retirement employee benefits ........................................................................

Other .....................................................................................................................

5.7

6.1

—

12.6

37.3

2.3

—

Valuation allowance ...............................................................................................

(53.2)

— $

9.7

—

11.2

12.4

—

0.4

—

15.0

—

24.9

51.5

3.9

—

(88.8)

—

17.0

16.6

—

5.9

—

Deferred Income Taxes ........................................................................................ $

10.8

24.0

16.2

39.5

A reconciliation of the beginning and ending deferred tax valuation allowance is as follows:

Years Ended November 30,

2018

2017

2016

(Dollars in millions)

Beginning balance December 1 ..................................................................................................... $

88.8

Additions (Reductions) Charged to Expense .................................................................................

Additions (Reductions) Charged to Other Accounts .......................................................................

Reduction due to Entity Disposition ................................................................................................

Foreign Currency Effects ................................................................................................................

(32.2)

(2.9)

—

(0.5)

14.1

79.9

(2.6)

(3.9)

1.3

Ending balance November 30 ........................................................................................................ $

53.2

88.8

10.2

4.0

—

(0.1)

14.1

At November 30, 2018, the Company has $93.1 million of U.S. federal net operating loss carryforwards (NOLC's), $8.1 million of U.S.
federal capital loss carryforwards, $0.1 million of foreign tax credit carryforwards, $0.3 million of AMT credit carryforwards, and $78.9 million of
state net operating loss carryforwards. As a result, cash tax payments in the U.S. are expected to be minimal for the foreseeable future. The
Company generated approximately $1.8 million of federal net operating loss carryforward for the year ended November 30, 2018. The Company
utilized approximately $7.8 million and $15.6 million of federal net operating loss carryforward for the years ended November 30, 2017 and 2016,

respectively. The majority of the federal, state, and local NOLCs will expire in tax years 2023 through 2038 while the foreign tax credit
carryforwards will expire in the tax years 2020 through 2022, and the capital loss will expire beginning in tax year 2022. The Company has a
valuation allowance against the U.S. federal and state NOLC's and the U.S. federal capital loss carryforward.

As of November 30, 2018, the Company had approximately $42.3 million of foreign NOLC's of which $30.5 million have an indefinite

carryforward period. The Company has recognized a valuation allowance against the $30.5 million foreign NOLC's which have an indefinite
carryforward period as the Company does not anticipate utilizing these carryforwards. Cash paid for income taxes in 2018, 2017, and 2016 was
$6.8 million, $4.5 million, and $4.2 million, respectively, and related primarily to foreign income taxes.

Total unrecognized tax benefits are $0.6 million and $0.3 million at November 30, 2018 and 2017, respectively. The $0.3 million increase

year over year relates to acquisitions made by the Company. The total amount of interest and penalties recognized in the consolidated balance
sheet was $0.2 million at November 30, 2018. There were minimal interest and penalties recognized in the consolidated balance sheet as of
November 30, 2017. Of the total $0.6 million of unrecognized tax benefits at November 30, 2018, $0.4 million would, if recognized, impact the
Company's effective tax rate. The amount of unrecognized tax benefits which impacted the Company's effective tax rate was $0.1 million in
2016. There was no impact to the effective tax rate in 2018 or 2017.

A reconciliation of the beginning and ending amounts of unrecognized tax benefits, excluding interest and penalties is as follows:

Years Ended November 30,

2018

2017

2016

(Dollars in millions)

Beginning balance, December 1 .................................................................................................... $

Increase based on tax positions related to current year .................................................................

Increase due to acquisition .............................................................................................................

Ending balance, November 30 ....................................................................................................... $

0.3

—

0.3

0.6

0.3

—

0.3

—

0.3

—

0.3

Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense. The Company

recognized minimal income tax expense related to interest and penalties in 2018, 2017, and 2016.

With limited exceptions, the Company is no longer open to audit under the statutes of limitation by the Internal Revenue Service and

various states and foreign taxing jurisdictions for years prior to 2013.

The Company has not provided for U.S. income taxes on undistributed earnings on certain of its non-U.S. subsidiaries as such amounts are

Note E—Accumulated Other Comprehensive Income (Loss)

The components of Accumulated Other Comprehensive Income (Loss) are as follows:

Foreign currency translation adjustments .................................................................................. $

Employee benefit plans ..............................................................................................................

Accumulated other comprehensive income (loss) ...................................................................... $

November 30,

2018

2017

(Dollars in millions)

(32.6)

(89.8)

(122.4)

(23.1)

(102.2)

(125.3)

The following table provides additional details of the amounts recognized into net earnings from accumulated other comprehensive income

(loss):

Foreign
Currency Items

Defined Benefit
Plans

(Dollars in millions)

Accumulated
Other
Comprehensive
Income (Loss)

Balance November 30, 2015 ................................................................................ $

(30.2)

(105.7)

(135.9)

Other comprehensive income (loss) before reclassifications ................................

Amounts reclassified from accumulated other comprehensive income (loss) ......

(5.3)

5.9

(5.3)

2.1

Balance November 30, 2016 ................................................................................ $

(29.6)

(108.9)

Other comprehensive income (loss) before reclassifications ................................

Amounts reclassified from accumulated other comprehensive income (loss) ......

12.8

(6.3)

2.7

4.0

Balance November 30, 2017 ................................................................................ $

(23.1)

(102.2)

Other comprehensive income (loss) before reclassifications ................................

Amounts reclassified from accumulated other comprehensive income (loss) ......

(9.5)

—

8.1

4.3

(10.6)

8.0

(138.5)

15.5

(2.3)

(125.3)

(1.4)

4.3

Balance November 30, 2018 ................................................................................ $

(32.6)

(89.8)

(122.4)

Note F—Earnings Per Share

The following table summarizes the computation of earnings per common share and earnings per common share, assuming dilution:

Years Ended November 30,

2018

2017

2016

(Dollars and shares in millions except per share data)

Numerator:

Net income (loss) ............................................................................................................................ $

20.7

(87.8)

(0.4)

Denominator for basic earnings per share - weighted average shares outstanding ........................

Effect of dilutive securities ..............................................................................................................

Denominator for dilutive earnings per share - adjusted weighted average shares and assumed
conversions .....................................................................................................................................

44.6

0.3

44.9

44.4

—

44.4

44.0

—

44.0

Net income (loss) per share - Basic and Diluted ............................................................................. $

0.46

(1.98)

(0.01)

Anti-dilutive share equivalents related to share-based incentive compensation are excluded from the computation of dilutive weighted-
average shares. Anti-dilutive share equivalents related to share-based incentive compensation consisted of 0.2 million, 0.6 million, and 1.0
million shares during 2018, 2017, and 2016, respectively.

Note G—Accounts Receivable

The Company’s net accounts receivable was $112.1 million and $99.0 million at November 30, 2018 and 2017, respectively, and are
generally unsecured. There was no single customer who represented more than 10% of the Company’s net trade receivables at November 30,
2018 or 2017.

The following table summarizes the Company's allowance for doubtful accounts:

Balance at beginning of period ....................................................................................................... $

Provision for bad debt .....................................................................................................................

Write-offs ..........................................................................................................................................

Reclassifications .............................................................................................................................

Currency translation adjustment .....................................................................................................

Balance at end of period ................................................................................................................. $

2.9

0.6

(0.3)

—

0.1

3.3

0.8

2.1

(0.1)

—

0.1

2.9

1.3

0.3

(0.2)

(0.6)

—

0.8

November 30,

2018

2017

2016

(Dollars in millions)

Note H—Inventories

The following table summarizes the Company's inventories:

November 30,

2018

2017

(Dollars in millions)

Raw materials and supplies ..................................................................................................................................... $

35.0

Work-in-process .......................................................................................................................................................

Finished goods .........................................................................................................................................................

Inventories, gross .............................................................................................................................................

LIFO reserve ............................................................................................................................................................

Obsolescence reserve .............................................................................................................................................

5.3

63.5

103.8

(18.1)

(6.9)

Inventories, net ................................................................................................................................................. $

78.8

30.6

4.5

62.1

97.2

(14.3)

(6.4)

76.5

Inventories valued using the LIFO method represented $47.6 million, or 45.9%, and $50.7 million, or 52.1%, of inventories at November 30,

2018 and 2017, respectively.

Note I—Property, Plant and Equipment, Net

The following table summarizes the Company's property, plant, and equipment, net:

November 30,

2018

2017

(Dollars in millions)

Land ......................................................................................................................................................................... $

23.3

Building and improvements ......................................................................................................................................

Machinery and equipment

........................................................................................................................................

Construction in progress ...........................................................................................................................................

145.8

413.6

19.1

601.8

18.5

145.9

402.8

15.1

582.3

Accumulated depreciation ........................................................................................................................................

(396.0)

(373.4)

Property, Plant, and Equipment, Net ......................................................................................................................... $

205.8

208.9

As of November 30, 2018, included in land and buildings and improvements are $3.0 million and $11.8 million (net of accumulated

depreciation of $2.4 million), respectively, of assets under capital leases.

Depreciation expense was $26.4 million, $24.4 million, and $26.8 million in 2018, 2017, and 2016, respectively. Included in depreciation
expense is $20.8 million, $19.2 million, and $22.3 million in 2018, 2017, and 2016, respectively, related to depreciation of manufacturing facilities
and equipment.

As of November 30, 2018 and 2017, the Company had $4.3 million and $6.0 million, respectively, of unamortized software costs included in
machinery and equipment, primarily related to an Enterprise Resource Planning (ERP) system. Depreciation expense of software costs was $2.3
million, $2.0 million, and $1.6 million in 2018, 2017, and 2016, respectively. The Company is depreciating these costs over five years.

Accelerated depreciation included in depreciation expense was $1.2 million and $3.0 million in fiscal 2018 and 2016, respectively. There

was no accelerated depreciation in fiscal 2017. Accelerated depreciation relates to the Company's restructuring activities discussed in Note B of
this annual report on Form 10-K.

Note J—Goodwill and Other Intangible Assets

Goodwill

The following table summarizes the Company's goodwill:

Total

Specialty
Solutions

Performance
Materials

(Dollars in millions)

Balance November 30, 2016 .................................................................................................. $

80.2

60.6

Acquisitions ............................................................................................................................

Impairment .............................................................................................................................

Currency translation adjustment ............................................................................................

Balance November 30, 2017 .................................................................................................

Acquisitions ............................................................................................................................

Currency translation adjustment ............................................................................................

1.6

(19.6)

4.1

66.3

6.4

(1.8)

1.6

—

4.1

66.3

6.4

(1.8)

Balance November 30, 2018 ................................................................................................. $

70.9

19.6

—

(19.6)

—

Intangible Assets

The following table summarizes the Company’s intangible assets:

November 30, 2018

November 30, 2017

November 30, 2018

Gross
Carrying
Amount

Accumulated
Amortization /
Impairment

Gross
Carrying
Amount

Accumulated
Amortization /
Impairment

Weighted Average
Remaining Life

(Dollars in millions)

Finite-lived intangible assets:

Patents ..................................................... $

20.2

19.1

20.7

Trademarks ..............................................

Technical know-how .................................

Customer lists ..........................................

Land use rights .........................................

Other ........................................................

9.4

6.9

34.6

5.8

2.1

7.3

4.7

20.7

0.8

2.1

7.9

6.0

34.4

6.1

2.1

Sub-total ................................................ $

79.0

54.7

77.2

Indefinite lived intangible assets:

Trademarks ...............................................

30.7

1.5

30.7

Total ............................................................. $

109.7

56.2

107.9

19.0

7.2

4.6

18.5

0.7

1.9

51.9

—

51.9

2.3

8.2

9.4

3.5

50.0

0.0

13.9

N/A

Amortization expense for finite-lived intangible assets was $3.8 million, $3.5 million, and $3.8 million for the years ended November 30,
2018, 2017, and 2016, respectively. The Company impaired a trademark during 2018, and recognized impairment expense of $1.5 million within
the results of the Performance Materials segment. Reductions in forecasted revenues or royalty rates could result in additional trademark
impairments.

The following table summarizes expected future annual amortization expense for the Company’s finite-lived intangible assets:

Year Ending November 30:

(Dollars in millions)

2019 ........................................................................................................................................................................................... $

2020 ...........................................................................................................................................................................................

2021 ...........................................................................................................................................................................................

2022 ...........................................................................................................................................................................................

2023 ...........................................................................................................................................................................................

Thereafter ..................................................................................................................................................................................

5.1

4.6

1.5

0.8

7.2

Total ........................................................................................................................................................................................................ $

24.3

Note K—Debt and Credit Lines

Short-term debt consists of the following debt obligations that are due within the next twelve months:

$350 million Term Loan B, due 2023, current portion (interest at 5.55% and 5.49% respectively) ........................... $

Capital lease obligations, current portion .................................................................................................................

Total

......................................................................................................................................................................... $

The Company’s long-term debt consists of the following:

November 30,

2018

2017

(Dollars in millions)

3.5

0.7

4.2

3.5

0.7

4.2

November 30,

2018

2017

(Dollars in millions)

$350 million Term Loan B, due 2023 (interest at 5.55% and 5.49% respectively) .................................................... $

302.1

345.6

Senior Secured Revolving Credit Facility, due 2021 (interest at 3.88% as of November 30, 2018) ..........................

Capital lease obligations ..........................................................................................................................................

Gross debt ................................................................................................................................................................

Less: current portion ................................................................................................................................................

Unamortized original issue discount .........................................................................................................................

Debt issuance costs .................................................................................................................................................

12.0

15.6

329.7

(4.2)

(2.1)

(4.7)

—

16.2

361.8

(4.2)

(2.8)

(5.0)

Total long-term debt, net of current portion ............................................................................................................... $

318.7

349.8

The following table summarizes payments on long-term debt (excluding capital lease obligations) through maturity:

Year Ending November 30:

(Dollars in millions)

2019 .........................................................................................................................................................................

2020 .........................................................................................................................................................................

2021 .........................................................................................................................................................................

2022 .........................................................................................................................................................................

2023 .........................................................................................................................................................................

Thereafter ................................................................................................................................................................

3.5

15.5

3.5

288.1

—

The weighted-average interest rate on the Company’s short-term debt was 5.40% and 5.32% during 2018 and 2017, respectively.

Term Loan

The Company's $350.0 million Term Loan B matures on August 26, 2023 and is primarily secured by all real property, plant, and equipment

of the Company's U.S. facilities and fully and unconditionally and jointly and severally guaranteed by the material U.S. subsidiaries of the
Company. The Term Loan B carries a variable interest rate based on, at the Company’s option, either a eurodollar rate or a base rate, in each
case plus an applicable margin. The eurodollar rate is a periodic fixed rate equal to the ICE London Interbank Offered Rate (“LIBOR”) subject to
a floor of 1.00%. The applicable margin for the eurodollar rate was originally 4.25%. The base interest rate is a fluctuating rate equal to the
higher of (i) the Prime Rate, (ii) the sum of the Federal Funds Effective Rate plus 0.50%, or (iii) the one-month eurodollar rate plus 1.00%. The
applicable margin for the base rate was originally 3.25%. Annual principal payments consist of $3.5 million due in quarterly installments plus
potential annual excess free cash flow payments as defined in the Term Loan B agreement, with any remaining balance to be paid on August 26,
2023. The Company is no longer subject to a prepayment penalty and can prepay any amount at any time upon proper notice and is subject to a
minimum dollar requirement. Prepayments will be applied towards any required annual excess free cash flow payment.

Additionally, the Term Loan B originally provided for additional borrowings of the greater of $85.0 million or an amount based on a senior

secured leverage ratio, as defined in the Term Loan B agreement, provided that certain requirements are met. The Term Loan B contains
affirmative and negative covenants, including limitations on additional debt, certain investments and acquisitions outside of the Company’s line of
business. The Term Loan B requires the Company to maintain a total net leverage ratio of less than 5.0 to 1.0. The Company is in compliance
with this covenant with a total net leverage ratio of 3.1 to 1.0 at November 30, 2018.

On March 2, 2018, the Company amended its Term Loan B Agreement. Primarily, the Term Loan Amendment (1) reduces the margins for

borrowings under the Term Loan Agreement by 100 basis points to 3.25% for Eurodollar rate loans and 2.25% for base rate loans and (2)
permits the Company to request additional term loans or incremental equivalent debt borrowings (the “Additional Term Loans”) in a maximum
aggregate amount equal to the greater of (a) $120.0 million (an increase from $85.0 million previously) and (b) an aggregate principal amount
such that, on a pro forma basis (giving effect to any Additional Term Loans), the Company’s senior secured net debt leverage ratio will not
exceed 4.0 to 1.0. The amendment also incorporated fallback provisions to address the phasing out of LIBOR, as discussed in more detail under
Item 1A. Risk Factors of this Form 10-K.

Senior Secured Revolving Credit Facility

The Company also has a Senior Secured Revolving Credit Facility (the "Facility") with a potential availability of $90.0 million, which can be
further increased up to $140.0 million subject to additional borrowing base assets and lender approval. The Facility matures on August 26, 2021.
The Facility is secured by U.S. accounts receivable, inventory (collectively the “Eligible Borrowing Base”) and intangible assets. Availability under
the Facility will fluctuate depending on the Eligible Borrowing Base and is determined by applying customary advance rates to the Eligible

Borrowing Base. The Facility includes a $5.0 million sub-limit for the issuance of commercial and standby letters of credit and a $10.0 million
sub-limit for swingline loans. Outstanding letters of credit on November 30, 2018 were $0.4 million. The Facility contains affirmative and negative
covenants, similar to the Term Loan B, including limitations on additional debt, certain investments and acquisitions outside of the Company’s
line of business. If the average excess availability of the Facility falls below $25.0 million during any fiscal quarter, the Company must then
maintain a fixed charge coverage ratio greater than 1.1 to 1.0 as defined in the agreement. Average excess availability is defined as the average
daily amount available for borrowing under the Facility during the Company’s fiscal quarter. The Company was in compliance with this
requirement as the average excess availability did not fall below $25.0 million during the fourth quarter of 2018.

Advances under the Facility bear interest, at the Company’s option, at either an alternate base rate or a eurodollar rate, in each case plus

an applicable margin. The alternate base interest rate is a fluctuating rate equal to the higher of the prime rate or the sum of the federal funds
effective rate plus 0.50%. The eurodollar rate is a periodic fixed rate equal to LIBOR. Applicable margins are based on the Company’s average
daily excess availability during the previous fiscal quarter. If average excess availability is greater than $50.0 million, the applicable margin will
be 1.50% on eurodollar loans and 0.50% on base rate borrowings. If average excess availability is greater than or equal to $25.0 million but less
than or equal to $50.0 million, the applicable margin will be 1.75% on eurodollar loans and 0.75% on base rate borrowings. If average excess
availability is less than $25.0 million, the applicable margin will be 2.00% on eurodollar loans and 1.00% on base rate borrowings. The
commitment fee for unused credit lines will be 0.25% if outstanding borrowings on the Facility are greater than or equal to 50% of the maximum
revolver amount and 0.375% if outstanding borrowings are less than 50% of the maximum revolver amount.

At November 30, 2018, there was $12.0 million borrowed under the Facility and the amount available for borrowing was $55.2 million.

Eurodollar Revolving Loan

On May 31, 2018, the Company established a Eurodollar Revolving Loan ("Revolver") with a potential availability of €16.0 million to provide
additional liquidity and working capital flexibility in Europe. The terms of the Revolver are materially consistent with the Company's U.S. Facility,
including the maturity date of August 26, 2021. This facility contains a €9.0 million expansion feature the Company may exercise in the future to
gain additional liquidity should secured collateral of accounts receivable increase. At November 30, 2018 there were no amounts borrowed under
the Revolver and the amount available for borrowing under the Revolver was €13.7 million.

Other Debt

The Company maintains borrowing facilities at certain foreign subsidiaries, which consist of working capital credit lines and facilities for the

issuance of letters of credit. As of November 30, 2018, total borrowing capacity for foreign working capital credit lines and letters of credit
facilities were $7.0 million, $6.6 million of which was available for utilization. These letters of credit support commitments made in the ordinary
course of business.

Capital Lease Obligations

At November 30, 2018, the Company had assets under capital leases totaling $14.8 million, which are included in property, plant, and

equipment in the accompanying Consolidated Balance Sheets.

The following is a schedule by year of future minimum lease payments for this capital lease together with the present value of the net

minimum lease payments as of November 30, 2018.

Year Ending November 30:

(Dollars in millions)

2019 ............................................................................................................................................................................ $

2020 ............................................................................................................................................................................

2021 ............................................................................................................................................................................

2022 ............................................................................................................................................................................

2023 ............................................................................................................................................................................

Thereafter ....................................................................................................................................................................

Total minimum lease payments ...................................................................................................................................

Less: Amount representing estimated executory costs ................................................................................................

Net minimum lease payments .....................................................................................................................................
Less: Amount representing interest .............................................................................................................................

Present value of minimum lease payments ................................................................................................................. $

1.5

1.4

15.1

22.4

(0.5)

21.9

(6.3)

15.6

Debt Issuance Costs and Original Issue Discounts

Debt issuance costs and original issue discounts incurred in connection with the issuance of the Company's debt are being amortized over

the respective terms of the underlying debt, including any amendments. Total amortization expense of debt issuance costs and original issue
discounts is included as a component of interest expense and was $1.3 million, $1.5 million, and $1.8 million for 2018, 2017, and 2016,
respectively. As a result of a $40.0 million Term Loan B prepayment in 2018 and a redemption of debt in 2016, the Company wrote-off $0.8
million and $2.9 million of existing debt issuance costs original issue discount in 2018 and 2016, respectively. On March 2, 2018, the Company
amended its Term Loan B Agreement and incurred $0.9 million of additional deferred financing fees which are being amortized over the
remaining term of the loan.

Note L—Employee Benefit Plans

The Company maintains a number of defined benefit and defined contribution plans to provide retirement benefits for employees. These

plans are maintained and contributions are made in accordance with the Employee Retirement Income Security Act of 1974 (“ERISA”), local
statutory law, or as determined by the Board of Directors. The plans generally provide benefits based upon years of service and compensation.

Pension plans are funded except for a U.S. non-qualified pension plan for certain key employees and certain foreign plans. The Company uses a
November 30 measurement date for its plans.

Defined Benefit Plans

The Company’s defined benefit plans generally provide benefits based on years of service and compensation for salaried employees and

under negotiated non-wage based formulas for union-represented employees.

Changes in benefit obligations and plan assets are as follows:

2018

2017

(Dollars in millions)

Change in Benefit Obligation:

Benefit obligation at beginning of year ..................................................................................................................... $

288.1

280.8

Service cost .............................................................................................................................................................

Interest cost .............................................................................................................................................................

Actuarial loss (gain) .................................................................................................................................................

Settlement ................................................................................................................................................................

Benefits and expenses paid net of retiree contributions ..........................................................................................

Exchange rate changes ...........................................................................................................................................

Benefit Obligation at End of Year .........................................................................................................................

Change in Plan Assets:

Fair value of plan assets at beginning of year .........................................................................................................

Actual return on assets ....................................................................................................................................

Employer contributions ....................................................................................................................................

Exchange rate changes ...................................................................................................................................

Benefits and expenses paid ............................................................................................................................

Fair Value of Plan Assets at End of Year ..............................................................................................................

Funded Status at November 30 ............................................................................................................................ $

Amounts Recognized in the Consolidated Balance Sheets:

Current liability ................................................................................................................................................. $

Non-current liability ..........................................................................................................................................

Net Amount Recognized ....................................................................................................................................... $

2.6

9.0

(21.6)

—

(18.1)

(0.5)

259.5

217.2

2.1

6.3

—

(18.1)

207.5

(52.0)

(0.4)

(51.6)

(52.0)

2.8

9.3

14.0

(0.4)

(19.6)

1.2

288.1

197.1

32.3

7.6

0.1

(19.9)

217.2

(70.9)

(0.4)

(70.5)

(70.9)

As of November 30, 2018 and 2017, the amounts included in Accumulated Other Comprehensive Income (Loss) that have not yet been

recognized in net periodic benefit cost consist of:

2018

2017

(Dollars in millions)

Net actuarial loss ...................................................................................................................................................... $

(119.7)

(133.2)

The after-tax amount of unrecognized net actuarial loss at November 30, 2018 was $105.1 million. The estimated net loss for defined

benefit plans that will be amortized from Accumulated Other Comprehensive Loss during 2019 is $4.6 million.

Net Periodic Benefit Cost

Net periodic benefit cost (income) consisted of the following for the years ended November 30:

2018

2017

2016

(Dollars in millions)

Net Periodic Benefit Cost:

Service costs for benefits earned ..................................................................................... $

Interest costs on benefit obligation ...................................................................................

Assumed return on plan assets ........................................................................................

Amortization of net loss ....................................................................................................

Curtailment and settlement (gain) loss .............................................................................

Total

................................................................................................................................. $

2.6

9.0

(15.7)

5.4

—

1.3

2.8

9.3

(15.3)

4.9

0.4

2.1

1.8

9.6

(15.3)

4.6

(0.1)

0.6

The Company made $6.3 million and $7.6 million in contributions to its plans during 2018 and 2017, respectively. The Company expects to

make a contribution to its pension plans of $6.4 million in 2019. The Company anticipates pension expense to be approximately $2.0 million in
2019.

Future service benefits are frozen for all participants under the Company's U.S. defined benefit plan. All benefits earned by affected
employees through the effective dates of the freezes have become fully vested with the affected employees eligible to receive benefits upon
retirement, as described in the Plan document.

Estimated future benefit payments to retirees from the Company's pension plans are as follows: 2019 - $17.7 million, 2020 - $17.8 million,

2021 - $17.6 million, 2022 - $18.3 million, 2023 - $18.2 million, and 2024 - 2028 - $89.4 million.

Information regarding pension plans with accumulated benefit obligations in excess of plan assets is as follows:

U.S. Pension Plans:

Projected benefit obligation ...................................................................................................................................... $

Accumulated benefit obligation ................................................................................................................................ $

Fair value of plan assets .......................................................................................................................................... $

Non-U.S. Pension Plans:

Projected benefit obligation ...................................................................................................................................... $

Accumulated benefit obligation ................................................................................................................................ $

Fair value of plan assets .......................................................................................................................................... $

Assumptions

2018

2017

(Dollars in millions)

247.7

206.9

11.8

8.6

0.6

275.9

216.5

12.2

8.5

0.7

Weighted average assumptions used to measure the benefit obligation for the Company’s defined benefit plans as of November 30, 2018

and 2017 were as follows:

Pension Plans

2018

2017

Weighted Average Assumptions:

Discount rate used for liability determination ............................................................................................................

Annual rates of salary increase (non-U.S. plans) .....................................................................................................

4.41%

3.35%

3.66%

3.47%

Weighted average assumptions used to measure the net periodic benefit cost for the Company’s defined benefit plans as of November 30,

2018, 2017, and 2016 were as follows:

Pension Plans

2018

2017

2016

Weighted Average Assumptions:

Discount rate used for expense determination ................................................................................

Assumed long-term rate of return on plan assets ...........................................................................

Annual rates of salary increase (non-U.S. plans) ............................................................................

3.66%

7.68%

3.47%

4.12%

7.68%

3.44%

4.29%

7.70%

3.77%

The discount rate used for the liability measurement reflects the current rate at which the pension liabilities could be effectively settled at the

end of the year. The discount rate used spot rates on a yield curve matching benefit payments to determine the weighted average discount rate
that would be applied in determining the benefit obligation at November 30, 2018. The increase in the discount rate used in 2018 is due to a
general increase in interest rates in the current economic environment. The assumed long-term rate of return on plan assets assumption is
based on the weighted average expected return of the various asset classes in the plans’ portfolios. The asset class return is developed using
historical asset return performance, as well as current market conditions, such as inflation, interest rates, and equity market performance. The
rate of compensation increase is based on management's estimates using historical experience and expected increases in rates.

Pension Plans Assets

The Company’s defined benefit plans are funded primarily through asset trusts or through general assets of the Company. The Company

employs a total return on investments approach for its U.S. defined benefit pension plan assets. A mix of equity securities, fixed income
securities, and collective trusts are used to maximize the long-term rate of return on assets for the level of acceptable risk. Asset allocation at
November 30, 2018, target allocation for 2018, and expected long-term rate of return by asset category are as follows:

Asset Category

Target
Allocation

Percentage of Plan Assets
At November 30,

2018

2017

Equity securities ..............................................................................................................................

Fixed income securities ...................................................................................................................

Collective trusts and other ...............................................................................................................

Total

................................................................................................................................................

58%

18%

24%

100%

52%

16%

32%

100%

54%

16%

30%

100%

The following table summarizes, by level within the fair value hierarchy, the U.S. defined benefit plans’ assets at November 30, 2018 and

November 30, 2017:

2018

Total

Level 1

Level 2

Level 3

(Dollars in millions)

Money market funds ...........................................................................................

0.1

— $

Registered investment companies:

Equity mutual funds ....................................................................................

Fixed income mutual funds .........................................................................

108.4

33.1

108.4

33.1

—

Total registered investment companies ......................................................

141.6

— $

Collective trust funds:

Core property collective .............................................................................

Structured credit collective .........................................................................

Energy debt collective ................................................................................

Total collective trust funds measured at NAV ..............................................

25.8

26.4

13.1

65.3

206.9

2017

Money market funds ...........................................................................................

0.1

— $

Registered investment companies:

Equity mutual funds ....................................................................................

Fixed income mutual funds .........................................................................

Total registered investment companies ......................................................

Real estate partnerships .....................................................................................

Collective trust funds:

Core property collective .............................................................................

Structured credit collective .........................................................................

Energy debt collective ................................................................................

Total collective trust funds measured at NAV ..............................................

117.6

31.9

149.5

0.3
149.9

23.7

30.6

12.3

66.6

216.5

117.6

31.9

149.5

—
149.6

—

0.3

Money market funds are valued at a net asset value ("NAV") of $1.00 per share held by the plan at year end, which approximates fair value.
Registered investment companies are valued at quoted market prices. The fair value of the participation units owned by the Plan in the collective
trust funds are based on the NAV of participating units held by the Plan. Investments in real estate partnerships are valued at the fair value of the
underlying assets based on comparable sales value for similar assets, discounted cash flow models, appraisals, and other valuation techniques.

The preceding methods described may produce a fair value calculation that may not be indicative of net realizable value or reflective of

future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market
participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a
different fair value measurement at the reporting date.

A reconciliation of the beginning and ending Level 3 measurements is as follows:

Real Estate
Partnerships

(Dollars in millions)

Balance November 30, 2016 .................................................................................................................................................... $

Redemptions ............................................................................................................................................................................

Unrealized net gains or losses included in funded status .........................................................................................................

Balance November 30, 2017 ....................................................................................................................................................

Redemptions .............................................................................................................................................................................

Realized net gains or losses included in funded status ............................................................................................................

Balance November 30, 2018 .................................................................................................................................................... $

0.3

—

0.3

(0.2)

(0.1)

—

The following table summarizes the Plan’s investments with a reported NAV, which are measured at NAV as a practical expedient to

estimate fair value and are not classified in the fair value hierarchy as of November 30, 2018 and 2017:

November 30,

2018

2017

(Dollars in millions)

SEI Structured Credit Collective Fund ................................................................................................................

(a)

SEI Energy Debt Collective Investment Trust ......................................................................................................

(b)

SEI Core Property Collective Investment Trust ...................................................................................................

(c)

26.4

13.1

25.8

30.6

12.3

23.7

(a) The SEI Structured Credit Collective Fund seeks to provide high general returns by investing in collateralized debt obligations (“CDO’s”) and other structured

credit instruments. This fund requires a two-year non-redemption period after which investments can be redeemed at any time; however, a 90 day redemption
notification period is required. The Plan has satisfied all funding obligations related to this investment and has surpassed the two-year non-redemption period.

(b) The SEI Energy Debt Collective Investment Trust seeks to generate high total returns by primarily investing in debt securities of U.S. and international energy

companies denominated in U.S. dollars. This trust will invest in investment grade bonds, below investment grade bonds, loans, rights issues, or equities of U.S.
companies. Equity investments will be limited. In most cases, equity investments will be attached to a debt investment for extending credit or if received in a
restructuring, though the Sub-Adviser is permitted to add-on to an existing equity position through a secondary market transaction.

(c) The SEI Core Property Collective Investment Trust, seeks both current income and long-term capital appreciation through investing in underlying funds that
acquire, manage, and dispose of commercial real estate properties. This trust expects to invest at least 85% of its assets in open-end core underlying funds
focused on properties in the U.S. with "core" meaning high-quality, low-leveraged, income-generating office, industrial, retail, and multi-family properties,
generally fully-leased to credit-worthy companies and governmental entities. Up to 5% of this trust's net assets may be invested in liquid real estate strategies
(publicly-traded REITs) for cash management purposes and the fund may have up to a 15% allocation to non-core sectors and strategies.

Defined Contribution Plans

The Company also sponsors a defined contribution 401(k) plan. Participation in this plan is available to substantially all U.S. salaried
employees and to certain groups of U.S. hourly employees. Company contributions to this plan are based on either a percentage of employee
contributions or on a specified amount per hour based on the provisions of the applicable collective bargaining agreement. Contribution expense
to this plan was approximately $2.6 million in 2018, $2.6 million in 2017, and $2.5 million in 2016. The defined contribution 401(k) plan contained
approximately 0.7 million and 0.8 million of the Company's common shares at November 30, 2018 and November 30, 2017, respectively.

Health Care Plans

The Company provides retiree medical plans for certain retired U.S. employees of which there were 65 retired participants as of
November 30, 2018. The plan is frozen to new participants. The plans generally provide for cost sharing in the form of retiree contributions,
deductibles, and coinsurance between the Company and its retirees, and a fixed cost cap on the amount the Company pays annually to provide
future retiree medical coverage. These post-retirement benefits are unfunded and are accrued by the date the employee becomes eligible for
benefits. Retirees in certain other countries are provided similar benefits by plans sponsored by local governments.

Changes in benefit obligations are as follows:

2018

2017

(Dollars in millions)

Change in Benefit Obligation:

Benefit obligation at beginning of year ..................................................................................................................... $

Interest cost .............................................................................................................................................................

Actuarial (gain) loss .................................................................................................................................................

Benefits paid net of retiree contributions .................................................................................................................

Benefit Obligation at End of Year .........................................................................................................................

Change in Plan Assets:

Fair value of plan assets at beginning of year .........................................................................................................

Employer contributions ....................................................................................................................................

Benefits and expenses paid, net of retiree contributions .................................................................................

Fair Value of Plan Assets at End of Year ..............................................................................................................

6.9

0.2

(0.4)

(0.8)

5.9

—

0.8

(0.8)

—

Funded Status at November 30 ............................................................................................................................ $

(5.9)

Amounts Recognized in the Consolidated Balance Sheets:

Current liability ................................................................................................................................................. $

(0.6)

Non-current liability ..........................................................................................................................................

(5.3)

Net Amount Recognized ....................................................................................................................................... $

(5.9)

6.9

0.2

0.4

(0.6)

6.9

—

0.6

(0.6)

—

(6.9)

(0.6)

(6.3)

(6.9)

As of November 30, 2018 and 2017, the amounts included in Accumulated Other Comprehensive Income (Loss) that have not been

recognized in net periodic benefit cost consist of:

Net actuarial gain ...................................................................................................................................................... $

10.6

Prior service credit

.................................................................................................................................................... $

— $

11.1

—

The after-tax amount of unrecognized net actuarial gain at November 30, 2018 was $15.7 million. The estimated net gain for post retirement

health care plans that will be amortized from Accumulated Other Comprehensive Loss during 2019 is $1.3 million.

Net periodic benefit cost (income) consisted of the following for the years ended, November 30:

2018

2017

(Dollars in millions)

Interest costs on benefit obligation .................................................................................................. $

Amortization of net gain ..................................................................................................................

Total

............................................................................................................................................... $

Estimated future benefit payments for the retiree health care plans are as follows:

2018

2017

2016

(Dollars in millions)

0.2

(0.9)

(0.7)

0.2

(1.0)

(0.8)

0.2

(1.0)

(0.8)

2019 ............................................................................................................................................................................ $

2020 ............................................................................................................................................................................

2021 ............................................................................................................................................................................

2022 ............................................................................................................................................................................

2023 ............................................................................................................................................................................

2024 - 2028 .................................................................................................................................................................

Benefit
Payments

(Dollars in millions)

0.6

0.5

2.1

The Company expects to record non-cash retiree medical health care reduction of expenses of approximately $1.1 million in 2019.

Assumptions

Weighted Average Assumptions:

2018

2017

2016

Discount rate used for liability determination ...................................................................................

Discount rate used for expense determination ................................................................................

Current health care cost trend rate assumed for the next year ........................................................

Ultimate trend rate for health care costs ..........................................................................................

Year reached ...................................................................................................................................

4.41%

3.62%

7.10%

4.50%

2037

3.62%

4.00%

7.60%

4.50%

2037

4.00%

4.15%

8.00%

4.50%

2037

The discount rate reflects the current rate at which the retiree medical liabilities could be effectively settled at the end of the year. The
discount rate used spot rates on a yield curve matching benefit payments to determine the weighted average discount rate that would be applied
in determining the benefit obligation at November 30, 2018. Because the Company’s retiree health care benefits are capped, assumed health
care cost trend rates have a minimal effect on the amounts reported for the retiree health care plans. A 1% increase or decrease in the current
health care cost trend rate would have an impact of less than $0.1 million on net periodic cost and the benefit obligation.

Note M—Contingencies and Commitments

Litigation

From time to time, the Company is subject to various claims, proceedings, and lawsuits related to products, services, contracts,

employment, environmental, safety, intellectual property, and other matters. The ultimate resolution of such claims, proceedings, and lawsuits is
inherently unpredictable and, as a result, the Company’s estimates of liability, if any, are subject to change. Actual results may materially differ
from the Company’s estimates and an unfavorable resolution of any matter could have a material adverse effect on the financial condition,
results of operations and/or cash flows of the Company. However, subject to the above and taking into account such amounts, if any, as are
accrued from time to time on the Company’s balance sheet, the Company does not believe, based on the information currently available to it,
that the ultimate resolution of these matters will have a material effect on the consolidated financial condition, results of operations, or cash flows
of the Company.

Leases

The Company leases certain facilities, machinery and equipment, and office buildings under long-term, non-cancelable operating leases.
The leases generally provide for renewal options ranging from 5 to 20 years and require the Company to pay for utilities, insurance, taxes, and
maintenance. Lease expense on operating leases was $5.7 million in 2018, $6.2 million in 2017, and $6.3 million in 2016. Future minimum
commitments at November 30, 2018 for non-cancelable operating leases were $16.2 million with annual amounts of $3.9 million in 2019, $2.9
million in 2020, $2.0 million in 2021, $1.7 million in 2022, $1.1 million in 2023, and $4.6 million for leases thereafter.

Environmental Matters

The Company’s policy is to conduct its businesses with due regard for the preservation and protection of the environment. The Company

devotes significant resources and management attention to comply with environmental laws and regulations. The Company’s Consolidated
Balance Sheets as of November 30, 2018 and 2017 reflects reserves for environmental remediation of $1.5 million and $1.6 million, respectively.
The Company’s estimates are subject to change and actual results may materially differ from the Company’s estimates. Management believes,
on the basis of presently available information, that resolution of known environmental matters will not materially affect liquidity, capital
resources, or the financial condition of the Company.

Collective Bargaining Agreements

At November 30, 2018, the Company employed approximately 1,900 employees at offices, plants, and other facilities located principally

throughout the United States, France, China, Portugal and Thailand. Approximately 11% of the Company’s U.S. employees are covered by
collective bargaining agreements of which approximately 140 employees are covered by agreements that expire within the next 12 months. In
addition, certain of our foreign employees are also covered by collective bargaining agreements.

Note N—Share-Based Compensation Plans

The Company provides compensation benefits to employees under the OMNOVA Solutions 2017 Equity Incentive Plan (the “Plan”), which

was approved by shareholders on March 22, 2017. The Plan permits the Company to grant to officers, key employees and non-employee
directors of the Company, incentives directly linked to the price of OMNOVA Solutions’ common shares. The Plan authorizes the issuance of
Company common shares in the aggregate for (a) awards of options rights to purchase Company common shares, (b) performance shares and
performance units, (c) restricted shares, (d) restricted share units, or (e) appreciation rights. Shares granted under the Plan may be either newly
issued shares or treasury shares or both. As of November 30, 2018, approximately 1.9 million Company common shares remained available for
grants under the Plan. All options granted under the Plan are granted at exercise prices equal to the market value of the Company’s common
shares on the date of grant. Additionally, the Plan provides that the term of any option granted under the Plan may not exceed 10 years. Prior to
March 22, 2017, the Company granted equity compensation under the OMNOVA Solutions Third Amended and Restated 1999 Equity and
Performance Incentive Plan, which had substantially similar features.

During the year ended November 30, 2018, the Company granted Performance Share Units ("PSU's") to its executive officers. The PSU's

provide recipients the right to receive the Company's common shares if specified performance goals, including a performance goal relative to
peers, are met over a three fiscal year measurement period. Each grantee receives a target grant of PSU's, but may earn between 0% and
200% (or in the case of the Company's Chief Executive Officer, between 0% and 160%) of the target grant depending on the Company's
performance against the stated performance goals. The estimated fair value of performance share units granted is based on the closing market
price of the Company’s common shares on the date of issuance and recorded based on achievement of target performance metrics.

Share-based compensation is measured at the grant date, based on the calculated fair value of the award, and is recognized as an
expense over the requisite service period (generally the vesting period). The fair value of Restricted Share Awards ("RSA's") and Restricted
Share Units ("RSU's") is determined based on the closing market price of the Company’s common shares at the date of grant. RSU's entitle the
holder to receive one ordinary share for each RSU at vesting, generally over a three year period from the date of grant. Estimates of fair value
are not intended to predict actual future events or the value ultimately realized by employees who receive equity awards, and subsequent events
are not indicative of the reasonableness of the original estimates of fair value made by the Company.

In accordance with the adoption of ASU 2016-09, the Company recognized a cumulative effect adjustment to retained earnings of $2.9

million in the Consolidated Financial Statements as of December 1, 2016 related to the recognition of deferred tax assets attributable to
previously issued restricted stock and options.

For RSA and RSU grants, which consist of the Company’s common shares, the fair value is equal to the market price of the Company’s
shares on the date of grant. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees
who receive equity awards, and subsequent events are not indicative of the reasonableness of the original estimates of fair value made by the
Company.

A summary of the Company’s restricted share and restricted share units activity and related information for the years ended November 30,

2018, 2017, and 2016 are as follows:

2018

2017

2016

Share
Awards &
Units

Weighted
Average
Grant
Date Fair
Value

Non-vested at beginning of year.............

567,600

Granted ..................................................

Vested ....................................................

Forfeited .................................................

Non-vested at end of year ......................

353,100

(198,350)

(32,502)

689,848

7.08

10.46

7.31

7.34

8.81

Share
Awards &
Units

1,008,150

209,650

(615,450)

(34,750)

567,600

Weighted
Average
Grant
Date Fair
Value

7.23

8.31

7.46

7.25

7.08

Share
Awards &
Units

872,200

416,500

(258,900)

(21,650)

1,008,150

Weighted
Average
Grant
Date Fair
Value

8.13

5.44

7.91

8.26

7.23

Compensation expense for all share-based payments included in general and administrative expense was $2.8 million, $1.9 million, and

$2.5 million during 2018, 2017, and 2016, respectively.

As of November 30, 2018, there was $3.6 million of total unrecognized compensation expense related to non-vested share-based

compensation arrangements to be amortized over a weighted average remaining period of 2.0 years.

The Company also provides employees the opportunity to purchase Company common shares through payroll deductions under the
OMNOVA Solutions Employee Share Purchase Plan (the "ESPP"). Under the ESPP, eligible employees receive a 15% discount from the trading
value of common shares purchased. The purchase price for common shares purchased from the Company will be 85% of the closing price of the
common shares on the New York Stock Exchange ("NYSE") on the investment date. Participants may contribute funds to the ESPP, not to
exceed twenty-five thousand dollars in any calendar year. If a participant terminates his or her employment with the Company or its subsidiaries,
the participant's participation will immediately terminate and the participant's account will be converted to a regular brokerage account. As of
November 30, 2018 the amount of shares held by eligible participants through the ESPP was not material.

Note O—Business Segment Information

The Company's two reporting segments are Specialty Solutions and Performance Materials. These two reporting segments were

determined based on products and services provided as defined under FASB Accounting Standards Codification ("ASC") 280, Segment
Reporting. Accounting policies of the segments are the same as the Company’s accounting policies. The Company’s reporting segments are
strategic business units that offer different products and services. They are managed separately based on certain differences in their operations,
technology, and marketing strategies.

Segment operating profit represents net sales less applicable costs, expenses and provisions for restructuring and severance costs, asset
write-offs and acquisition and integration related expenses relating to operations. However, Management excludes restructuring and severance
costs, asset write-offs and acquisition and integration related costs when evaluating the results and allocating resources to the segments.

Segment operating profit excludes certain unallocated corporate headquarters expenses. Corporate headquarters expense includes the
cost of providing and maintaining the corporate headquarters functions, including salaries, rent, travel and entertainment expenses, depreciation,
utility costs, outside services and amortization of deferred financing costs.

In 2018, segment operating profit for Specialty Solutions includes restructuring and severance charges of $0.7 million and asset impairment

and facility closure costs $1.1 million, and acquisition integration related expense of $1.8 million, and accelerated depreciation expense of $0.1
million, while the Performance Materials operating profit includes restructuring and severance charges of $1.1 million, asset impairment and
facility closure costs of $14.3 million, accelerated depreciation of $1.1 million and environmental costs of $0.2 million.

In 2017, segment operating profit for Specialty Solutions includes restructuring and severance charges of $0.6 million, and asset
impairment and facility closure costs of $0.3 million, while the Performance Materials operating profit includes restructuring and severance
charges of $1.7 million, asset impairment and facility closure costs of $33.6 million, and a reduction in environmental costs of $2.0 million.

In 2016, segment operating profit for Specialty Solutions includes restructuring and severance charges of $0.2 million, and asset
impairment and facility closure costs and other of $0.2 million, while the Performance Materials operating profit includes restructuring and

severance charges of $3.3 million, asset impairment and facility closure costs of $4.2 million, acquisition and integration expenses of $1.1
million, environmental costs of $0.3 million, operational improvement gains of $0.4 million, and accelerated depreciation charges of $3.0 million.

The following table summarizes operations by segment and a reconciliation of segment sales to consolidated sales and segment operating

profit to income (loss) before income taxes:

2018

2017

2016

(Dollars in millions)

Net Sales

Specialty Solutions ................................................................................................................ $

Performance Materials ..........................................................................................................

Total Net Sales ..............................................................................................................................

Segment Operating Profit

Specialty Solutions ................................................................................................................ $

Performance Materials ..........................................................................................................

Total segment operating profit ........................................................................................................

Interest expense ............................................................................................................................

Corporate expenses ......................................................................................................................

Corporate severance .....................................................................................................................

Operational improvement costs .....................................................................................................

Asset impairments .........................................................................................................................

Acquisition and integration related expense ..................................................................................

Gain on sale of assets ...................................................................................................................

Debt issuance costs write-off .........................................................................................................

Pension settlement ........................................................................................................................

487.6

282.2

769.8

70.7

(9.8)

60.9

(19.3)

(24.0)

(0.9)

—

(0.1)

(2.2)

0.9

(0.8)

—

441.4

341.7

783.1

59.9

(12.6)

47.3

(21.5)

(24.5)

(2.9)

—

(1.8)

(0.3)

—

(0.4)

Income (Loss) Before Income Taxes ..........................................................................................

14.5

(4.1)

404.3

355.6

759.9

59.8

8.5

68.3

(24.7)

(25.8)

(4.9)

0.8

—

(0.9)

—

(2.9)

—

9.9

Capital Expenditures:

Specialty Solutions ........................................................................................................................

Performance Materials ..................................................................................................................

Corporate .......................................................................................................................................

Depreciation and Amortization:

Specialty Solutions ........................................................................................................................

Performance Materials ..................................................................................................................

Corporate ......................................................................................................................................

2018

2017

2016

(Dollars in millions)

16.9

6.0

0.9

23.8

17.6

12.4

0.2

13.4

10.9

0.8

25.1

14.5

11.4

2.0

30.2

27.9

11.9

1.8

25.6

13.3

16.2

1.1

30.6

The Company does not disclose assets by business segment as the Chief Operating Decision Maker ("CODM"), its Chief Executive Officer

("CEO"), does not use this information to make decisions, assess performance or allocate resources by business segment.

GEOGRAPHIC INFORMATION

2018

2017

2016

(Dollars in millions)

Net Sales:

United States ................................................................................................................................. $

Europe ...........................................................................................................................................

Asia ................................................................................................................................................

Segment Operating Profit:

United States ................................................................................................................................. $

Europe ...........................................................................................................................................

Asia ................................................................................................................................................

Total Assets:

United States ................................................................................................................................. $

Europe ...........................................................................................................................................

Asia ................................................................................................................................................

449.6

164.0

156.2

769.8

37.1

18.6

5.2

60.9

246.4

261.1

81.7

589.2

Long-Lived Assets:

United States ................................................................................................................................. $

115.7

Europe ...........................................................................................................................................

Asia ................................................................................................................................................

61.1

29.0

481.7

141.4

160.0

783.1

38.4

17.4

(8.5)

47.3

313.5

205.9

93.4

612.8

124.7

49.8

34.4

454.0

129.9

176.0

759.9

56.7

10.9

0.7

68.3

362.4

197.9

127.0

687.3

125.3

45.3

32.1

205.8

208.9

202.7

Note P—Financial Instruments and Fair Value Measurements

Financial Risk Management Objectives and Policies

The Company is exposed primarily to credit, interest rate, and foreign currency rate risks, which arise in the normal course of business.

Credit Risk

Credit risk is the potential financial loss resulting from the failure of a customer or counterparty to settle its financial and contractual

obligations with the Company as and when they fall due. The primary credit risk for the Company is its accounts receivable and notes receivable,
which are generally unsecured. The Company has established credit limits for customers and monitors their balances to mitigate its risk of loss.
Concentrations of credit risk with respect to accounts receivable are generally limited due to the wide variety of customers and markets using the
Company's products. There was no single customer who represented more than 10% of the Company's consolidated net sales for the year
ended November 30, 2018. There was one Performance Materials' customer that represented approximately 10% of the Company’s
consolidated net sales during the years ended November 30, 2017 and 2016. There was no single customer who represented more than 10% of
the Company’s net trade receivables at November 30, 2018 or 2017.

Interest Rate Risk

The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company’s $350.0 million Term Loan B

(balance of $302.1 million at November 30, 2018), Senior Secured Revolving Credit Facility, and various foreign subsidiary borrowings, which
bear interest at variable rates, approximating market interest rates. The Term Loan B has a LIBOR floor of 1.00%. As of November 30, 2018, the
LIBOR rate applicable to the Term Loan B was 2.30%.

Foreign Currency Rate Risk

The Company incurs foreign currency risk on sales and purchases denominated in other than the functional currency. The currencies giving

rise to this risk are primarily the Euro, Great Britain Pound Sterling, Renminbi, and Thai Baht.

Foreign currency exchange contracts are used by the Company to manage risks from the change in market exchange rates on cash

payments by the Company's foreign subsidiaries and U.S. Dollar cash holdings in foreign locations. These forward contracts are used on a
continuing basis for periods of approximately thirty days, consistent with the underlying hedged transactions. Hedging limits the impact of foreign
exchange rate movements on the Company’s operating results. The counterparties to these instruments are investment grade financial
institutions and the Company does not anticipate any non-performance. The Company maintains control over the size of positions entered into
with any one counterparty and regularly monitors the credit rating of these institutions. Such instruments are not purchased or sold for trading
purposes. These contracts are not designated as hedging instruments and changes in fair value of these instruments are recognized in earnings
immediately. Net losses on foreign currency contracts that were recorded in the Consolidated Statement of Operations, as a component of other
income, were $1.0 million for the year ended November 30, 2018. Net gains on foreign currency contracts for the year ended November 30,
2017 were $0.7 million.

Derivative Instruments

The Company recognizes the fair value of qualifying derivative instruments as either an asset or a liability within its statement of financial

position. For derivative instruments not designated as hedges, the change in fair value of the derivative is recognized in earnings each reporting

period. The Company defines fair value as the price that would be received to transfer an asset or that would be paid to transfer a liability in an
orderly transaction between market participants at the measurement date. The Company uses a hierarchy of valuation inputs to measure fair
value.

The hierarchy prioritizes the inputs into three broad levels:

The fair value of derivative financial instruments recognized in the Consolidated Statements of Financial Position are as follows:

Derivatives - November 30, 2018

Foreign currency exchange contracts ...................... $

Total ........................................................................... $

Derivatives - November 30, 2017

Foreign currency exchange contracts ...................... $

Total ............................................................................... $

Fair Value Measurements

Notional
Amount

Other
Current
Assets

Other
Current
Liabilities

Type of
Hedge

Term

(Dollars in millions)

16.5

9.8
9.8

0.1

— Cash Flow

30 days

—

— Cash Flow

30 days

—

The Company uses the market approach and the income approach to value assets and liabilities as appropriate. The model uses Level 2
market observable inputs including currency spot prices. The following financial assets and liabilities are measured and presented at fair value
on a recurring basis as of November 30, 2018 and November 30, 2017:

Fair Value

Level 1

Level 2

Level 3

(Dollars in millions)

Fair Value Measurements - November 30, 2018

Financial Assets

Foreign currency exchange contracts ..................................................... $

Total Assets ............................................................................................. $

Financial Liabilities

Contingent consideration ........................................................................ $

Total Liabilities ....................................................................................... $

Fair Value Measurements - November 30, 2017

Financial Assets

Foreign currency exchange contracts ..................................................... $
Total Assets ............................................................................................. $

Financial Liabilities

Contingent Consideration .......................................................................... $

Total Liabilities ........................................................................................ $

0.1

0.6

0.1
0.1

1.0

$
$

— $

— $
— $

— $

0.1

— $

0.1
0.1

$
$

— $

The following table summarizes changes in fair value of contingent consideration classified as Level 3:

(Dollars in millions)

Balance November 30, 2016 ....................................................................................................................................... $

Additions from acquisitions ..........................................................................................................................................

Balance November 30, 2017 .......................................................................................................................................

Adjustments .................................................................................................................................................................

Payments .....................................................................................................................................................................

Balance November 30, 2018 ....................................................................................................................................... $

—

0.6

—
—

1.0

—

1.0

0.1
(0.5)
0.6

During fiscal year 2018 and 2017, the Company did not record any material other-than-temporary impairments on financial assets required

to be measured at fair value on a nonrecurring basis.

The Company measures the fair value of its foreign exchange forward contracts using month-end currency spot prices.

In connection with the Creole acquisition, the Company recorded a contingent consideration liability with a fair value of $1.0 million as of

November 30, 2017. The fair value has been adjusted to $0.6 million as of November 30, 2018 based on payments made and changes in
expected value. Changes in expected value are recognized in other income within the consolidated statements of operations. Under the
contingent consideration agreement, the amounts to be paid are based upon actual financial results of the acquired product sales over a two-
year period. The fair value of the contingent consideration is a Level 3 valuation and fair valued using a probability weighted discounted cash
flow analysis. There were no transfers into or out of Level 3 during 2018 or 2017.

The fair value of the Company’s Term Loan B at November 30, 2018 approximated $301.3 million, which is less than the book value of

$302.1 million as a result of prevailing market rates on the Company’s debt. The fair value of the Term Loan B is based on market price
information and is measured using the last available trade of the instrument on a secondary market in each respective period and therefore is
considered a Level 2 measurement. The fair value is not indicative of the amount that the Company would have to pay to redeem these
instruments since they are infrequently traded and are not callable at this value. The carrying value of the Senior Secured Revolving Credit
Facility approximates fair value. The fair value of the Company's capital lease obligation approximates its carrying amount based on estimated
borrowing rates to discount the cash flows to their present value.

Note Q—Treasury Stock Purchases

On September 25, 2018, the Company's Board of Directors authorized the repurchase of up to $20.0 million of the Company's common

shares, which authorization expires upon the completion of the $20.0 million in repurchases. The Company may use various methods to make
the repurchases, including open market repurchases, negotiated block transactions, or open market solicitations for shares. Because the
Company has not adopted a Rule 10b5-1 plan for these repurchases, repurchases may only be made during open window periods depending
upon relevant factors including market or business conditions. Repurchases may be discontinued at any time.

The Company did not repurchase any shares during 2018 or 2017 under an approved plan. Shares acquired during 2018 or 2017 resulted

from common shares deemed surrendered by employees in connection with the Company’s equity compensation and benefit plans to satisfy
employee income tax obligations upon vesting.

Note R—Acquisitions

Resiquimica

On September 25, 2018, the Company acquired all of the outstanding shares of Resiquimica S.A. and certain related entities

("Resiquimica") from Socer - Imobiliaria e Investimentos, S.A. Resiquimica is a Portugal-based producer of polymers and resins for coatings and
construction applications in Europe, Middle East and Africa ("EMEA"). Resiquimica, with approximately €56.0 million in annual sales, brings new
technology, expanded product portfolio and a manufacturing base in Sintra, Portugal, which will provide production flexibility in the EMEA region.
The total purchase price for Resiquimica was €21.8 million ($25.6 million), net of acquired cash plus debt assumed of $9.8 million. Cash
payments were primarily funded with cash on hand and borrowings on the Facility. Of the total purchase price, $22.8 million was paid in fiscal
2018, and $2.8 million was paid subsequently in December 2018. Resiquimica's results are included within the Specialty Solutions segment. The
debt assumed was subsequently paid in full and the related cash flows are reflected as financing cash flows within the Consolidated Statement
of Cash Flows.

The information included herein has been prepared based on the preliminary allocation of the purchase price using estimates of the fair
value of assets acquired and liabilities assumed which were determined with the assistance of independent valuations using discounted cash
flow and comparative market multiple approaches, quoted market prices and estimates made by management. The purchase price allocation is
subject to further adjustment until all pertinent information regarding the assets and liabilities acquired are fully evaluated by the Company, not to
exceed one year as permitted under ASC 805, Business Combinations.

The following table presents the preliminary estimated fair value of the assets acquired and liabilities assumed at the date of acquisition:

Assets acquired:

(Dollars in millions)

Accounts receivable ............................................................................................................................................... $

Inventories ..............................................................................................................................................................

Prepaid expenses and other ..................................................................................................................................

Property, plant, and equipment ...............................................................................................................................

Intangible assets ....................................................................................................................................................

Goodwill .................................................................................................................................................................

Total assets acquired .................................................................................................................................................

Liabilities assumed:

Accounts payable ...................................................................................................................................................

Accrued payroll and personal property taxes .........................................................................................................

Other current liabilities ...........................................................................................................................................

Deferred income taxes ...........................................................................................................................................

Total liabilities assumed ............................................................................................................................................

Net assets acquired .................................................................................................................................................. $

20.0

8.8

0.5
13.7

3.5

6.4
52.9

11.5

1.7

1.2

3.1
17.5

35.4

The Company recorded acquired intangible assets of $3.5 million, with an estimated weighted-average useful life of 9.1 years. These

intangible assets include customer lists of $1.1 million, technical know-how of $0.9 million, and trademarks of $1.5 million, with estimated
weighted-average useful lives ranging from 7 to 10 years.

The Company incurred $2.1 million of acquisition-related costs for Resiquimica, which have been included in acquisition and integration
related expense within the consolidated statements of operations. The gross contractual amount of accounts receivable acquired was $20.3
million. The Company repaid the acquired debt of $9.8 million within 60 days of the acquisition date.

Goodwill is calculated as the excess of the purchase price over the estimated fair values of the assets acquired and the liabilities assumed

in the acquisition, and represents the future economic benefits arising from other assets acquired that could not be individually identified and
separately recognized. The amount allocated to goodwill is primarily the result of anticipated synergies resulting from the consolidation of sales,
logistics, and purchasing activities, as well as the elimination of duplicate administrative costs. This goodwill has been allocated to the
Company's Specialty Solutions segment and is not deductible for income tax purposes.

Creole

On March 13, 2017, the Company acquired the assets of Creole Chemicals, Inc., a producer of specialty oilfield additives based in

Houston, Texas. This acquisition allows the Company to accelerate growth, round out its existing offerings and broaden its solutions portfolio in
the oil and gas product line. Assets acquired included inventory and intellectual property. The Company paid $2.5 million cash, as well as
contingent consideration that will be based on future profitability of acquired product sales over a two-year period. The acquisition date fair value
of the contingent consideration was $0.7 million.

OMNOVA SOLUTIONS INC.
Selected Quarterly Financial Data (Unaudited)

Three Months Ended

2018

February 28

May 31

August 31

November 30

Net sales .............................................................................................. $
Gross profit(1)(2) ....................................................................................
Restructuring and severance ...............................................................

(Gain) Loss on asset sales ..................................................................

Asset impairments and write-offs .........................................................

Debt issuance costs write-off ...............................................................
Net income (loss)(3) ............................................................................

Net income (loss) per basic and diluted share ..................................

(4)

Common stock price range per share - high ........................................

Common stock price range per share - low .........................................

(Dollars in millions, except per share amounts)

178.7

206.3

193.6

191.3

46.6

1.3

—

0.8

7.3

0.16

11.60

9.55

51.6

0.2

—

0.4

—

8.4

0.19

11.90

9.95

49.1

0.3

—

9.2

—

(1.9)

(0.04)

10.80

8.30

43.5

1.7

(0.9)

3.9

—

6.9

0.15

10.70

7.36

2017

February 28

May 31

August 31

November 30

Three Months Ended

(Gain) Loss on asset sales ..................................................................

Asset impairments and write-offs .........................................................
Net income (loss)(3) ............................................................................

Net income (loss) per basic and diluted share ..................................

(4)

Common stock price range per share - high ........................................

Common stock price range per share - low .........................................

(Dollars in millions, except per share amounts)

174.6

221.3

200.9

43.9

1.0

—

3.6

0.08

10.05

8.60

53.2

3.6

—

12.9

(6.3)

(0.14)

9.90

8.55

57.8

0.4

—

0.4

7.9

0.18

10.15

8.40

186.3

45.9

0.6

0.4

19.6

(92.9)

(2.10)

11.45

8.70

(1) Gross profit excludes depreciation and amortization expense. Depreciation and amortization expense related to manufacturing facilities and equipment was

$4.9 million, $5.0 million, $5.5 million, and $5.4 million for the three months ended February 28, 2018, May 31, 2018, August 31, 2018, and
November 30, 2018 and $4.7 million, $4.8 million, $4.8 million, and $5.0 million for the three months ended February 28, 2017, May 31, 2017,
August 31, 2017, and November 30, 2017, respectively.

(2) Gross profit includes net LIFO inventory reserve adjustments of $0.8 million of expense, $1.5 million of expense, $0.9 million of expense, and $0.6 million of
expense for the three months ended February 28, 2018, May 31, 2018, August 31, 2018 and November 30, 2018, respectively, and $1.3 million of expense,
$0.3 million of expense, $1.2 million of income and $1.0 million of expense for the three months ended February 28, 2017, May 31, 2017, August 31, 2017,
and November 30, 2017, respectively.

(3) The Company’s income tax benefit (expense) was $6.2 million and $(83.7) million for 2018 and 2017, respectively. The 2017 income tax expense was

significantly higher than 2018 primarily as a result of a $79.9 million income tax expense related to valuation allowances on deferred tax assets recorded in
2017. Of that amount, $75.7 million income tax expense was recorded in the U.S. during the fourth quarter of 2017.

(4) The sum of the quarterly earnings per share amounts may not equal the annual amount due to changes in the number of shares outstanding during the year.

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

There have been no changes in accountants or disagreements with the Company’s independent registered public accounting firm regarding
accounting and financial disclosure matters during the two most recent years of the Company or during any period subsequent to the date of the
Company’s most recent consolidated financial statements.

Item 9A. Controls and Procedures

Management of the Company, including the Chief Executive Officer and the Chief Financial Officer, has evaluated the effectiveness of the
Company’s disclosure controls and procedures as of November 30, 2018, using criteria set forth by the Committee of Sponsoring Organizations
of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013). Based on its evaluation, management has determined
that the Company’s disclosure controls and procedures are effective. Further, during the quarter ended November 30, 2018, there were no
changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the
Company’s internal control over financial reporting. Management’s annual report on the Company’s internal control over financial reporting and
the attestation report of the Company’s independent registered public accounting firm are set forth in this report, respectively, and are
incorporated herein by reference.

Item 9B. Other Information

Not applicable.

Item 10. Directors and Executive Officers of the Registrant

PART III

The below biographical information for OMNOVA's executive officers is given as of January 31, 2019. Except as otherwise indicated, each

individual has held the same office during the preceding five-year period.

Anne P. Noonan, age 55, President and Chief Executive Officer of the Company as of December 1, 2016. Ms. Noonan served as President

of the Performance Chemicals business from September 2014 to December 2016. Ms. Noonan joined OMNOVA from Chemtura Corporation, a
global manufacturer of specialty chemicals that was formed from the 2005 merger of Great Lakes Chemical Corp. and Crompton Corp. She most
recently served as Senior Vice President and President of Chemtura’s Industrial Engineered Products business from October 2013 until
September 2014. Prior roles at Chemtura include Vice President, Strategic Business Development and President, Great Lakes Solutions from
2012 until 2013; President, Great Lakes Solutions from 2009 until 2012; Group President, Polymer Additives from 2007 until 2009; and Vice
President & General Manager, Flame Retardants & Brominated Performance Products from 2005 until 2007. Ms. Noonan held several senior
management positions at Great Lakes Chemical Corp. from 1987 until 2005, and began her career as an Analytical Research Chemist with
McNeil Specialty Chemical Company and Squibb-Linson, Co. from 1985 until 1987.

Paul F. DeSantis, age 54, Senior Vice President and Chief Financial Officer; Treasurer since July 2014. Mr. DeSantis joined the Company

from Bob Evans Farms, Inc., a restaurants owner/operator and packaged foods business, where he served as Chief Financial Officer from
March 2011 until June 2014. Prior to Bob Evans Farms, he was Chief Financial Officer for A. Schulman, Inc., a leading global plastic
compounding company, from 2006 until 2011. Previously, he served in senior finance roles for The Scotts-Miracle-Gro Co., a leading supplier of
branded consumer products for lawn and garden care, from 1997 until 2006; and for the Kellogg Company, a manufacturer and marketer of
ready-to-eat cereal and convenience foods, from 1993 until 1997.

James C. LeMay, age 62, Senior Vice President, Corporate Development; General Counsel since December 1, 2000. Previously, Mr.

LeMay was Senior Vice President, Law and General Counsel of OMNOVA Solutions Inc. since its formation. Prior to the spin-off of OMNOVA
Solutions in October 1999, Mr. LeMay served as Assistant General Counsel of GenCorp Inc.

Marshall D. Moore, age 54, Chief Technology Officer and Senior Vice President of Operations as of January 11, 2018. Mr. Moore served

as Senior Vice President and Chief Technology Officer from January 2017 to January 2018 and served as Vice President, Technology and
Innovation Excellence for Performance Chemicals from March 2015 to January 2017. Prior to joining OMNOVA, Mr. Moore served in a range of
leadership roles at Chemtura Corporation including Director of Research & Development, Advocacy and Marketing from September 2008 to
December of 2014, and Vice President of Quality and Process Excellence from July 2003 to August 2008. Prior roles included Global
Technology Director and Six Sigma Master Black Belt at GE Specialty Chemicals from February 2000 to July 2003, and Global Product Design
Leader at GE Plastics from to 1996 to 2000.

Michael A. Quinn, age 55, Senior Vice President and Chief Human Resources Officer since October 2013. Prior to joining OMNOVA, Mr.
Quinn spent 28 years in human resources positions with high technology, manufacturing, and service companies. Most recently, Mr. Quinn had
served since January 2009 as Vice President, Human Resources for the Specialty Diagnostics Group of Thermo Fisher Scientific (the world
leader in serving science through products and services that help customers solve complex analytical challenges, improve patient diagnostics,
and increase laboratory productivity). Previously, Mr. Quinn had served as Vice President, Talent Management and Development for Thermo
Fisher Scientific since June 2007. Before joining Thermo Fisher Scientific, Mr. Quinn spent four years as Director, Talent Acquisition and
Development for the Integrated Defense Systems business of Raytheon Company (a leading defense and aerospace company).

The Company’s executive officers generally hold terms of office of one year and/or until their successors are elected.

The information required by this item is set forth in the following sections of OMNOVA’s Definitive Proxy Statement for the 2019 Annual

Meeting of Shareholders to be held March 20, 2019 (the “2019 Proxy Statement”) and these sections are incorporated herein by reference:

• “Nominees for election at this Annual Meeting”

• “Continuing directors not up for election”

• “Ownership of OMNOVA Equity Securities - Section 16(a) beneficial ownership reporting compliance”

• “Corporate Governance Documents - Business Conduct Policies (Code of Ethics)”

• “Audit Matters - Audit committee independence and financial experts”

OMNOVA expects to file the 2019 Proxy Statement with the SEC on or before February 8, 2019. Any amendment to, or waiver from a
provision of, the Code of Ethics that applies to its Chief Executive Officer, Chief Financial Officer, or any other executive officer or director, will be
promptly disclosed on its website (www.omnova.com) as required by laws, rules and regulations of the SEC.

Item 11. Executive Compensation

The information required by this item is set forth in the following sections of the 2019 Proxy Statement and these sections are incorporated

herein by reference:

• “Compensation Discussion & Analysis”

• “Compensation of Executive Officers”

• “Compensation & Organization Committee Report”

• “Corporate Governance and the Board - Risk management - Oversight of compensation practices and risks”

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

The information required by this item is set forth in the section captioned “Ownership of OMNOVA Equity Securities” of the 2019 Proxy

Statement and is incorporated herein by reference.

Equity Compensation Plan Information

OMNOVA is currently authorized to issue its common shares under OMNOVA’s 2017 Equity Incentive Plan (approved by the Company's

shareholders in 2017), Third Amended and Restated 1999 Equity and Performance Incentive Plan (approved by the Company’s shareholders in
2012), and OMNOVA’s Employee Share Purchase Plan (approved by the Company’s shareholders in 2016).

The following table sets forth certain information as of November 30, 2018 concerning those plans:

Plan Category

Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights

Weighted average
grant date fair value
of options, warrants
and rights

Number of securities
remaining available
for issuance under
equity compensation
plans

Equity compensation plans approved by security holders .........

Equity compensation plans not approved by security holders ...

Total ...........................................................................................

689,848

N/A

689,848

$8.81

N/A

$8.81

1,949,126

N/A

1,949,126

Item 13. Certain Relationships and Related Transactions, Director Independence

The information required by this item is set forth in the following sections of the 2019 Proxy Statement and these sections are incorporated

herein by reference:

• “Corporate Governance and the Board - Director independence”

• “Corporate Governance and the Board - Related-party transactions”

Item 14. Principal Accountant Fees and Services

The information required by this item is set forth in the section captioned “Audit Matters” of the 2019 Proxy Statement and is incorporated

herein by reference.

Item 15. Exhibits and Financial Statement Schedules

(a)(1) Consolidated Financial Statements:

PART IV

The following consolidated financial statements of OMNOVA Solutions Inc. are included in Item 8:

Consolidated Statements of Operations for the years ended November 30, 2018, 2017, and 2016
Consolidated Statements of Comprehensive Income (Loss) for the years ended November 30, 2018, 2017, and 2016
Consolidated Balance Sheets at November 30, 2018 and 2017
Consolidated Statements of Shareholders’ Equity for the years ended November 30, 2018, 2017, and 2016
Consolidated Statements of Cash Flows for the years ended November 30, 2018, 2017, and 2016
Notes to Consolidated Financial Statements

(a)(2) Schedules

All schedules for which provision is made in the applicable accounting regulation of the Securities and Exchange Commission are either
presented in the Company's consolidated financial statements or are not required under the related instructions or are inapplicable and therefore
have been omitted.

(a)(3) Exhibits

Exhibit Description

CHARTER DOCUMENTS

EXHIBIT INDEX

3.1

3.2

10.1†

10.2†

10.3†

10.4†

10.5†

10.6†

10.7†

10.8†

10.9†

10.10†

10.11†

10.12†

Amended and Restated Articles of Incorporation of OMNOVA Solutions Inc. (incorporated by reference to the same
numbered exhibit to the Company’s Annual Report on Form 10-Q for the fiscal quarter ended May 31, 2016 (File No.
1-15147)).

Amended and Restated Code of Regulations of OMNOVA Solutions Inc. (incorporated by reference to the same numbered
exhibit to the Company's Annual Report on Form 10-Q for the fiscal quarter ended May 31, 2016 (File No. 1-15147)).

MATERIAL CONTRACTS

Form of Amended and Restated Severance Agreement granted to certain executive officers of OMNOVA Solutions
(incorporated by reference to Exhibit 10.6 to the Company’s Annual Report on Form 10-K for the year ended November 30,
2008 (File No. 1-15147)).

OMNOVA Solutions 2017 Equity Incentive Plan (incorporated by reference to Annex C to the Company's 2017 Proxy
Statement filed with the Securities and Exchange Commission on February 3, 2017 (File No. 1-15147).

OMNOVA Solutions Third Amended and Restated 1999 Equity and Performance Incentive Plan (incorporated by reference
to Appendix C to the Company's 2012 Proxy Statement filed with the Securities and Exchange Commission on February 3,
2012 (File No. 1-15147).

OMNOVA Solutions Deferred Compensation Plan for Nonemployee Directors, as amended and restated effective January
1, 2009 (incorporated by reference to Exhibit 10.8 to the Company’s Annual Report on Form 10-K for the year ended
November 30, 2008 (File No. 1-15147)).

Retirement Plan for Nonemployee Directors of OMNOVA Solutions, as amended and restated effective January 1, 2009
(incorporated by reference to Exhibit 10.9 to the Company’s Annual Report on Form 10-K for the year ended November 30,
2008 (File No. 1-15147)).

Savings Benefits Restoration Plan for Salaried Employees of OMNOVA Solutions (incorporated by reference to Exhibit
10.11 to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).

Pension Benefits Restoration Plan for Salaried Employees of OMNOVA Solutions (incorporated by reference to Exhibit
10.12 to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).

OMNOVA Solutions Amended and Restated Corporate Officers Severance Plan, effective April 1, 2018 (incorporated by
reference to Exhibit 10.13 to the Company’s Quarterly Report on Form 10-Q for the quarter ended May 31, 2018 (File No.
1-15147)).

OMNOVA Solutions Long-Term Incentive Program, as amended and restated effective January 19, 2012 (incorporated by
reference to Appendix B to the Company’s 2012 Proxy Statement filed with the Securities and Exchange Commission on
February 3, 2012 (File No. 1-15147)).

Form of Restricted Share Units Agreement (for restricted share units grants issued to executive officers after January 1,
2018) (incorporated by reference to Exhibit 10.10 to the Company's Annual Report on Form 10-K for the year ended
November 30, 2017 (File No. 1-15147)).

Form of Performance Shares Agreement (for performance share grants issued to executive officers after January 1, 2018)
(incorporated by reference to Exhibit 10.11 to the Company's Annual Report on Form 10-K for the year ended November
30, 2017 (File No. 1-15147)).

Form of Restricted Share Units Agreement (for restricted share units grants issued to non-executive directors after January
1, 2018) (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K for the year ended
November 30, 2017 (File No. 1-15147)).

10.13†

10.14†

10.15†

10.16†

10.17†

10.18†

10.19†

10.20

10.21

10.22

10.23

10.24

10.25

10.26

10.27

Form of Deferred Share Agreement (incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form
10-K for the year ended November 30, 2009 (File No. 1-15147)).

Form of Performance Share Agreement (incorporated by reference to Exhibit 10.23 to the Company’s Annual Report on
Form 10-K for the year ended November 30, 2012 (File No. 1-15147)).

Form of Restricted Stock Agreement (incorporated by reference to Exhibit 10.24 to the Company’s Annual Report on Form
10-K for the year ended November 30, 2011 (File No. 1-15147)).

Form of Restricted Share Units Agreement (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on
Form 10-K for the year ended November 30, 2016 (File No. 1-15147)).

Form of Indemnification Agreement by and among OMNOVA Solutions Inc. and the directors and officers of the Company
(incorporated by reference to Exhibit 10.39 to the Company’s Annual Report on Form 10-K for the year ended November
30, 2015).

OMNOVA Solutions Inc. Annual Incentive Plan (incorporated by reference to Annex A to the Company’s 2017 Proxy
Statement filed with the Securities and Exchange Commission on February 3, 2017 (File No. 1-15147)).

Chief Executive Officer Employment Agreement dated December 1, 2016 by and between OMNOVA Solutions Inc. and
Anne P. Noonan (incorporated by reference to Exhibit 10.15 to the Company's Annual Report on Form 10-K for the year
ended November 30, 2016).

Second Amended and Restated Term Loan Credit Agreement dated as of December 9, 2010 by and among OMNOVA
Solutions Inc., as Borrower, the financial institutions party thereto as Lenders, and Deutsche Bank Trust Company
Americas, as agent for the Lenders (incorporated by reference to Exhibit 10.30 to the Company’s Annual Report on
Form 10-K for the year ended November 30, 2010 (File No. 1-15147)).

Amendment dated March 7, 2013, to Second Amended and Restated Term Loan Credit Agreement dated as of December
9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and
Deutsche Bank Trust Company Americas, as agent for the Lenders (incorporated by reference to Exhibit 10.33 to the
Company’s Annual Report on Form 10-K for the year ended November 30, 2013 (File No. 1-15147)).

Amendment No. 2, dated March 28, 2014, to Second Amended and Restated Term Loan Credit Agreement dated as of
December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders,
and Deutsche Bank Trust Company Americas, as agent for the Lenders (incorporated by reference to Exhibit 10.35 to the
Company’s Annual Report on Form 10-K for the year ended November 30, 2014 (File No. 1-15147)).

Amendment No. 3, dated August 26, 2016, to Second Amended and Restated Credit Agreement dated as of December 9,
2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and
Deutsche Bank Trust Company Americas, as agent for the Lenders (incorporated by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the quarter ended August 31, 2016 (File No. 1-15147)).

Amendment No. 4, dated March 2, 2018, to Second Amended and Restated Credit Agreement dated as of December 9,
2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and
Deutsche Bank Trust Company Americas, as agent for the Lenders (incorporated by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the quarter ended May 31, 2018 (File No. 1-15147)).

Consent to Limited Release of Collateral, dated November 21, 2014, to Second Amended and Restated Term Loan Credit
Agreement dated as of December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions
party thereto, as Lenders, and Deutsche Bank Trust Company Americas, as agent for the Lenders (incorporated by
reference to Exhibit 10.36 to the Company’s Annual Report on Form 10-K for the year ended November 30, 2014 (File No.
1-15147)).

Third Amended and Restated Senior Secured Credit Facility dated as of November 30, 2016 by and among OMNOVA
Solutions Inc. as borrower, the financial institutions party thereto as lenders, and JPMorgan Chase Bank N.A., as agent for
the lenders (incorporated by reference to Exhibit 10.20 to the Company's Annual Report on Form 10-K for the year ended
November 30, 2016 (File No. 1-15147).

Amendment No. 1, dated May 31, 2018, to Third Amended and Restated Senior Secured Credit Facility dated as of
November 30, 2016, by and among OMNOVA Solutions Inc. as borrower, the financial institutions party thereto as lenders,
and JPMorgan Chase Bank N.A., as agent for the lenders (incorporated by reference to Exhibit 10.2 to the Company's
Quarterly Report on Form 10-Q for the quarter ended May 31, 2018 (File No. 1-15147)).

SUBSIDIARIES OF THE REGISTRANT

21.1

Listing of Subsidiaries.

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

23.1

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.

POWER OF ATTORNEY

24.1

Powers of Attorney.

CERTIFICATIONS

31.1

31.2

32.1

101

Principal Executive Officer’s Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Principal Financial Officer’s Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

The following financial information from our Annual Report on Form 10-K for 2018, filed with the SEC on January 31, 2019,
formatted in XBRL: (i) the Consolidated Statements of Operations for the years ended November 30, 2018, 2017, and
2016; (ii) the Consolidated Statements of Comprehensive Income (Loss) for the years ended November 30, 2018, 2017,
and 2016; (iii) the Consolidated Balance Sheets at November 30, 2018 and 2017; (iv) the Consolidated Statements of
Shareholders’ Equity for the years ended November 30, 2018, 2017, and 2016; (v) the Consolidated Statements of Cash
Flows for the years ended November 30, 2018, 2017, and 2016; and (vi) the Notes to the Consolidated Financial
Statements.

The Company will supply copies of any of the foregoing exhibits to any shareholder upon receipt of a written request
addressed to OMNOVA Solutions Inc., 25435 Harvard Road, Beachwood, Ohio 44122-6201, Attention: Corporate
Secretary, and payment of $1 per page to help defray the costs of handling, copying, and return postage.

†

Management contract or compensatory arrangement.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to

be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

Date:

January 31, 2019

OMNOVA Solutions Inc.

/s/ Anne P. Noonan

Anne P. Noonan
President and Chief Executive Officer and Director
(Principal Executive Officer)

/s/ Paul F. DeSantis

Paul F. DeSantis
Senior Vice President and Chief Financial Officer;
Treasurer
(Principal Financial Officer)

/s/ Donald B. McMillan

Donald B. McMillan
Vice President, Chief Accounting Officer
(Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf

of the registrant and in the capacities and on the dates indicated.

Signature

Title

Date

William R. Seelbach

D. J. D’Antoni

Janet Plaut Giesselman

Joseph M. Gingo

Michael J. Merriman

James A. Mitarotonda

Steven W. Percy

Larry B. Porcellato

Allan R. Rothwell

*Signed by the undersigned as attorney-in-fact and
agent for the Directors indicated.

/s/ James C. LeMay

James C. LeMay

Chairman and Director

January 31, 2019

Director

January 31, 2019

Exhibit 31.1

I, Anne P. Noonan, certify that:

CERTIFICATIONS

I have reviewed this Annual Report on Form 10-K of OMNOVA Solutions Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period
in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over
financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and

any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.

Date:

January 31, 2019

/s/ Anne P. Noonan

Name: Anne P. Noonan

Title: President and Chief Executive Officer

Exhibit 31.2

I, Paul F. DeSantis, certify that:

CERTIFICATIONS

I have reviewed this Annual Report on Form 10-K of OMNOVA Solutions Inc.;

any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.

Date:

January 31, 2019

/s/ Paul F. DeSantis

Name: Paul F. DeSantis

Senior Vice President and Chief Financial Officer; Treasurer

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.1

In connection with the Annual Report of OMNOVA Solutions Inc. (the “Company”) on Form 10-K for the year ended
November 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the
undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results
of operations of the Company as of the dates and for the periods expressed in the Report.

Date:

January 31, 2019

/s/ Anne P. Noonan

Name: Anne P. Noonan

Title:

President and Chief Executive Officer

/s/ Paul F. DeSantis

Name:

Paul F. DeSantis

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the
Report or as a separate disclosure document.

Title:

Senior Vice President and Chief Financial Officer; Treasurer